Microsatellite regions in the type II transforming growth factor - beta receptor ( TGF - beta RII) gene appear to be targets for mutation in some cancers displaying microsatellite instability ( replication error phenotype, RER +).	"type II transforming growth factor - beta receptor	30	80	Gene_or_gene_product"	"TGF - beta RII	83	97	Gene_or_gene_product"	"cancers	146	153	Cancer"	"[{""token"": ""type II transforming growth factor - beta receptor"", ""start_span"": 30, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF - beta RII"", ""start_span"": 83, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancers"", ""start_span"": 146, ""end_span"": 153, ""type"": ""Cancer""}]"
Furthermore, TGF - beta RII mutations in RER + tumors have been associated with decreased TGF - beta RII mRNA levels.	"TGF - beta RII	13	27	Gene_or_gene_product"	"RER + tumors	41	53	Cancer"	"TGF - beta RII	90	104	Gene_or_gene_product"	"[{""token"": ""TGF - beta RII"", ""start_span"": 13, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""RER + tumors"", ""start_span"": 41, ""end_span"": 53, ""type"": ""Cancer""}, {""token"": ""TGF - beta RII"", ""start_span"": 90, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}]"
As TGF - beta is a potent negative growth regulator of hematopoietic cells, investigations were undertaken to determine whether inactivation of the receptor by microsatellite alteration might be involved in the progression of CML.	"TGF - beta	3	13	Gene_or_gene_product"	"hematopoietic cells	55	74	Cell"	"CML	226	229	Cancer"	"[{""token"": ""TGF - beta"", ""start_span"": 3, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""hematopoietic cells"", ""start_span"": 55, ""end_span"": 74, ""type"": ""Cell""}, {""token"": ""CML"", ""start_span"": 226, ""end_span"": 229, ""type"": ""Cancer""}]"
However, during each phase of the disease, low levels of TGF - beta RII were detected when compared with the hematopoietic cells of normal donors.	"TGF - beta RII	57	71	Gene_or_gene_product"	"hematopoietic cells	109	128	Cell"	"donors	139	145	Organism"	"[{""token"": ""TGF - beta RII"", ""start_span"": 57, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""hematopoietic cells"", ""start_span"": 109, ""end_span"": 128, ""type"": ""Cell""}, {""token"": ""donors"", ""start_span"": 139, ""end_span"": 145, ""type"": ""Organism""}]"
The leukemia cell lines K562 and HL - 60 had no detectable TGF - beta RII mRNA.	"leukemia cell lines K562	4	28	Cell"	"HL - 60	33	40	Cell"	"TGF - beta RII	59	73	Gene_or_gene_product"	"[{""token"": ""leukemia cell lines K562"", ""start_span"": 4, ""end_span"": 28, ""type"": ""Cell""}, {""token"": ""HL - 60"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Cell""}, {""token"": ""TGF - beta RII"", ""start_span"": 59, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}]"
Decreased expression of TGF - beta RII in CML cells and leukemia cell lines raises the possibility that altered expression of the receptor may play a role in the initiation and / or maintenance of the disease state.	"TGF - beta RII	24	38	Gene_or_gene_product"	"CML cells	42	51	Cell"	"leukemia cell lines	56	75	Cell"	"[{""token"": ""TGF - beta RII"", ""start_span"": 24, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""CML cells"", ""start_span"": 42, ""end_span"": 51, ""type"": ""Cell""}, {""token"": ""leukemia cell lines"", ""start_span"": 56, ""end_span"": 75, ""type"": ""Cell""}]"
Treatment with tunicamycin produced a 40 - 50% inhibition of 2 - deoxyglucose uptake and this was associated with a 2 - 2. 5 - fold decrease in transporter affinity for glucose ( Km) without a change in Vmax.	"tunicamycin	15	26	Chemical"	"2 - deoxyglucose	61	77	Chemical"	"glucose	169	176	Chemical"	"[{""token"": ""tunicamycin"", ""start_span"": 15, ""end_span"": 26, ""type"": ""Chemical""}, {""token"": ""2 - deoxyglucose"", ""start_span"": 61, ""end_span"": 77, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 169, ""end_span"": 176, ""type"": ""Chemical""}]"
Treatment of K562 cells with tunicamycin for 18 h, resulted in extensive loss of the 50 - 60 kDa glycoprotein, appearance of a 30 - 40 kDa band and increased staining of a 45 kDa band.	"K562 cells	13	23	Cell"	"tunicamycin	29	40	Chemical"	"glycoprotein	97	109	Gene_or_gene_product"	"[{""token"": ""K562 cells"", ""start_span"": 13, ""end_span"": 23, ""type"": ""Cell""}, {""token"": ""tunicamycin"", ""start_span"": 29, ""end_span"": 40, ""type"": ""Chemical""}, {""token"": ""glycoprotein"", ""start_span"": 97, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}]"
In contrast, tunicamycin had little effect on the viability and MTT responses of the cells used.	"tunicamycin	13	24	Chemical"	"MTT	64	67	Chemical"	"cells	85	90	Cell"	"[{""token"": ""tunicamycin"", ""start_span"": 13, ""end_span"": 24, ""type"": ""Chemical""}, {""token"": ""MTT"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Chemical""}, {""token"": ""cells"", ""start_span"": 85, ""end_span"": 90, ""type"": ""Cell""}]"
We examined the expression of nm23 - H1 gene product in surgically resected 46 pairs of primary lung cancers and metastatic lymph nodes by immunohistochemistry.	"nm23 - H1	30	39	Gene_or_gene_product"	"lung cancers	96	108	Cancer"	"lymph nodes	124	135	Multi"	"[{""token"": ""nm23 - H1"", ""start_span"": 30, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""lung cancers"", ""start_span"": 96, ""end_span"": 108, ""type"": ""Cancer""}, {""token"": ""lymph nodes"", ""start_span"": 124, ""end_span"": 135, ""type"": ""Multi""}]"
The positive staining of nm23 - H1 gene product in primary cancers and metastatic lymph nodes were observed in 56. 5 and 67. 4%, respectively.	"nm23 - H1	25	34	Gene_or_gene_product"	"primary cancers	51	66	Cancer"	"lymph nodes	82	93	Multi"	"[{""token"": ""nm23 - H1"", ""start_span"": 25, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""primary cancers"", ""start_span"": 51, ""end_span"": 66, ""type"": ""Cancer""}, {""token"": ""lymph nodes"", ""start_span"": 82, ""end_span"": 93, ""type"": ""Multi""}]"
The heterogeneity of nm23 - H1 gene product expression between primary cancers and metastatic lymph nodes was observed in 41. 3%.	"nm23 - H1	21	30	Gene_or_gene_product"	"primary cancers	63	78	Cancer"	"lymph nodes	94	105	Multi"	"[{""token"": ""nm23 - H1"", ""start_span"": 21, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""primary cancers"", ""start_span"": 63, ""end_span"": 78, ""type"": ""Cancer""}, {""token"": ""lymph nodes"", ""start_span"": 94, ""end_span"": 105, ""type"": ""Multi""}]"
No correlations were found between the nm23 - H1 gene product expression in lung cancers and the patients survival.	"nm23 - H1	39	48	Gene_or_gene_product"	"lung cancers	76	88	Cancer"	"patients	97	105	Organism"	"[{""token"": ""nm23 - H1"", ""start_span"": 39, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""lung cancers"", ""start_span"": 76, ""end_span"": 88, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 97, ""end_span"": 105, ""type"": ""Organism""}]"
No significant association was also observed between nm23 - H1 gene product expression in lymph nodes and the patients survival.	"nm23 - H1	53	62	Gene_or_gene_product"	"lymph nodes	90	101	Multi"	"patients	110	118	Organism"	"[{""token"": ""nm23 - H1"", ""start_span"": 53, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph nodes"", ""start_span"": 90, ""end_span"": 101, ""type"": ""Multi""}, {""token"": ""patients"", ""start_span"": 110, ""end_span"": 118, ""type"": ""Organism""}]"
Expression of nm23 - H1 gene product in metastatic lymph nodes was also unrelated to patients survival.	"nm23 - H1	14	23	Gene_or_gene_product"	"lymph nodes	51	62	Multi"	"patients	85	93	Organism"	"[{""token"": ""nm23 - H1"", ""start_span"": 14, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph nodes"", ""start_span"": 51, ""end_span"": 62, ""type"": ""Multi""}, {""token"": ""patients"", ""start_span"": 85, ""end_span"": 93, ""type"": ""Organism""}]"
Bradycardia was induced in rats by administering the bradycardic drug alinidine ( 3 mg / kg body weight) twice daily.	"rats	27	31	Organism"	"alinidine	70	79	Chemical"	"body	92	96	Organism_subdivision"	"[{""token"": ""rats"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Organism""}, {""token"": ""alinidine"", ""start_span"": 70, ""end_span"": 79, ""type"": ""Chemical""}, {""token"": ""body"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Organism_subdivision""}]"
Left ventricular capillary length density ( mm / mm ( 3)) increased gradually with alinidine administration; a 15% increase after 2 weeks and a 40% increase after 3 weeks of alinidine treatment were documented.	"Left ventricular capillary	0	26	Tissue"	"alinidine	83	92	Chemical"	"alinidine	174	183	Chemical"	"[{""token"": ""Left ventricular capillary"", ""start_span"": 0, ""end_span"": 26, ""type"": ""Tissue""}, {""token"": ""alinidine"", ""start_span"": 83, ""end_span"": 92, ""type"": ""Chemical""}, {""token"": ""alinidine"", ""start_span"": 174, ""end_span"": 183, ""type"": ""Chemical""}]"
Left ventricular weight, body weight, and their ratio were not significantly altered by alinidine treatment.	"Left ventricular	0	16	Multi"	"body	25	29	Organism_subdivision"	"alinidine	88	97	Chemical"	"[{""token"": ""Left ventricular"", ""start_span"": 0, ""end_span"": 16, ""type"": ""Multi""}, {""token"": ""body"", ""start_span"": 25, ""end_span"": 29, ""type"": ""Organism_subdivision""}, {""token"": ""alinidine"", ""start_span"": 88, ""end_span"": 97, ""type"": ""Chemical""}]"
VEGF protein was higher in alinidine - treated rats than in controls after 2 weeks and increased further after 3 weeks of treatment.	"VEGF	0	4	Gene_or_gene_product"	"alinidine	27	36	Chemical"	"rats	47	51	Organism"	"[{""token"": ""VEGF"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""alinidine"", ""start_span"": 27, ""end_span"": 36, ""type"": ""Chemical""}, {""token"": ""rats"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Organism""}]"
This first analysis is based on 73 patients ( 50 women, 23 men, median age 74. 3 years), with a median follow - up of 13. 3 months and a minimum follow - up of 11 months.	"patients	35	43	Organism"	"women	49	54	Organism"	"men	59	62	Organism"	"[{""token"": ""patients"", ""start_span"": 35, ""end_span"": 43, ""type"": ""Organism""}, {""token"": ""women"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Organism""}, {""token"": ""men"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Organism""}]"
Insulin - induced vascular endothelial growth factor expression in retina.	"Insulin	0	7	Gene_or_gene_product"	"vascular endothelial growth factor	18	52	Gene_or_gene_product"	"retina	67	73	Multi"	"[{""token"": ""Insulin"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 18, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""retina"", ""start_span"": 67, ""end_span"": 73, ""type"": ""Multi""}]"
The mechanisms underlying the initial insulin - induced deterioration of retinal status in patients with diabetes remain unknown.	"insulin	38	45	Gene_or_gene_product"	"retinal	73	80	Multi"	"patients	91	99	Organism"	"[{""token"": ""insulin"", ""start_span"": 38, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""retinal"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Multi""}, {""token"": ""patients"", ""start_span"": 91, ""end_span"": 99, ""type"": ""Organism""}]"
The current study was conducted to characterize the effect of insulin on retinal VEGF gene expression in vitro and in vivo.	"insulin	62	69	Gene_or_gene_product"	"retinal	73	80	Multi"	"VEGF	81	85	Gene_or_gene_product"	"[{""token"": ""insulin"", ""start_span"": 62, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""retinal"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Multi""}, {""token"": ""VEGF"", ""start_span"": 81, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}]"
The capacity of insulin to stimulate the VEGF promoter linked to a luciferase reporter gene was characterized in transient transfection assays.	"insulin	16	23	Gene_or_gene_product"	"VEGF	41	45	Gene_or_gene_product"	"luciferase	67	77	Gene_or_gene_product"	"[{""token"": ""insulin"", ""start_span"": 16, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""luciferase"", ""start_span"": 67, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}]"
Insulin treatment also increased VEGF protein levels in conditioned RPE cell media in a dose - dependent manner with a median effective concentration of 5 nM.	"Insulin	0	7	Gene_or_gene_product"	"VEGF	33	37	Gene_or_gene_product"	"RPE cell	68	76	Cell"	"[{""token"": ""Insulin"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""RPE cell"", ""start_span"": 68, ""end_span"": 76, ""type"": ""Cell""}]"
The antiangiogenic agent linomide inhibits the growth rate of von Hippel - Lindau paraganglioma xenografts to mice.	"linomide	25	33	Chemical"	"von Hippel - Lindau paraganglioma xenografts	62	106	Cancer"	"mice	110	114	Organism"	"[{""token"": ""linomide"", ""start_span"": 25, ""end_span"": 33, ""type"": ""Chemical""}, {""token"": ""von Hippel - Lindau paraganglioma xenografts"", ""start_span"": 62, ""end_span"": 106, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Organism""}]"
In addition, LMP1 plays pleiotropic roles in cell growth arrest, differentiation, and apoptosis, depending on the background of the target cells.	"LMP1	13	17	Gene_or_gene_product"	"cell	45	49	Cell"	"cells	139	144	Cell"	"[{""token"": ""LMP1"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 139, ""end_span"": 144, ""type"": ""Cell""}]"
In addition, it significantly extends the passage number of MEF cells to more than 30 after retroviral infection, compared with less than 5 for uninfected MEF cells.	"MEF cells	60	69	Cell"	"retroviral	92	102	Organism"	"MEF cells	155	164	Cell"	"[{""token"": ""MEF cells"", ""start_span"": 60, ""end_span"": 69, ""type"": ""Cell""}, {""token"": ""retroviral"", ""start_span"": 92, ""end_span"": 102, ""type"": ""Organism""}, {""token"": ""MEF cells"", ""start_span"": 155, ""end_span"": 164, ""type"": ""Cell""}]"
Autotaxin ( ATX), an exo - nucleotide pyrophosphatase and phosphodiesterase, was originally isolated as a potent stimulator of tumor cell motility.	"Autotaxin	0	9	Gene_or_gene_product"	"ATX	12	15	Gene_or_gene_product"	"tumor cell	127	137	Cell"	"[{""token"": ""Autotaxin"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""ATX"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cell"", ""start_span"": 127, ""end_span"": 137, ""type"": ""Cell""}]"
In MatrigelTM invasion assays, all subclones, which secreted enzymatically active ATX, demonstrated greater spontaneous and ATX - stimulated invasion than appropriate controls.	"subclones	35	44	Cell"	"ATX	82	85	Gene_or_gene_product"	"ATX	124	127	Gene_or_gene_product"	"[{""token"": ""subclones"", ""start_span"": 35, ""end_span"": 44, ""type"": ""Cell""}, {""token"": ""ATX"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""ATX"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}]"
In vivo studies with athymic nude mice demonstrated that injection of atx - transfected NIH3T3 cells resulted in a weak tumorigenic capacity with few experimental metastases.	"athymic nude mice	21	38	Organism"	"atx	70	73	Gene_or_gene_product"	"NIH3T3 cells	88	100	Cell"	"[{""token"": ""athymic nude mice"", ""start_span"": 21, ""end_span"": 38, ""type"": ""Organism""}, {""token"": ""atx"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""NIH3T3 cells"", ""start_span"": 88, ""end_span"": 100, ""type"": ""Cell""}]"
Thus, ATX appears to augment cellular characteristics necessary for tumor aggressiveness.	"ATX	6	9	Gene_or_gene_product"	"cellular	29	37	Cell"	"tumor	68	73	Cancer"	"[{""token"": ""ATX"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 68, ""end_span"": 73, ""type"": ""Cancer""}]"
We have previously characterized the structure of a gene in A - 172 human glioma cells that encodes a 190 - kDa EGFR mutant with tandem duplication of the tyrosine kinase ( TK) and calcium - mediated internalization ( CAIN) domains.	"A - 172 human glioma cells	60	86	Cell"	"EGFR	112	116	Gene_or_gene_product"	"calcium	181	188	Chemical"	"[{""token"": ""A - 172 human glioma cells"", ""start_span"": 60, ""end_span"": 86, ""type"": ""Cell""}, {""token"": ""EGFR"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""calcium"", ""start_span"": 181, ""end_span"": 188, ""type"": ""Chemical""}]"
Fluroquinolone antibiotics such as ciprofloxacin, which can be administered p. o., may have a profound effect in bladder cancer management.	"Fluroquinolone	0	14	Chemical"	"ciprofloxacin	35	48	Chemical"	"bladder cancer	113	127	Cancer"	"[{""token"": ""Fluroquinolone"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Chemical""}, {""token"": ""ciprofloxacin"", ""start_span"": 35, ""end_span"": 48, ""type"": ""Chemical""}, {""token"": ""bladder cancer"", ""start_span"": 113, ""end_span"": 127, ""type"": ""Cancer""}]"
Recent studies revealed that p21WAF1 protects cells from apoptosis by arresting them in G1 and further binds to pro - caspase - 3, preventing its activation and thus, inhibiting the apoptotic cascade.	"p21WAF1	29	36	Gene_or_gene_product"	"cells	46	51	Cell"	"pro - caspase - 3	112	129	Gene_or_gene_product"	"[{""token"": ""p21WAF1"", ""start_span"": 29, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Cell""}, {""token"": ""pro - caspase - 3"", ""start_span"": 112, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}]"
The results of our current studies provide strong experimental evidence for the use of ciprofloxacin as a potential preventive and / or therapeutic agent for the management of transitional cell carcinoma of the bladder.	"ciprofloxacin	87	100	Chemical"	"transitional cell carcinoma	176	203	Cancer"	"bladder	211	218	Organ"	"[{""token"": ""ciprofloxacin"", ""start_span"": 87, ""end_span"": 100, ""type"": ""Chemical""}, {""token"": ""transitional cell carcinoma"", ""start_span"": 176, ""end_span"": 203, ""type"": ""Cancer""}, {""token"": ""bladder"", ""start_span"": 211, ""end_span"": 218, ""type"": ""Organ""}]"
The hypothesis that modifications of activity and / or expression of nitric oxide synthase ( NOS) isozymes might play a role in these modifications, via enhanced local production of nitric oxide, was tested in this study.	"nitric oxide synthase	69	90	Gene_or_gene_product"	"NOS	93	96	Gene_or_gene_product"	"nitric oxide	182	194	Chemical"	"[{""token"": ""nitric oxide synthase"", ""start_span"": 69, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""NOS"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}, {""token"": ""nitric oxide"", ""start_span"": 182, ""end_span"": 194, ""type"": ""Chemical""}]"
Peritoneal NOS activity is increased fivefold in long - term PD patients compared with control subjects.	"Peritoneal	0	10	Multi"	"NOS	11	14	Gene_or_gene_product"	"patients	64	72	Organism"	"[{""token"": ""Peritoneal"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Multi""}, {""token"": ""NOS"", ""start_span"": 11, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 64, ""end_span"": 72, ""type"": ""Organism""}]"
Increased NOS activity is mediated solely by Ca ( 2 +) - dependent NOS and, as shown by immunoblotting, an upregulation of endothelial NOS.	"NOS	10	13	Gene_or_gene_product"	"NOS	67	70	Gene_or_gene_product"	"endothelial NOS	123	138	Gene_or_gene_product"	"[{""token"": ""NOS"", ""start_span"": 10, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""NOS"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial NOS"", ""start_span"": 123, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}]"
These data provide a morphologic ( angiogenesis and increased endothelial area) and molecular ( enhanced NOS activity and endothelial NOS upregulation) basis for explaining the permeability changes observed in long - term PD.	"endothelial area	62	78	Tissue"	"NOS	105	108	Gene_or_gene_product"	"endothelial NOS	122	137	Gene_or_gene_product"	"[{""token"": ""endothelial area"", ""start_span"": 62, ""end_span"": 78, ""type"": ""Tissue""}, {""token"": ""NOS"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial NOS"", ""start_span"": 122, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}]"
Thus, angiogenesis is a physiologic event in normal postnatal murine skin, apparently is dictated by the hair follicle, and appears to be required for normal anagen development.	"murine	62	68	Organism"	"skin	69	73	Organ"	"hair follicle	105	118	Multi"	"[{""token"": ""murine"", ""start_span"": 62, ""end_span"": 68, ""type"": ""Organism""}, {""token"": ""skin"", ""start_span"": 69, ""end_span"": 73, ""type"": ""Organ""}, {""token"": ""hair follicle"", ""start_span"": 105, ""end_span"": 118, ""type"": ""Multi""}]"
RESULTS: Chang hepatocytes grown in the coculture conditioned media have an increase in TNF - alpha and Fas ligand.	"Chang hepatocytes	9	26	Cell"	"TNF - alpha	88	99	Gene_or_gene_product"	"Fas ligand	104	114	Gene_or_gene_product"	"[{""token"": ""Chang hepatocytes"", ""start_span"": 9, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""TNF - alpha"", ""start_span"": 88, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas ligand"", ""start_span"": 104, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}]"
CONCLUSIONS: Neuroblastoma cells grown in coculture conditioned media show increased expression of Bcl - 2 and decreased Fas ligand levels.	"Neuroblastoma cells	13	32	Cell"	"Bcl - 2	99	106	Gene_or_gene_product"	"Fas ligand	121	131	Gene_or_gene_product"	"[{""token"": ""Neuroblastoma cells"", ""start_span"": 13, ""end_span"": 32, ""type"": ""Cell""}, {""token"": ""Bcl - 2"", ""start_span"": 99, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas ligand"", ""start_span"": 121, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}]"
A tumor ' s ability to successfully metastasize may be dependent on mediators generated in the tumor - host interaction, and may not be just an independent characteristic of the tumor itself.	"tumor	2	7	Cancer"	"tumor	95	100	Cancer"	"tumor	178	183	Cancer"	"[{""token"": ""tumor"", ""start_span"": 2, ""end_span"": 7, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 178, ""end_span"": 183, ""type"": ""Cancer""}]"
Notch proteins are plasma membrane - spanning receptors that mediate important cell fate decisions such as differentiation, proliferation, and apoptosis.	"Notch	0	5	Gene_or_gene_product"	"plasma membrane	19	34	Cellular_component"	"cell	79	83	Cell"	"[{""token"": ""Notch"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""plasma membrane"", ""start_span"": 19, ""end_span"": 34, ""type"": ""Cellular_component""}, {""token"": ""cell"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Cell""}]"
The prevailing model for Notch signaling suggests that ligand, presented on a neighboring cell, triggers proteolytic processing of Notch.	"Notch	25	30	Gene_or_gene_product"	"cell	90	94	Cell"	"Notch	131	136	Gene_or_gene_product"	"[{""token"": ""Notch"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Cell""}, {""token"": ""Notch"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}]"
Following proteolysis, it is thought that the intracellular portion of Notch ( N ( ic)) translocates to the nucleus, where it is involved in regulating gene expression.	"intracellular	46	59	Immaterial_anatomical_entity"	"Notch	71	76	Gene_or_gene_product"	"nucleus	108	115	Cellular_component"	"[{""token"": ""intracellular"", ""start_span"": 46, ""end_span"": 59, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""Notch"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""nucleus"", ""start_span"": 108, ""end_span"": 115, ""type"": ""Cellular_component""}]"
There is considerable debate concerning where in the cell Notch functions and what proteins serve as effectors of the Notch signal.	"cell	53	57	Cell"	"Notch	58	63	Gene_or_gene_product"	"Notch	118	123	Gene_or_gene_product"	"[{""token"": ""cell"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Cell""}, {""token"": ""Notch"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""Notch"", ""start_span"": 118, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}]"
Activation of Notch proto - oncogenes has been associated with tumorigenesis in several human and other mammalian cancers.	"Notch	14	19	Gene_or_gene_product"	"human	88	93	Organism"	"mammalian cancers	104	121	Cancer"	"[{""token"": ""Notch"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Organism""}, {""token"": ""mammalian cancers"", ""start_span"": 104, ""end_span"": 121, ""type"": ""Cancer""}]"
Alpha - melanocyte - stimulating hormone ( alpha - MSH) has evolved as a mediator of diverse biological activities in an ever - growing number of non - melanocytic cell types.	"Alpha - melanocyte - stimulating hormone	0	40	Gene_or_gene_product"	"alpha - MSH	43	54	Gene_or_gene_product"	"non - melanocytic cell	146	168	Cell"	"[{""token"": ""Alpha - melanocyte - stimulating hormone"", ""start_span"": 0, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""alpha - MSH"", ""start_span"": 43, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""non - melanocytic cell"", ""start_span"": 146, ""end_span"": 168, ""type"": ""Cell""}]"
One mechanism by which alpha - MSH exerts its effects is modulation of AP - 1 and NF - kappa B.	"alpha - MSH	23	34	Gene_or_gene_product"	"AP - 1	71	77	Gene_or_gene_product"	"NF - kappa B	82	94	Gene_or_gene_product"	"[{""token"": ""alpha - MSH"", ""start_span"": 23, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""AP - 1"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappa B"", ""start_span"": 82, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}]"
These effects of alpha - MSH may have important regulatory functions in extracellular matrix composition, wound healing, or angiogenesis.	"alpha - MSH	17	28	Gene_or_gene_product"	"extracellular matrix	72	92	Cellular_component"	"wound	106	111	Pathological_formation"	"[{""token"": ""alpha - MSH"", ""start_span"": 17, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""extracellular matrix"", ""start_span"": 72, ""end_span"": 92, ""type"": ""Cellular_component""}, {""token"": ""wound"", ""start_span"": 106, ""end_span"": 111, ""type"": ""Pathological_formation""}]"
CD40 expression on human lung cancer correlates with metastatic spread.	"CD40	0	4	Gene_or_gene_product"	"human	19	24	Organism"	"lung cancer	25	36	Cancer"	"[{""token"": ""CD40"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Organism""}, {""token"": ""lung cancer"", ""start_span"": 25, ""end_span"": 36, ""type"": ""Cancer""}]"
However, a statistically significant correlation was found between the surface expression of CD40 and the metastatic spread of the tumor.	"surface	71	78	Cellular_component"	"CD40	93	97	Gene_or_gene_product"	"tumor	131	136	Cancer"	"[{""token"": ""surface"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Cellular_component""}, {""token"": ""CD40"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Cancer""}]"
In this study, 14 of 18 lung cancer cell lines ( 78%) expressed CD40 on their surface.	"lung cancer cell lines	24	46	Cell"	"CD40	64	68	Gene_or_gene_product"	"surface	78	85	Cellular_component"	"[{""token"": ""lung cancer cell lines"", ""start_span"": 24, ""end_span"": 46, ""type"": ""Cell""}, {""token"": ""CD40"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""surface"", ""start_span"": 78, ""end_span"": 85, ""type"": ""Cellular_component""}]"
All of the 4 tumors that were CD40 - negative, were stage I tumors, without any evidence of regional or distant metastasis.	"tumors	13	19	Cancer"	"CD40	30	34	Gene_or_gene_product"	"tumors	60	66	Cancer"	"[{""token"": ""tumors"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Cancer""}, {""token"": ""CD40"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 60, ""end_span"": 66, ""type"": ""Cancer""}]"
Of the 14 tumors that expressed CD40, all but 1 ( 93%) had either nodal or systemic metastasis at the time of diagnosis.	"tumors	10	16	Cancer"	"CD40	32	36	Gene_or_gene_product"	"nodal	66	71	Multi"	"[{""token"": ""tumors"", ""start_span"": 10, ""end_span"": 16, ""type"": ""Cancer""}, {""token"": ""CD40"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""nodal"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Multi""}]"
Interleukins ( ILs) may mediate regression or progression of cancer.	"Interleukins	0	12	Gene_or_gene_product"	"ILs	15	18	Gene_or_gene_product"	"cancer	61	67	Cancer"	"[{""token"": ""Interleukins"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""ILs"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Cancer""}]"
Unexpectedly, cells expressing both Ras and TEL grew as aggregates.	"cells	14	19	Cell"	"Ras	36	39	Gene_or_gene_product"	"TEL	44	47	Gene_or_gene_product"	"[{""token"": ""cells"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Cell""}, {""token"": ""Ras"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""TEL"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}]"
TEL bound sequences in the stromelysin - 1 promoter and repressed the promoter in transient - expression assays, suggesting that it is a direct target for TEL - mediated regulation.	"TEL	0	3	Gene_or_gene_product"	"stromelysin - 1	27	42	Gene_or_gene_product"	"TEL	155	158	Gene_or_gene_product"	"[{""token"": ""TEL"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""stromelysin - 1"", ""start_span"": 27, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""TEL"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}]"
Mutants of TEL that removed a binding site for the mSin3A corepressor but retained the ETS domain failed to repress stromelysin - 1.	"TEL	11	14	Gene_or_gene_product"	"mSin3A	51	57	Gene_or_gene_product"	"stromelysin - 1	116	131	Gene_or_gene_product"	"[{""token"": ""TEL"", ""start_span"": 11, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""mSin3A"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""stromelysin - 1"", ""start_span"": 116, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}]"
In addition, TEL inhibited the invasiveness of Ras - transformed cells in vitro and in vivo.	"TEL	13	16	Gene_or_gene_product"	"Ras	47	50	Gene_or_gene_product"	"cells	65	70	Cell"	"[{""token"": ""TEL"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ras"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Cell""}]"
Our results suggest that TEL acts as a tumor suppressor, in part, by transcriptional repression of stromelysin - 1.	"TEL	25	28	Gene_or_gene_product"	"tumor	39	44	Cancer"	"stromelysin - 1	99	114	Gene_or_gene_product"	"[{""token"": ""TEL"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Cancer""}, {""token"": ""stromelysin - 1"", ""start_span"": 99, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}]"
Reconstitution of MCF - 7 cells by stable transfection of CASP - 3 cDNA restores all these defects and results in an extensive apoptosis after cisplatin treatment.	"MCF - 7 cells	18	31	Cell"	"CASP - 3	58	66	Gene_or_gene_product"	"cisplatin	143	152	Chemical"	"[{""token"": ""MCF - 7 cells"", ""start_span"": 18, ""end_span"": 31, ""type"": ""Cell""}, {""token"": ""CASP - 3"", ""start_span"": 58, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""cisplatin"", ""start_span"": 143, ""end_span"": 152, ""type"": ""Chemical""}]"
Reconstitution of MCF - 7 cell extracts with procaspase - 3 corrects this defect, resulting in an efficient and complete processing of procaspase - 9.	"MCF - 7 cell extracts	18	39	Organism_substance"	"procaspase - 3	45	59	Gene_or_gene_product"	"procaspase - 9	135	149	Gene_or_gene_product"	"[{""token"": ""MCF - 7 cell extracts"", ""start_span"": 18, ""end_span"": 39, ""type"": ""Organism_substance""}, {""token"": ""procaspase - 3"", ""start_span"": 45, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""procaspase - 9"", ""start_span"": 135, ""end_span"": 149, ""type"": ""Gene_or_gene_product""}]"
In this study, we have expressed wild - type and mutant forms of VASP in endothelial cells to determine in what aspects of cytoskeletal behavior this protein participates.	"VASP	65	69	Gene_or_gene_product"	"endothelial cells	73	90	Cell"	"cytoskeletal	123	135	Cellular_component"	"[{""token"": ""VASP"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 73, ""end_span"": 90, ""type"": ""Cell""}, {""token"": ""cytoskeletal"", ""start_span"": 123, ""end_span"": 135, ""type"": ""Cellular_component""}]"
Deletion of the proline - rich domain of VASP abolishes its ability to bind profilin but does not affect ruffling or stress fiber formation.	"VASP	41	45	Gene_or_gene_product"	"profilin	76	84	Gene_or_gene_product"	"stress fiber	117	129	Cellular_component"	"[{""token"": ""VASP"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""profilin"", ""start_span"": 76, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""stress fiber"", ""start_span"": 117, ""end_span"": 129, ""type"": ""Cellular_component""}]"
Ruffling occurs only on the expression of forms of VASP that possess bundling activity and the capacity to bind zyxin / vinculin - derived peptide.	"VASP	51	55	Gene_or_gene_product"	"zyxin	112	117	Gene_or_gene_product"	"vinculin	120	128	Gene_or_gene_product"	"[{""token"": ""VASP"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""zyxin"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""vinculin"", ""start_span"": 120, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}]"
uPAR is also coexpressed with caveolin and members of the integrin adhesion receptor superfamily.	"uPAR	0	4	Gene_or_gene_product"	"caveolin	30	38	Gene_or_gene_product"	"integrin adhesion receptor	58	84	Gene_or_gene_product"	"[{""token"": ""uPAR"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""caveolin"", ""start_span"": 30, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""integrin adhesion receptor"", ""start_span"": 58, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}]"
The formation of functional units with these various proteins allows the uPAR to mediate the focused proteolysis required for cell migration and invasion and to contribute both directly and indirectly to cell adhesive processes in a non - proteolytic fashion.	"uPAR	73	77	Gene_or_gene_product"	"cell	126	130	Cell"	"cell	204	208	Cell"	"[{""token"": ""uPAR"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 204, ""end_span"": 208, ""type"": ""Cell""}]"
p75 mediated apoptosis in neuroblastoma cells is inhibited by expression of TrkA.	"p75	0	3	Gene_or_gene_product"	"neuroblastoma cells	26	45	Cell"	"TrkA	76	80	Gene_or_gene_product"	"[{""token"": ""p75"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuroblastoma cells"", ""start_span"": 26, ""end_span"": 45, ""type"": ""Cell""}, {""token"": ""TrkA"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}]"
BACKGROUND: Neurotrophins mediate their effects by binding to members of the Trk family of receptor tyrosine kinases and to the low - affinity nerve growth factor receptor p75.	"Neurotrophins	12	25	Gene_or_gene_product"	"Trk	77	80	Gene_or_gene_product"	"p75	172	175	Gene_or_gene_product"	"[{""token"": ""Neurotrophins"", ""start_span"": 12, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""Trk"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""p75"", ""start_span"": 172, ""end_span"": 175, ""type"": ""Gene_or_gene_product""}]"
Nerve growth factor ( NGF) has been demonstrated to support survival and differentiation of neuroblastoma ( NB) cells by activation of the TrkA receptor.	"Nerve growth factor	0	19	Gene_or_gene_product"	"NGF	22	25	Gene_or_gene_product"	"TrkA	139	143	Gene_or_gene_product"	"[{""token"": ""Nerve growth factor"", ""start_span"": 0, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""NGF"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""TrkA"", ""start_span"": 139, ""end_span"": 143, ""type"": ""Gene_or_gene_product""}]"
RESULTS: Cell clones expressing elevated levels of p75 showed a high degree of apoptosis even in 10% serum - supplemented medium.	"Cell clones	9	20	Cell"	"p75	51	54	Gene_or_gene_product"	"serum	101	106	Organism_substance"	"[{""token"": ""Cell clones"", ""start_span"": 9, ""end_span"": 20, ""type"": ""Cell""}, {""token"": ""p75"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""serum"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Organism_substance""}]"
CONCLUSIONS: Thus, expression of the TrkA receptor itself inhibits p75 mediated apoptosis in NB cells.	"TrkA	37	41	Gene_or_gene_product"	"p75	67	70	Gene_or_gene_product"	"NB cells	93	101	Cell"	"[{""token"": ""TrkA"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""p75"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""NB cells"", ""start_span"": 93, ""end_span"": 101, ""type"": ""Cell""}]"
RNA damage and inhibition of neoplastic endothelial cell growth: effects of human and amphibian ribonucleases.	"neoplastic endothelial cell	29	56	Cell"	"human	76	81	Organism"	"ribonucleases	96	109	Gene_or_gene_product"	"[{""token"": ""neoplastic endothelial cell"", ""start_span"": 29, ""end_span"": 56, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Organism""}, {""token"": ""ribonucleases"", ""start_span"": 96, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}]"
Recombinant EBV containing LMP1 with TES2 deleted induces a limited proliferation of B cells.	"EBV	12	15	Organism"	"LMP1	27	31	Gene_or_gene_product"	"B cells	85	92	Cell"	"[{""token"": ""EBV"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Organism""}, {""token"": ""LMP1"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""B cells"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Cell""}]"
However, it is not sufficient for the immortalization of MEF, and MEF - LMP1 ( TRADD) cells eventually enter growth arrest.	"MEF	57	60	Cell"	"LMP1	72	76	Gene_or_gene_product"	"TRADD	79	84	Gene_or_gene_product"	"[{""token"": ""MEF"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Cell""}, {""token"": ""LMP1"", ""start_span"": 72, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""TRADD"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}]"
The migration of vascular endothelial cells ( ECs) plays an important role in vascular remodeling.	"vascular endothelial cells	17	43	Cell"	"ECs	46	49	Cell"	"vascular	78	86	Multi"	"[{""token"": ""vascular endothelial cells"", ""start_span"": 17, ""end_span"": 43, ""type"": ""Cell""}, {""token"": ""ECs"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Cell""}, {""token"": ""vascular"", ""start_span"": 78, ""end_span"": 86, ""type"": ""Multi""}]"
TSP - 2 deficiency dramatically enhanced susceptibility to skin carcinogenesis and resulted in accelerated and increased tumor formation.	"TSP - 2	0	7	Gene_or_gene_product"	"skin	59	63	Organ"	"tumor	121	126	Cancer"	"[{""token"": ""TSP - 2"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""skin"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Organ""}, {""token"": ""tumor"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Cancer""}]"
While TSP - 2 deficiency did not affect tumor differentiation or proliferation, tumor cell apoptosis was significantly reduced.	"TSP - 2	6	13	Gene_or_gene_product"	"tumor	40	45	Cancer"	"tumor cell	80	90	Cell"	"[{""token"": ""TSP - 2"", ""start_span"": 6, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Cancer""}, {""token"": ""tumor cell"", ""start_span"": 80, ""end_span"": 90, ""type"": ""Cell""}]"
The purpose of this study was to evaluate the biological features of gastric cancer of the remnant stomach ( RSC).	"gastric cancer	69	83	Cancer"	"remnant stomach	91	106	Organ"	"RSC	109	112	Cancer"	"[{""token"": ""gastric cancer"", ""start_span"": 69, ""end_span"": 83, ""type"": ""Cancer""}, {""token"": ""remnant stomach"", ""start_span"": 91, ""end_span"": 106, ""type"": ""Organ""}, {""token"": ""RSC"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Cancer""}]"
In animal or cell culture studies, the growth and spread of cancer can be slowed by many nutrients, food factors, herbal extracts, and well - tolerated, available drugs that are still rarely used in the clinical management of cancer, in part because they seem unlikely to constitute definitive therapies in themselves.	"cell	13	17	Cell"	"cancer	60	66	Cancer"	"cancer	226	232	Cancer"	"[{""token"": ""cell"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Cell""}, {""token"": ""cancer"", ""start_span"": 60, ""end_span"": 66, ""type"": ""Cancer""}, {""token"": ""cancer"", ""start_span"": 226, ""end_span"": 232, ""type"": ""Cancer""}]"
We also demonstrated that Evi - 1 represses Smad - induced transcriptional activation by recruiting CtBP as a corepressor.	"Evi - 1	26	33	Gene_or_gene_product"	"Smad	44	48	Gene_or_gene_product"	"CtBP	100	104	Gene_or_gene_product"	"[{""token"": ""Evi - 1"", ""start_span"": 26, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""CtBP"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}]"
Antibodies to PAI - 1 alter the invasive and migratory properties of human tumour cells in vitro.	"PAI - 1	14	21	Gene_or_gene_product"	"human	69	74	Organism"	"tumour cells	75	87	Cell"	"[{""token"": ""PAI - 1"", ""start_span"": 14, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Organism""}, {""token"": ""tumour cells"", ""start_span"": 75, ""end_span"": 87, ""type"": ""Cell""}]"
Recent reports suggest that elevated levels of plasminogen activator inhibitor - 1 ( PAI - 1) may contribute to tumour progression.	"plasminogen activator inhibitor - 1	47	82	Gene_or_gene_product"	"PAI - 1	85	92	Gene_or_gene_product"	"tumour	112	118	Cancer"	"[{""token"": ""plasminogen activator inhibitor - 1"", ""start_span"": 47, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""PAI - 1"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumour"", ""start_span"": 112, ""end_span"": 118, ""type"": ""Cancer""}]"
SPARC ( secreted protein, acidic, and rich in cysteine) is a matrix - associated glycoprotein that modulates the adhesion and proliferation of vascular cells.	"SPARC	0	5	Gene_or_gene_product"	"matrix	61	67	Cellular_component"	"vascular cells	143	157	Cell"	"[{""token"": ""SPARC"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Cellular_component""}, {""token"": ""vascular cells"", ""start_span"": 143, ""end_span"": 157, ""type"": ""Cell""}]"
Binding studies with SPARC and SPARC peptides indicate specific and saturable interaction with smooth muscle cells that involves the C - terminal Ca2 + - binding region of the protein.	"SPARC	21	26	Gene_or_gene_product"	"SPARC peptides	31	45	Gene_or_gene_product"	"smooth muscle cells	95	114	Cell"	"[{""token"": ""SPARC"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""SPARC peptides"", ""start_span"": 31, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""smooth muscle cells"", ""start_span"": 95, ""end_span"": 114, ""type"": ""Cell""}]"
Heat shock protein 27 ( HSP27) is one of the small heat shock proteins.	"Heat shock protein 27	0	21	Gene_or_gene_product"	"HSP27	24	29	Gene_or_gene_product"	"small heat shock proteins	45	70	Gene_or_gene_product"	"[{""token"": ""Heat shock protein 27"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""HSP27"", ""start_span"": 24, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""small heat shock proteins"", ""start_span"": 45, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}]"
RESULTS: VEGF isoforms and its receptors ' mRNA were expressed in neuroblastoma and control tissues.	"VEGF	9	13	Gene_or_gene_product"	"neuroblastoma	66	79	Cancer"	"tissues	92	99	Tissue"	"[{""token"": ""VEGF"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuroblastoma"", ""start_span"": 66, ""end_span"": 79, ""type"": ""Cancer""}, {""token"": ""tissues"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Tissue""}]"
VEGF - A ( 165) mainly contributes to increased serum VEGF levels and may serve as a diagnostic tool in advanced - stage neuroblastoma.	"serum	48	53	Organism_substance"	"VEGF	54	58	Gene_or_gene_product"	"advanced - stage neuroblastoma	104	134	Cancer"	"[{""token"": ""serum"", ""start_span"": 48, ""end_span"": 53, ""type"": ""Organism_substance""}, {""token"": ""VEGF"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""advanced - stage neuroblastoma"", ""start_span"": 104, ""end_span"": 134, ""type"": ""Cancer""}]"
Almost all patients respond to G - CSF with increased neutrophils, reduced infections, and improved survival.	"patients	11	19	Organism"	"G - CSF	31	38	Gene_or_gene_product"	"neutrophils	54	65	Cell"	"[{""token"": ""patients"", ""start_span"": 11, ""end_span"": 19, ""type"": ""Organism""}, {""token"": ""G - CSF"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""neutrophils"", ""start_span"": 54, ""end_span"": 65, ""type"": ""Cell""}]"
Some responders with congenital neutropenia and Shwachman - Diamond syndrome ( SDS) have developed myelodysplastic syndrome and acute myeloid leukemia ( MDS / AML), which raises the question of the role of G - CSF in pathogenesis.	"acute myeloid leukemia	128	150	Cancer"	"AML	159	162	Cancer"	"G - CSF	206	213	Gene_or_gene_product"	"[{""token"": ""acute myeloid leukemia"", ""start_span"": 128, ""end_span"": 150, ""type"": ""Cancer""}, {""token"": ""AML"", ""start_span"": 159, ""end_span"": 162, ""type"": ""Cancer""}, {""token"": ""G - CSF"", ""start_span"": 206, ""end_span"": 213, ""type"": ""Gene_or_gene_product""}]"
In murine models, the latter produces a hyperproliferative response to G - CSF, confers resistance to apoptosis, and enhances cell survival.	"murine	3	9	Organism"	"G - CSF	71	78	Gene_or_gene_product"	"cell	126	130	Cell"	"[{""token"": ""murine"", ""start_span"": 3, ""end_span"": 9, ""type"": ""Organism""}, {""token"": ""G - CSF"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Cell""}]"
In patients who transform to overt MDS or AML, hematopoietic stem cell transplantation is the only chance for cure.	"patients	3	11	Organism"	"AML	42	45	Cancer"	"hematopoietic stem cell	47	70	Cell"	"[{""token"": ""patients"", ""start_span"": 3, ""end_span"": 11, ""type"": ""Organism""}, {""token"": ""AML"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Cancer""}, {""token"": ""hematopoietic stem cell"", ""start_span"": 47, ""end_span"": 70, ""type"": ""Cell""}]"
Hypoxic induction of HIF - 1alpha and VEGF expression in head and neck squamous cell carcinoma lines is mediated by stress activated protein kinases.	"HIF - 1alpha	21	33	Gene_or_gene_product"	"VEGF	38	42	Gene_or_gene_product"	"head and neck squamous cell carcinoma lines	57	100	Cell"	"[{""token"": ""HIF - 1alpha"", ""start_span"": 21, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""head and neck squamous cell carcinoma lines"", ""start_span"": 57, ""end_span"": 100, ""type"": ""Cell""}]"
The mechanisms by which hypoxic tumor environments induce HIF - 1alpha and VEGF expression are largely unknown.	"tumor	32	37	Cancer"	"HIF - 1alpha	58	70	Gene_or_gene_product"	"VEGF	75	79	Gene_or_gene_product"	"[{""token"": ""tumor"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Cancer""}, {""token"": ""HIF - 1alpha"", ""start_span"": 58, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}]"
Jun N terminal kinase ( JNK1) and p38 kinase are activated by a variety of stress stimuli.	"Jun N terminal kinase	0	21	Gene_or_gene_product"	"JNK1	24	28	Gene_or_gene_product"	"p38 kinase	34	44	Gene_or_gene_product"	"[{""token"": ""Jun N terminal kinase"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""JNK1"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""p38 kinase"", ""start_span"": 34, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}]"
Hypoxia rapidly induced both JNK1 and p38 activity in these cells.	"JNK1	29	33	Gene_or_gene_product"	"p38	38	41	Gene_or_gene_product"	"cells	60	65	Cell"	"[{""token"": ""JNK1"", ""start_span"": 29, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""p38"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 60, ""end_span"": 65, ""type"": ""Cell""}]"
Hypoxia also increased VEGF production by SCC lines, which was inhibited by treatment with SB203580.	"VEGF	23	27	Gene_or_gene_product"	"SCC lines	42	51	Cell"	"SB203580	91	99	Chemical"	"[{""token"": ""VEGF"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""SCC lines"", ""start_span"": 42, ""end_span"": 51, ""type"": ""Cell""}, {""token"": ""SB203580"", ""start_span"": 91, ""end_span"": 99, ""type"": ""Chemical""}]"
Transformation of primary cells in cultures requires both overcoming growth arrest by stimulating the cell cycle and blocking cell death activities presumably activated by oncogene - mediated hyperproliferation signals.	"cells	26	31	Cell"	"cell	102	106	Cell"	"cell	126	130	Cell"	"[{""token"": ""cells"", ""start_span"": 26, ""end_span"": 31, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Cell""}]"
An N - terminal segment containing the first 127 T - antigen amino acids ( T1 - 127) was sufficient to sensitize cells.	"T - antigen	49	60	Gene_or_gene_product"	"amino acids	61	72	Amino_acid"	"cells	113	118	Cell"	"[{""token"": ""T - antigen"", ""start_span"": 49, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""amino acids"", ""start_span"": 61, ""end_span"": 72, ""type"": ""Amino_acid""}, {""token"": ""cells"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Cell""}]"
Optimizing treatment of choroidal neovascularization feeder vessels associated with age - related macular degeneration.	"choroidal	24	33	Multi"	"feeder vessels	53	67	Multi"	"macular	98	105	Tissue"	"[{""token"": ""choroidal"", ""start_span"": 24, ""end_span"": 33, ""type"": ""Multi""}, {""token"": ""feeder vessels"", ""start_span"": 53, ""end_span"": 67, ""type"": ""Multi""}, {""token"": ""macular"", ""start_span"": 98, ""end_span"": 105, ""type"": ""Tissue""}]"
The system also permits precise aiming and delivery of 810 - nm wavelength photocoagulation laser energy to target FVs on a real - time ICG angiogram image of the choroidal vasculature.	"FVs	115	118	Multi"	"ICG	136	139	Chemical"	"choroidal vasculature	163	184	Multi"	"[{""token"": ""FVs"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Multi""}, {""token"": ""ICG"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Chemical""}, {""token"": ""choroidal vasculature"", ""start_span"": 163, ""end_span"": 184, ""type"": ""Multi""}]"
Successful FV closure was usually indicated immediately by presence of incarcerated ICG dye in the vessel adjacent to the burn site.	"FV	11	13	Multi"	"ICG dye	84	91	Chemical"	"vessel	99	105	Multi"	"[{""token"": ""FV"", ""start_span"": 11, ""end_span"": 13, ""type"": ""Multi""}, {""token"": ""ICG dye"", ""start_span"": 84, ""end_span"": 91, ""type"": ""Chemical""}, {""token"": ""vessel"", ""start_span"": 99, ""end_span"": 105, ""type"": ""Multi""}]"
After 7 days, the pellets from animals fed the control diet were infiltrated by abundant branching networks of blood vessels with patent lumen - containing RBCs.	"networks of blood vessels	99	124	Multi"	"lumen	137	142	Immaterial_anatomical_entity"	"RBCs	156	160	Cell"	"[{""token"": ""networks of blood vessels"", ""start_span"": 99, ""end_span"": 124, ""type"": ""Multi""}, {""token"": ""lumen"", ""start_span"": 137, ""end_span"": 142, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""RBCs"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Cell""}]"
Both levels of dietary CLA showed similar effects, with the number of RBC - containing vessels per 20x field decreased to a third of that seen in control.	"CLA	23	26	Chemical"	"RBC	70	73	Cell"	"vessels	87	94	Multi"	"[{""token"": ""CLA"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Chemical""}, {""token"": ""RBC"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""vessels"", ""start_span"": 87, ""end_span"": 94, ""type"": ""Multi""}]"
Attenuation of the proangiogenic effects by neutralizing VEGF antibodies suggests VEGF play a key role in the acquisition of the angiogenic phenotype in oral cancer cells.	"VEGF antibodies	57	72	Gene_or_gene_product"	"VEGF	82	86	Gene_or_gene_product"	"oral cancer cells	153	170	Cell"	"[{""token"": ""VEGF antibodies"", ""start_span"": 57, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""oral cancer cells"", ""start_span"": 153, ""end_span"": 170, ""type"": ""Cell""}]"
In summary, the angiogenic property of oral cancer cells is mediated by many factors in addition to VEGF and the functional status of p53.	"oral cancer cells	39	56	Cell"	"VEGF	100	104	Gene_or_gene_product"	"p53	134	137	Gene_or_gene_product"	"[{""token"": ""oral cancer cells"", ""start_span"": 39, ""end_span"": 56, ""type"": ""Cell""}, {""token"": ""VEGF"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}]"
Brn - 3a, a neuronal transcription factor of the POU gene family: indications for its involvement in cancer and angiogenesis.	"Brn - 3a	0	8	Gene_or_gene_product"	"neuronal	12	20	Cell"	"cancer	101	107	Cancer"	"[{""token"": ""Brn - 3a"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuronal"", ""start_span"": 12, ""end_span"": 20, ""type"": ""Cell""}, {""token"": ""cancer"", ""start_span"": 101, ""end_span"": 107, ""type"": ""Cancer""}]"
In neuronal cells, following Brn - 3a gene transfection and superexpression, an increase of 30 fold of the Bcl - 2 protein occurs, leading to apoptosis protection.	"neuronal cells	3	17	Cell"	"Brn - 3a	29	37	Gene_or_gene_product"	"Bcl - 2	107	114	Gene_or_gene_product"	"[{""token"": ""neuronal cells"", ""start_span"": 3, ""end_span"": 17, ""type"": ""Cell""}, {""token"": ""Brn - 3a"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 107, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}]"
The A431 cells exhibited typical in vitro cell adhesion to the endothelial F - 2 cells.	"A431 cells	4	14	Cell"	"cell	42	46	Cell"	"endothelial F - 2 cells	63	86	Cell"	"[{""token"": ""A431 cells"", ""start_span"": 4, ""end_span"": 14, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Cell""}, {""token"": ""endothelial F - 2 cells"", ""start_span"": 63, ""end_span"": 86, ""type"": ""Cell""}]"
The initial step of adhesion was mediated by sialyl Lewis ( x) ( Le ( x)) and sialyl Le ( a), the carbohydrate determinants expressed on the cancer cells, and E - selectin expressed constitutively on F - 2 cells.	"cancer cells	141	153	Cell"	"E - selectin	159	171	Gene_or_gene_product"	"F - 2 cells	200	211	Cell"	"[{""token"": ""cancer cells"", ""start_span"": 141, ""end_span"": 153, ""type"": ""Cell""}, {""token"": ""E - selectin"", ""start_span"": 159, ""end_span"": 171, ""type"": ""Gene_or_gene_product""}, {""token"": ""F - 2 cells"", ""start_span"": 200, ""end_span"": 211, ""type"": ""Cell""}]"
Prolonged culture led to the implantation of cancer cells into the monolayer of the F - 2 cells, which was mediated mainly by alpha ( 3) beta ( 1) - integrin.	"cancer cells	45	57	Cell"	"monolayer	67	76	Cell"	"F - 2 cells	84	95	Cell"	"[{""token"": ""cancer cells"", ""start_span"": 45, ""end_span"": 57, ""type"": ""Cell""}, {""token"": ""monolayer"", ""start_span"": 67, ""end_span"": 76, ""type"": ""Cell""}, {""token"": ""F - 2 cells"", ""start_span"": 84, ""end_span"": 95, ""type"": ""Cell""}]"
The tumor mass thus formed was an average 5. 8 - fold as large as control A431 tumors that were grown without F - 2 cells.	"tumor	4	9	Cancer"	"A431 tumors	74	85	Cancer"	"F - 2 cells	110	121	Cell"	"[{""token"": ""tumor"", ""start_span"": 4, ""end_span"": 9, ""type"": ""Cancer""}, {""token"": ""A431 tumors"", ""start_span"": 74, ""end_span"": 85, ""type"": ""Cancer""}, {""token"": ""F - 2 cells"", ""start_span"": 110, ""end_span"": 121, ""type"": ""Cell""}]"
The size of these A431 tumors did not differ significantly from those of control A431 tumors raised without F - 2 cells.	"A431 tumors	18	29	Cancer"	"A431 tumors	81	92	Cancer"	"F - 2 cells	108	119	Cell"	"[{""token"": ""A431 tumors"", ""start_span"": 18, ""end_span"": 29, ""type"": ""Cancer""}, {""token"": ""A431 tumors"", ""start_span"": 81, ""end_span"": 92, ""type"": ""Cancer""}, {""token"": ""F - 2 cells"", ""start_span"": 108, ""end_span"": 119, ""type"": ""Cell""}]"
Keratinocyte progenitor cells from TPA - treated Tg. AC mice were isolated with fluorescence - activated cell sorting and expression was analyzed using cDNA microarray technology.	"Keratinocyte progenitor cells	0	29	Cell"	"TPA	35	38	Chemical"	"cell	105	109	Cell"	"[{""token"": ""Keratinocyte progenitor cells"", ""start_span"": 0, ""end_span"": 29, ""type"": ""Cell""}, {""token"": ""TPA"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 105, ""end_span"": 109, ""type"": ""Cell""}]"
cDNA microarray expression analysis showed that the mouse homologue of Dss1 is induced by TPA.	"mouse	52	57	Organism"	"Dss1	71	75	Gene_or_gene_product"	"TPA	90	93	Chemical"	"[{""token"": ""mouse"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Organism""}, {""token"": ""Dss1"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""TPA"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Chemical""}]"
These results strongly suggest that Dss1 is a TPA - inducible gene that may play an important role in the early stages of skin carcinogenesis.	"Dss1	36	40	Gene_or_gene_product"	"TPA	46	49	Chemical"	"skin	122	126	Organ"	"[{""token"": ""Dss1"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""TPA"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Chemical""}, {""token"": ""skin"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Organ""}]"
Downregulation of c - FLIP sensitizes DU145 prostate cancer cells to Fas - mediated apoptosis.	"c - FLIP	18	26	Gene_or_gene_product"	"DU145 prostate cancer cells	38	65	Cell"	"Fas	69	72	Gene_or_gene_product"	"[{""token"": ""c - FLIP"", ""start_span"": 18, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""DU145 prostate cancer cells"", ""start_span"": 38, ""end_span"": 65, ""type"": ""Cell""}, {""token"": ""Fas"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}]"
The purpose of this study was to try to understand why DU145 cells are resistant to CH - 11 and determine the signaling pathway utilized by AdGFPFasL ( TET) to induce apoptosis in these Fas - resistant cells.	"DU145 cells	55	66	Cell"	"Fas	145	148	Gene_or_gene_product"	"cells	202	207	Cell"	"[{""token"": ""DU145 cells"", ""start_span"": 55, ""end_span"": 66, ""type"": ""Cell""}, {""token"": ""Fas"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 202, ""end_span"": 207, ""type"": ""Cell""}]"
Using c - FLIP anti - sense oligonucleotides to down - regulate c - FLIP we sensitized DU145 cells to CH - 11 - induced apoptosis.	"c - FLIP	6	14	Gene_or_gene_product"	"c - FLIP	64	72	Gene_or_gene_product"	"DU145 cells	87	98	Cell"	"[{""token"": ""c - FLIP"", ""start_span"": 6, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - FLIP"", ""start_span"": 64, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""DU145 cells"", ""start_span"": 87, ""end_span"": 98, ""type"": ""Cell""}]"
Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases.	"Topoisomerase I	0	15	Gene_or_gene_product"	"primary colorectal cancer	38	63	Cancer"	"lymph node metastases	68	89	Cancer"	"[{""token"": ""Topoisomerase I"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""primary colorectal cancer"", ""start_span"": 38, ""end_span"": 63, ""type"": ""Cancer""}, {""token"": ""lymph node metastases"", ""start_span"": 68, ""end_span"": 89, ""type"": ""Cancer""}]"
Topo I expression was described as the percentage of cells staining positive for topo I, along with the intensity and localization of the staining.	"Topo I	0	6	Gene_or_gene_product"	"cells	53	58	Cell"	"topo I	81	87	Gene_or_gene_product"	"[{""token"": ""Topo I"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Cell""}, {""token"": ""topo I"", ""start_span"": 81, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}]"
Clinicopathologic data ( sex, age, Dukes ' stage, differentiation grade, survival status), p53 status, and PCNA status were statistically analyzed for association with topo I protein expression.	"p53	91	94	Gene_or_gene_product"	"PCNA	107	111	Gene_or_gene_product"	"topo I	168	174	Gene_or_gene_product"	"[{""token"": ""p53"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""PCNA"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}, {""token"": ""topo I"", ""start_span"": 168, ""end_span"": 174, ""type"": ""Gene_or_gene_product""}]"
Topo I protein expression was detected in 127 ( 51%) samples, including 24. 4% with > 50% positive tumor cells.	"Topo I	0	6	Gene_or_gene_product"	"samples	53	60	Cancer"	"tumor cells	99	110	Cell"	"[{""token"": ""Topo I"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene_or_gene_product""}, {""token"": ""samples"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Cancer""}, {""token"": ""tumor cells"", ""start_span"": 99, ""end_span"": 110, ""type"": ""Cell""}]"
The majority had nuclear ( 70. 1%) or nuclear and cytoplasmic staining ( 17. 3%).	"nuclear	17	24	Cellular_component"	"nuclear	38	45	Cellular_component"	"cytoplasmic	50	61	Organism_substance"	"[{""token"": ""nuclear"", ""start_span"": 17, ""end_span"": 24, ""type"": ""Cellular_component""}, {""token"": ""nuclear"", ""start_span"": 38, ""end_span"": 45, ""type"": ""Cellular_component""}, {""token"": ""cytoplasmic"", ""start_span"": 50, ""end_span"": 61, ""type"": ""Organism_substance""}]"
A higher percentage of cells expressing topo I in primary colorectal cancer was significantly associated with advanced age ( P =. 040).	"cells	23	28	Cell"	"topo I	40	46	Gene_or_gene_product"	"primary colorectal cancer	50	75	Cancer"	"[{""token"": ""cells"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Cell""}, {""token"": ""topo I"", ""start_span"": 40, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""primary colorectal cancer"", ""start_span"": 50, ""end_span"": 75, ""type"": ""Cancer""}]"
No significant correlation was found between topo I protein expression and sex, Dukes ' stage, differentiation grade, survival status, p53 status, and PCNA status.	"topo I	45	51	Gene_or_gene_product"	"p53	135	138	Gene_or_gene_product"	"PCNA	151	155	Gene_or_gene_product"	"[{""token"": ""topo I"", ""start_span"": 45, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""PCNA"", ""start_span"": 151, ""end_span"": 155, ""type"": ""Gene_or_gene_product""}]"
Concordance in topo I staining between primary and lymph node metastases was observed in 33 of 42 cases ( P =. 029).	"topo I	15	21	Gene_or_gene_product"	"primary	39	46	Cancer"	"lymph node	51	61	Multi"	"[{""token"": ""topo I"", ""start_span"": 15, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""primary"", ""start_span"": 39, ""end_span"": 46, ""type"": ""Cancer""}, {""token"": ""lymph node"", ""start_span"": 51, ""end_span"": 61, ""type"": ""Multi""}]"
This suggests that the activity of topo I inhibitors will not differ across various tumor stages, pathology, and patient gender.	"topo I	35	41	Gene_or_gene_product"	"tumor	84	89	Cancer"	"patient	113	120	Organism"	"[{""token"": ""topo I"", ""start_span"": 35, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 84, ""end_span"": 89, ""type"": ""Cancer""}, {""token"": ""patient"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Organism""}]"
Topo I expression now needs to be evaluated in patients undergoing topo I - inhibitor therapy, to better define the role of this protein as a predictive marker.	"Topo I	0	6	Gene_or_gene_product"	"patients	47	55	Organism"	"topo I	67	73	Gene_or_gene_product"	"[{""token"": ""Topo I"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 47, ""end_span"": 55, ""type"": ""Organism""}, {""token"": ""topo I"", ""start_span"": 67, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}]"
Dysregulation of the signaling mechanisms of the TGF - beta superfamily proteins is associated with clinical diseases such as cancer, fibrotic diseases, and vascular disorders.	"TGF - beta	49	59	Gene_or_gene_product"	"cancer	126	132	Cancer"	"vascular	157	165	Multi"	"[{""token"": ""TGF - beta"", ""start_span"": 49, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer"", ""start_span"": 126, ""end_span"": 132, ""type"": ""Cancer""}, {""token"": ""vascular"", ""start_span"": 157, ""end_span"": 165, ""type"": ""Multi""}]"
OBJECTIVE: To investigate the effect of the expression and mutation of c - kit gene and its relationship with clinical pathology and prognosis of gastrointestinal stromal tumor ( GIST).	"c - kit	71	78	Gene_or_gene_product"	"gastrointestinal stromal tumor	146	176	Cancer"	"GIST	179	183	Cancer"	"[{""token"": ""c - kit"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastrointestinal stromal tumor"", ""start_span"": 146, ""end_span"": 176, ""type"": ""Cancer""}, {""token"": ""GIST"", ""start_span"": 179, ""end_span"": 183, ""type"": ""Cancer""}]"
We investigated how inhibition of glucose metabolism could affect death receptor - mediated apoptosis in human tumor cells of diverse origin.	"glucose	34	41	Chemical"	"human	105	110	Organism"	"tumor cells	111	122	Cell"	"[{""token"": ""glucose"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Organism""}, {""token"": ""tumor cells"", ""start_span"": 111, ""end_span"": 122, ""type"": ""Cell""}]"
Caspase activation, mitochondrial depolarization, and cytochrome c release were increased under these conditions.	"Caspase	0	7	Gene_or_gene_product"	"mitochondrial	20	33	Cellular_component"	"cytochrome c	54	66	Gene_or_gene_product"	"[{""token"": ""Caspase"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitochondrial"", ""start_span"": 20, ""end_span"": 33, ""type"": ""Cellular_component""}, {""token"": ""cytochrome c"", ""start_span"": 54, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}]"
Glucose deprivation - mediated sensitization to apoptosis was prevented in MCF - 7 cells overexpressing BCL - 2.	"Glucose	0	7	Chemical"	"MCF - 7 cells	75	88	Cell"	"BCL - 2	104	111	Gene_or_gene_product"	"[{""token"": ""Glucose"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""MCF - 7 cells"", ""start_span"": 75, ""end_span"": 88, ""type"": ""Cell""}, {""token"": ""BCL - 2"", ""start_span"": 104, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}]"
Changes in c - FLIP ( L) and cFLIPs levels were observed in some but not all the cell lines studied following glucose deprivation.	"cFLIPs	29	35	Gene_or_gene_product"	"cell lines	81	91	Cell"	"glucose	110	117	Chemical"	"[{""token"": ""cFLIPs"", ""start_span"": 29, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell lines"", ""start_span"": 81, ""end_span"": 91, ""type"": ""Cell""}, {""token"": ""glucose"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Chemical""}]"
Glucose deprivation enhanced death receptor - triggered formation of death - inducing signaling complex and early processing of procaspase - 8.	"Glucose	0	7	Chemical"	"death - inducing signaling complex	69	103	Gene_or_gene_product"	"procaspase - 8	128	142	Gene_or_gene_product"	"[{""token"": ""Glucose"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""death - inducing signaling complex"", ""start_span"": 69, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""procaspase - 8"", ""start_span"": 128, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}]"
Many observations in various animal models and humans support that the remodeling of preexisting collateral vessels is the mechanism of collateral artery formation.	"humans	47	53	Organism"	"collateral vessels	97	115	Multi"	"collateral artery	136	153	Multi"	"[{""token"": ""humans"", ""start_span"": 47, ""end_span"": 53, ""type"": ""Organism""}, {""token"": ""collateral vessels"", ""start_span"": 97, ""end_span"": 115, ""type"": ""Multi""}, {""token"": ""collateral artery"", ""start_span"": 136, ""end_span"": 153, ""type"": ""Multi""}]"
In addition, reverse transcription - polymerase chain reaction and prostaglandin E ( 2) ( PGE ( 2)) immunoassay were performed to verify whether BV possesses an inhibitory effect on the expression of cyclooxygenase ( COX) and PGE ( 2) synthesis.	"BV	145	147	Organism_substance"	"cyclooxygenase	200	214	Gene_or_gene_product"	"COX	217	220	Gene_or_gene_product"	"[{""token"": ""BV"", ""start_span"": 145, ""end_span"": 147, ""type"": ""Organism_substance""}, {""token"": ""cyclooxygenase"", ""start_span"": 200, ""end_span"": 214, ""type"": ""Gene_or_gene_product""}, {""token"": ""COX"", ""start_span"": 217, ""end_span"": 220, ""type"": ""Gene_or_gene_product""}]"
None of the inhibitors had any effect on the weight of the superovulated ovaries or on the synthesis of progesterone by cultured luteal cells.	"superovulated ovaries	59	80	Organ"	"progesterone	104	116	Chemical"	"cultured luteal cells	120	141	Cell"	"[{""token"": ""superovulated ovaries"", ""start_span"": 59, ""end_span"": 80, ""type"": ""Organ""}, {""token"": ""progesterone"", ""start_span"": 104, ""end_span"": 116, ""type"": ""Chemical""}, {""token"": ""cultured luteal cells"", ""start_span"": 120, ""end_span"": 141, ""type"": ""Cell""}]"
The expression of endothelial cell ( EC) adhesion molecules involved in leukocyte - vessel wall interactions is suppressed in malignancies.	"leukocyte	72	81	Cell"	"vessel wall	84	95	Multi"	"malignancies	126	138	Cancer"	"[{""token"": ""leukocyte"", ""start_span"": 72, ""end_span"": 81, ""type"": ""Cell""}, {""token"": ""vessel wall"", ""start_span"": 84, ""end_span"": 95, ""type"": ""Multi""}, {""token"": ""malignancies"", ""start_span"": 126, ""end_span"": 138, ""type"": ""Cancer""}]"
In the present study, we investigated in vivo the regulation of leukocyte - vessel wall interactions by the presence of a tumor.	"leukocyte	64	73	Cell"	"vessel wall	76	87	Multi"	"tumor	122	127	Cancer"	"[{""token"": ""leukocyte"", ""start_span"": 64, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""vessel wall"", ""start_span"": 76, ""end_span"": 87, ""type"": ""Multi""}, {""token"": ""tumor"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Cancer""}]"
This study was designed to investigate the effect of EBV - LMP1 on related factors of metastasis of nasopharyngeal carcinoma cell line CNE1.	"EBV	53	56	Organism"	"LMP1	59	63	Gene_or_gene_product"	"nasopharyngeal carcinoma cell line CNE1	100	139	Cell"	"[{""token"": ""EBV"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Organism""}, {""token"": ""LMP1"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""nasopharyngeal carcinoma cell line CNE1"", ""start_span"": 100, ""end_span"": 139, ""type"": ""Cell""}]"
Cell - matrix adhesion assay was used to study the adhesive ability of CNE1 - GL cells.	"Cell	0	4	Cell"	"matrix	7	13	Cellular_component"	"CNE1 - GL cells	71	86	Cell"	"[{""token"": ""Cell"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Cell""}, {""token"": ""matrix"", ""start_span"": 7, ""end_span"": 13, ""type"": ""Cellular_component""}, {""token"": ""CNE1 - GL cells"", ""start_span"": 71, ""end_span"": 86, ""type"": ""Cell""}]"
The positive rates of expression of MMP - 9 in CNE1 and CNE1 - GL cells were 30. 2% and 98. 2%, respectively ( P < 0. 05).	"MMP - 9	36	43	Gene_or_gene_product"	"CNE1	47	51	Cell"	"CNE1 - GL cells	56	71	Cell"	"[{""token"": ""MMP - 9"", ""start_span"": 36, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""CNE1"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Cell""}, {""token"": ""CNE1 - GL cells"", ""start_span"": 56, ""end_span"": 71, ""type"": ""Cell""}]"
CONCLUSION: The transfection of LMP1 can increase the expression of MMP - 9 in CNE1 cells.	"LMP1	32	36	Gene_or_gene_product"	"MMP - 9	68	75	Gene_or_gene_product"	"CNE1 cells	79	89	Cell"	"[{""token"": ""LMP1"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 9"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""CNE1 cells"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Cell""}]"
It is suggested that MMP - 9 may have a role in the LMP1 - induced acceleration of invasion and metastasis of NPC cells.	"MMP - 9	21	28	Gene_or_gene_product"	"LMP1	52	56	Gene_or_gene_product"	"NPC cells	110	119	Cell"	"[{""token"": ""MMP - 9"", ""start_span"": 21, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""LMP1"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""NPC cells"", ""start_span"": 110, ""end_span"": 119, ""type"": ""Cell""}]"
PURPOSE: The goal of this research was to evaluate a potential therapeutic agent for breast cancer based on galectin - 3 that has been implicated in tumorigenicity and metastasis of breast cancer.	"breast cancer	85	98	Cancer"	"galectin - 3	108	120	Gene_or_gene_product"	"breast cancer	182	195	Cancer"	"[{""token"": ""breast cancer"", ""start_span"": 85, ""end_span"": 98, ""type"": ""Cancer""}, {""token"": ""galectin - 3"", ""start_span"": 108, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer"", ""start_span"": 182, ""end_span"": 195, ""type"": ""Cancer""}]"
The hypothesis was that therapy with NH ( 2) - terminally truncated form of galectin - 3 ( galectin - 3C) will be efficacious for reduction in tumor growth and for inhibition of metastases.	"galectin - 3	76	88	Gene_or_gene_product"	"galectin - 3C	91	104	Gene_or_gene_product"	"tumor	143	148	Cancer"	"[{""token"": ""galectin - 3"", ""start_span"": 76, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""galectin - 3C"", ""start_span"": 91, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 143, ""end_span"": 148, ""type"": ""Cancer""}]"
The elimination half - life when administered i. m. was found to be 3. 0 h in the serum and 4. 3 h in the cellular fraction of the blood.	"serum	82	87	Organism_substance"	"cellular	106	114	Cell"	"blood	131	136	Organism_substance"	"[{""token"": ""serum"", ""start_span"": 82, ""end_span"": 87, ""type"": ""Organism_substance""}, {""token"": ""cellular"", ""start_span"": 106, ""end_span"": 114, ""type"": ""Cell""}, {""token"": ""blood"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Organism_substance""}]"
The most common genetic alterations found in a wide variety of cancers are p53 tumor suppressor gene mutations.	"cancers	63	70	Cancer"	"p53	75	78	Gene_or_gene_product"	"tumor	79	84	Cancer"	"[{""token"": ""cancers"", ""start_span"": 63, ""end_span"": 70, ""type"": ""Cancer""}, {""token"": ""p53"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Cancer""}]"
Vascular endothelial growth factor ( VEGF), a recently identified growth factor with significant angiogenic properties, may be a major tumor angiogenesis regulator.	"Vascular endothelial growth factor	0	34	Gene_or_gene_product"	"VEGF	37	41	Gene_or_gene_product"	"tumor	135	140	Cancer"	"[{""token"": ""Vascular endothelial growth factor"", ""start_span"": 0, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 135, ""end_span"": 140, ""type"": ""Cancer""}]"
Few studies have investigated the association between p53 and VEGF expressions and prognosis in esophageal carcinoma.	"p53	54	57	Gene_or_gene_product"	"VEGF	62	66	Gene_or_gene_product"	"esophageal carcinoma	96	116	Cancer"	"[{""token"": ""p53"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""esophageal carcinoma"", ""start_span"": 96, ""end_span"": 116, ""type"": ""Cancer""}]"
VEGF and p53 expressions were observed in 40% and 53% of the tumors, respectively.	"VEGF	0	4	Gene_or_gene_product"	"p53	9	12	Gene_or_gene_product"	"tumors	61	67	Cancer"	"[{""token"": ""VEGF"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Cancer""}]"
Dioleoyl phosphatidylethanolamine - based lipoplexes were found to give low expression, apparently because of an immediate loss of integrity in serum, without lipid - DNA dissociation.	"Dioleoyl phosphatidylethanolamine - based lipoplexes	0	52	Chemical"	"serum	144	149	Organism_substance"	"DNA	167	170	Cellular_component"	"[{""token"": ""Dioleoyl phosphatidylethanolamine - based lipoplexes"", ""start_span"": 0, ""end_span"": 52, ""type"": ""Chemical""}, {""token"": ""serum"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Organism_substance""}, {""token"": ""DNA"", ""start_span"": 167, ""end_span"": 170, ""type"": ""Cellular_component""}]"
"Our study suggests that efficient in vivo lipofection is the result of cross - talk between lipoplex composition, interaction with serum, hemodynamics, and target tissue "" susceptibility "" to transfection."	"lipoplex	92	100	Chemical"	"serum	131	136	Organism_substance"	"tissue	163	169	Tissue"	"[{""token"": ""lipoplex"", ""start_span"": 92, ""end_span"": 100, ""type"": ""Chemical""}, {""token"": ""serum"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Organism_substance""}, {""token"": ""tissue"", ""start_span"": 163, ""end_span"": 169, ""type"": ""Tissue""}]"
Aqueous humor was collected at cataract surgery from 19 diabetic patients and from 13 age - and sex - matched normoglycemic controls.	"Aqueous humor	0	13	Organism_substance"	"patients	65	73	Organism"	"controls	124	132	Organism"	"[{""token"": ""Aqueous humor"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Organism_substance""}, {""token"": ""patients"", ""start_span"": 65, ""end_span"": 73, ""type"": ""Organism""}, {""token"": ""controls"", ""start_span"": 124, ""end_span"": 132, ""type"": ""Organism""}]"
Angiogenic activity in samples of patients from the control group was generally inhibitory due to PEDF, and inhibition was blocked by neutralizing antibodies to PEDF.	"patients	34	42	Organism"	"PEDF	98	102	Gene_or_gene_product"	"PEDF	161	165	Gene_or_gene_product"	"[{""token"": ""patients"", ""start_span"": 34, ""end_span"": 42, ""type"": ""Organism""}, {""token"": ""PEDF"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""PEDF"", ""start_span"": 161, ""end_span"": 165, ""type"": ""Gene_or_gene_product""}]"
In contrast, osteoprotegerin ( OPG) inhibits osteoclast development.	"osteoprotegerin	13	28	Gene_or_gene_product"	"OPG	31	34	Gene_or_gene_product"	"osteoclast	45	55	Cell"	"[{""token"": ""osteoprotegerin"", ""start_span"": 13, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""OPG"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""osteoclast"", ""start_span"": 45, ""end_span"": 55, ""type"": ""Cell""}]"
Osteoclast - like cells and tartarate resistant acid phosphatase ( TRAP) activities were then quantitated.	"Osteoclast - like cells	0	23	Cell"	"tartarate resistant acid phosphatase	28	64	Gene_or_gene_product"	"TRAP	67	71	Gene_or_gene_product"	"[{""token"": ""Osteoclast - like cells"", ""start_span"": 0, ""end_span"": 23, ""type"": ""Cell""}, {""token"": ""tartarate resistant acid phosphatase"", ""start_span"": 28, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""TRAP"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}]"
MDA - MB - 231 cells alone or breast cancer samples did not express RANKL mRNA.	"MDA - MB - 231 cells	0	20	Cell"	"breast cancer	30	43	Cancer"	"RANKL	68	73	Gene_or_gene_product"	"[{""token"": ""MDA - MB - 231 cells"", ""start_span"": 0, ""end_span"": 20, ""type"": ""Cell""}, {""token"": ""breast cancer"", ""start_span"": 30, ""end_span"": 43, ""type"": ""Cancer""}, {""token"": ""RANKL"", ""start_span"": 68, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}]"
Interleukin - 1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat.	"Interleukin - 1 receptor antagonist	0	35	Gene_or_gene_product"	"neuronal	71	79	Cell"	"rat	94	97	Organism"	"[{""token"": ""Interleukin - 1 receptor antagonist"", ""start_span"": 0, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuronal"", ""start_span"": 71, ""end_span"": 79, ""type"": ""Cell""}, {""token"": ""rat"", ""start_span"": 94, ""end_span"": 97, ""type"": ""Organism""}]"
Excitotoxic damage due to striatal infusion of an NMDA - receptor agonist ( cis - 2, 4 - methanoglutamate) was also markedly inhibited ( 71%) by injection of the IL - 1ra.	"striatal	26	34	Multi"	"NMDA	50	54	Chemical"	"IL - 1ra	162	170	Gene_or_gene_product"	"[{""token"": ""striatal"", ""start_span"": 26, ""end_span"": 34, ""type"": ""Multi""}, {""token"": ""NMDA"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Chemical""}, {""token"": ""IL - 1ra"", ""start_span"": 162, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}]"
Tie1 is an orphan tyrosine kinase receptor expressed almost exclusively in endothelial cells and is required for normal vascular development and maintenance.	"Tie1	0	4	Gene_or_gene_product"	"endothelial cells	75	92	Cell"	"vascular	120	128	Multi"	"[{""token"": ""Tie1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 75, ""end_span"": 92, ""type"": ""Cell""}, {""token"": ""vascular"", ""start_span"": 120, ""end_span"": 128, ""type"": ""Multi""}]"
This down - regulation is accompanied by a rapid cleavage of Tie1 and binding of the cleaved Tie1 45 kDa endodomain to Tie2.	"Tie1	61	65	Gene_or_gene_product"	"Tie1	93	97	Gene_or_gene_product"	"Tie2	119	123	Gene_or_gene_product"	"[{""token"": ""Tie1"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""Tie1"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""Tie2"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}]"
Blood and vascular disorders underlie a plethora of pathologic conditions and are the single most frequent cause of human disease.	"Blood	0	5	Organism_substance"	"vascular	10	18	Multi"	"human	116	121	Organism"	"[{""token"": ""Blood"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Organism_substance""}, {""token"": ""vascular"", ""start_span"": 10, ""end_span"": 18, ""type"": ""Multi""}, {""token"": ""human"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Organism""}]"
There is accumulating evidence of a role for IGF - 1 in multiple vascular pathologies, including atherosclerosis, hypertension, restenosis, angiogenesis, and diabetic vascular disease.	"IGF - 1	45	52	Gene_or_gene_product"	"vascular	65	73	Multi"	"vascular	167	175	Multi"	"[{""token"": ""IGF - 1"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular"", ""start_span"": 65, ""end_span"": 73, ""type"": ""Multi""}, {""token"": ""vascular"", ""start_span"": 167, ""end_span"": 175, ""type"": ""Multi""}]"
Vascular endothelial growth factor ( VEGF) is a mitogen that acts exclusively on endothelial cells.	"Vascular endothelial growth factor	0	34	Gene_or_gene_product"	"VEGF	37	41	Gene_or_gene_product"	"endothelial cells	81	98	Cell"	"[{""token"": ""Vascular endothelial growth factor"", ""start_span"": 0, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 81, ""end_span"": 98, ""type"": ""Cell""}]"
CONCLUSION: The data suggest that both h - MVD and VEGF immunoreactivity may be useful predictors for the progression of a subset of OSCC associated mostly with betel use.	"VEGF	51	55	Gene_or_gene_product"	"OSCC	133	137	Cancer"	"betel	161	166	Organism_subdivision"	"[{""token"": ""VEGF"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""OSCC"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Cancer""}, {""token"": ""betel"", ""start_span"": 161, ""end_span"": 166, ""type"": ""Organism_subdivision""}]"
Molecular analyses of tumors in beclin 1 heterozygous mice show that the remaining wild - type allele is neither mutated nor silenced.	"tumors	22	28	Cancer"	"beclin 1	32	40	Gene_or_gene_product"	"mice	54	58	Organism"	"[{""token"": ""tumors"", ""start_span"": 22, ""end_span"": 28, ""type"": ""Cancer""}, {""token"": ""beclin 1"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Organism""}]"
Thus, mutation of beclin 1 or other autophagy genes may contribute to the pathogenesis of human cancers.	"beclin 1	18	26	Gene_or_gene_product"	"human	90	95	Organism"	"cancers	96	103	Cancer"	"[{""token"": ""beclin 1"", ""start_span"": 18, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 90, ""end_span"": 95, ""type"": ""Organism""}, {""token"": ""cancers"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Cancer""}]"
Weaning IL - 2 ( null) x beta ( 2) m ( null) mice were randomized to receive 0 ( deficient; n = 40), 2 ( basal requirement; control; n = 46), or 8 ( supplemented; n = 36) mg folate / kg diet for 32 weeks.	"IL - 2	8	14	Gene_or_gene_product"	"mice	45	49	Organism"	"folate	174	180	Chemical"	"[{""token"": ""IL - 2"", ""start_span"": 8, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Organism""}, {""token"": ""folate"", ""start_span"": 174, ""end_span"": 180, ""type"": ""Chemical""}]"
At necropsy, all macroscopic colonic tumors were identified and histologically classified as dysplasia or adenocarcinoma.	"colonic tumors	29	43	Cancer"	"dysplasia	93	102	Pathological_formation"	"adenocarcinoma	106	120	Cancer"	"[{""token"": ""colonic tumors"", ""start_span"": 29, ""end_span"": 43, ""type"": ""Cancer""}, {""token"": ""dysplasia"", ""start_span"": 93, ""end_span"": 102, ""type"": ""Pathological_formation""}, {""token"": ""adenocarcinoma"", ""start_span"": 106, ""end_span"": 120, ""type"": ""Cancer""}]"
These data also suggest that folate deficiency may inhibit colorectal carcinogenesis in chronic UC.	"folate	29	35	Chemical"	"colorectal	59	69	Multi"	"UC	96	98	Pathological_formation"	"[{""token"": ""folate"", ""start_span"": 29, ""end_span"": 35, ""type"": ""Chemical""}, {""token"": ""colorectal"", ""start_span"": 59, ""end_span"": 69, ""type"": ""Multi""}, {""token"": ""UC"", ""start_span"": 96, ""end_span"": 98, ""type"": ""Pathological_formation""}]"
Most Group I compounds except doxorubicin ( which induced DNA fragmentation less effectively than others) activated caspase 3 more efficiently than Group II compounds.	"doxorubicin	30	41	Chemical"	"DNA	58	61	Cellular_component"	"caspase 3	116	125	Gene_or_gene_product"	"[{""token"": ""doxorubicin"", ""start_span"": 30, ""end_span"": 41, ""type"": ""Chemical""}, {""token"": ""DNA"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Cellular_component""}, {""token"": ""caspase 3"", ""start_span"": 116, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}]"
The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis.	"tumour	14	20	Cancer"	"ING4	40	44	Gene_or_gene_product"	"brain tumour	55	67	Cancer"	"[{""token"": ""tumour"", ""start_span"": 14, ""end_span"": 20, ""type"": ""Cancer""}, {""token"": ""ING4"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""brain tumour"", ""start_span"": 55, ""end_span"": 67, ""type"": ""Cancer""}]"
Here we report that a candidate tumour suppressor gene, ING4, is involved in regulating brain tumour growth and angiogenesis.	"tumour	32	38	Cancer"	"ING4	56	60	Gene_or_gene_product"	"brain tumour	88	100	Cancer"	"[{""token"": ""tumour"", ""start_span"": 32, ""end_span"": 38, ""type"": ""Cancer""}, {""token"": ""ING4"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""brain tumour"", ""start_span"": 88, ""end_span"": 100, ""type"": ""Cancer""}]"
TGFbeta1 was initially identified in culture media from transformed cells as part of a factor that could produce a transformed phenotype in a nontransformed cell line.	"TGFbeta1	0	8	Gene_or_gene_product"	"transformed cells	56	73	Cell"	"nontransformed cell	142	161	Cell"	"[{""token"": ""TGFbeta1"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""transformed cells"", ""start_span"": 56, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""nontransformed cell"", ""start_span"": 142, ""end_span"": 161, ""type"": ""Cell""}]"
Subsequently this activity was separated into TGFbeta and TGFalpha an EGF receptor ligand.	"TGFbeta	46	53	Gene_or_gene_product"	"TGFalpha	58	66	Gene_or_gene_product"	"EGF	70	73	Gene_or_gene_product"	"[{""token"": ""TGFbeta"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGFalpha"", ""start_span"": 58, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGF"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}]"
It is proposed that the switch from tumor suppressor to oncogene reflects genetic or epigenetic alterations in signaling pathways in tumor cells that alter the readout from the TGFbeta1 pathway.	"tumor	36	41	Cancer"	"tumor cells	133	144	Cell"	"TGFbeta1	177	185	Gene_or_gene_product"	"[{""token"": ""tumor"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Cancer""}, {""token"": ""tumor cells"", ""start_span"": 133, ""end_span"": 144, ""type"": ""Cell""}, {""token"": ""TGFbeta1"", ""start_span"": 177, ""end_span"": 185, ""type"": ""Gene_or_gene_product""}]"
Clinical, laboratory, histopathological, and pharmacological evidence support the notion that the coagulation system, which is activated in most cancer patients, plays an important role in tumor biology.	"cancer	145	151	Cancer"	"patients	152	160	Organism"	"tumor	189	194	Cancer"	"[{""token"": ""cancer"", ""start_span"": 145, ""end_span"": 151, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 152, ""end_span"": 160, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 189, ""end_span"": 194, ""type"": ""Cancer""}]"
Thrombin decreases the ability of endothelial cells to attach to basement membrane proteins.	"Thrombin	0	8	Gene_or_gene_product"	"endothelial cells	34	51	Cell"	"basement membrane	65	82	Cellular_component"	"[{""token"": ""Thrombin"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 34, ""end_span"": 51, ""type"": ""Cell""}, {""token"": ""basement membrane"", ""start_span"": 65, ""end_span"": 82, ""type"": ""Cellular_component""}]"
These results could explain the angiogenic and tumor - promoting effect of thrombin and provide the basis for development of thrombin receptor mimetics or antagonists for therapeutic application.	"tumor	47	52	Cancer"	"thrombin	75	83	Gene_or_gene_product"	"thrombin receptor	125	142	Gene_or_gene_product"	"[{""token"": ""tumor"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Cancer""}, {""token"": ""thrombin"", ""start_span"": 75, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""thrombin receptor"", ""start_span"": 125, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}]"
However, after they formed tumors in nude mice, every clone acquired high metastatic ability and the gene amplification increased, with elevated mRNA expression.	"tumors	27	33	Cancer"	"nude mice	37	46	Organism"	"clone	54	59	Cell"	"[{""token"": ""tumors"", ""start_span"": 27, ""end_span"": 33, ""type"": ""Cancer""}, {""token"": ""nude mice"", ""start_span"": 37, ""end_span"": 46, ""type"": ""Organism""}, {""token"": ""clone"", ""start_span"": 54, ""end_span"": 59, ""type"": ""Cell""}]"
The low metastatic and G - 418 - resistant H - 3 cells were co - cultured with BALB / c3T3 fibroblasts for 2 - 4 weeks.	"G - 418	23	30	Chemical"	"H - 3 cells	43	54	Cell"	"BALB / c3T3 fibroblasts	79	102	Cell"	"[{""token"": ""G - 418"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Chemical""}, {""token"": ""H - 3 cells"", ""start_span"": 43, ""end_span"": 54, ""type"": ""Cell""}, {""token"": ""BALB / c3T3 fibroblasts"", ""start_span"": 79, ""end_span"": 102, ""type"": ""Cell""}]"
Fibroblasts of the host animal may thus have an important role in generating enhanced metastatic activity of H - 3 cells.	"Fibroblasts	0	11	Cell"	"animal	24	30	Organism"	"H - 3 cells	109	120	Cell"	"[{""token"": ""Fibroblasts"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Cell""}, {""token"": ""animal"", ""start_span"": 24, ""end_span"": 30, ""type"": ""Organism""}, {""token"": ""H - 3 cells"", ""start_span"": 109, ""end_span"": 120, ""type"": ""Cell""}]"
Western blot analysis demonstrated a > 2. 5 - fold increase in Fas protein expression, as well as elevation of the active forms of both caspase - 8 and caspase - 3.	"Fas	63	66	Gene_or_gene_product"	"caspase - 8	136	147	Gene_or_gene_product"	"caspase - 3	152	163	Gene_or_gene_product"	"[{""token"": ""Fas"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""caspase - 8"", ""start_span"": 136, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""caspase - 3"", ""start_span"": 152, ""end_span"": 163, ""type"": ""Gene_or_gene_product""}]"
These results suggest that apoptosis caused by elevated expression of Fas is involved in chemoprevention by lactoferrin of colon carcinogenesis.	"Fas	70	73	Gene_or_gene_product"	"lactoferrin	108	119	Gene_or_gene_product"	"colon	123	128	Organ"	"[{""token"": ""Fas"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""lactoferrin"", ""start_span"": 108, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}, {""token"": ""colon"", ""start_span"": 123, ""end_span"": 128, ""type"": ""Organ""}]"
Dynein light chain 1, a p21 - activated kinase 1 - interacting substrate, promotes cancerous phenotypes.	"Dynein light chain 1	0	20	Gene_or_gene_product"	"p21 - activated kinase 1	24	48	Gene_or_gene_product"	"cancerous	83	92	Cancer"	"[{""token"": ""Dynein light chain 1"", ""start_span"": 0, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""p21 - activated kinase 1"", ""start_span"": 24, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancerous"", ""start_span"": 83, ""end_span"": 92, ""type"": ""Cancer""}]"
Pak1 associates with the complex of DLC1 and BimL, a proapoptotic BH3 - only protein, and phosphorylates both proteins.	"Pak1	0	4	Gene_or_gene_product"	"DLC1	36	40	Gene_or_gene_product"	"BimL	45	49	Gene_or_gene_product"	"[{""token"": ""Pak1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""DLC1"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""BimL"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}]"
Phosphorylation of BimL by Pak1 prevents it from interacting with and inactivation of Bcl - 2, an antiapoptotic protein.	"BimL	19	23	Gene_or_gene_product"	"Pak1	27	31	Gene_or_gene_product"	"Bcl - 2	86	93	Gene_or_gene_product"	"[{""token"": ""BimL"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""Pak1"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}]"
DLC1 protein level is elevated in more than 90% of human breast tumors.	"DLC1	0	4	Gene_or_gene_product"	"human	51	56	Organism"	"breast tumors	57	70	Cancer"	"[{""token"": ""DLC1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Organism""}, {""token"": ""breast tumors"", ""start_span"": 57, ""end_span"": 70, ""type"": ""Cancer""}]"
Matrix metalloproteinases can collectively cleave all components of the extracellular matrix, with the endogenous tissue inhibitor of metalloproteinase - 1 regulating their activity.	"Matrix metalloproteinases	0	25	Gene_or_gene_product"	"extracellular matrix	72	92	Cellular_component"	"tissue inhibitor of metalloproteinase - 1	114	155	Gene_or_gene_product"	"[{""token"": ""Matrix metalloproteinases"", ""start_span"": 0, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""extracellular matrix"", ""start_span"": 72, ""end_span"": 92, ""type"": ""Cellular_component""}, {""token"": ""tissue inhibitor of metalloproteinase - 1"", ""start_span"": 114, ""end_span"": 155, ""type"": ""Gene_or_gene_product""}]"
Immunohistochemistry scores for matrix metalloproteinase - 9 expression were significantly elevated compared to controls in scar endothelial cells and fibroblasts from 2 until 12 and 20 weeks, respectively.	"matrix metalloproteinase - 9	32	60	Gene_or_gene_product"	"scar endothelial cells	124	146	Cell"	"fibroblasts	151	162	Cell"	"[{""token"": ""matrix metalloproteinase - 9"", ""start_span"": 32, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""scar endothelial cells"", ""start_span"": 124, ""end_span"": 146, ""type"": ""Cell""}, {""token"": ""fibroblasts"", ""start_span"": 151, ""end_span"": 162, ""type"": ""Cell""}]"
These results show that matrix metalloproteinases are present at elevated levels during early wound healing, when angiogenesis occurs, and suggest that matrix metalloproteinase - 9 may play a significant role.	"matrix metalloproteinases	24	49	Gene_or_gene_product"	"wound	94	99	Pathological_formation"	"matrix metalloproteinase - 9	152	180	Gene_or_gene_product"	"[{""token"": ""matrix metalloproteinases"", ""start_span"": 24, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""wound"", ""start_span"": 94, ""end_span"": 99, ""type"": ""Pathological_formation""}, {""token"": ""matrix metalloproteinase - 9"", ""start_span"": 152, ""end_span"": 180, ""type"": ""Gene_or_gene_product""}]"
Enhanced IGF - 1 expression improves smooth muscle cell engraftment after cell transplantation.	"IGF - 1	9	16	Gene_or_gene_product"	"smooth muscle cell	37	55	Cell"	"cell	74	78	Cell"	"[{""token"": ""IGF - 1"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""smooth muscle cell"", ""start_span"": 37, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Cell""}]"
The functional benefit of cell transplantation after a myocardial infarction is diminished by early cell losses.	"cell	26	30	Cell"	"myocardial	55	65	Multi"	"cell	100	104	Cell"	"[{""token"": ""cell"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Cell""}, {""token"": ""myocardial"", ""start_span"": 55, ""end_span"": 65, ""type"": ""Multi""}, {""token"": ""cell"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Cell""}]"
The proportion of SMCs surviving in the implanted region was greater ( P less than 0. 05) in the IGF - 1 - transfected group than in the vector or cell controls.	"SMCs	18	22	Cell"	"IGF - 1	97	104	Gene_or_gene_product"	"cell	147	151	Cell"	"[{""token"": ""SMCs"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Cell""}, {""token"": ""IGF - 1"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Cell""}]"
Gene enhancement with IGF - 1 improved donor cell proliferation, survival, and engraftment after cell transplantation, perhaps mediated by enhanced angiogenesis and reduced apoptosis.	"IGF - 1	22	29	Gene_or_gene_product"	"donor cell	39	49	Cell"	"cell	97	101	Cell"	"[{""token"": ""IGF - 1"", ""start_span"": 22, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""donor cell"", ""start_span"": 39, ""end_span"": 49, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Cell""}]"
OBJECTIVE: To investigate the expression of PTEN and loss of heterozygosity ( LOH) of its epigenetic microsatellite in gastric carcinoma and explore their roles in progression of gastric carcinoma.	"PTEN	44	48	Gene_or_gene_product"	"gastric carcinoma	119	136	Cancer"	"gastric carcinoma	179	196	Cancer"	"[{""token"": ""PTEN"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric carcinoma"", ""start_span"": 119, ""end_span"": 136, ""type"": ""Cancer""}, {""token"": ""gastric carcinoma"", ""start_span"": 179, ""end_span"": 196, ""type"": ""Cancer""}]"
Expression of PTEN mRNA and protein in normal gastric mucosa and gastric cancer was evaluated by RT - PCR and SABC immunohistochemistry, respectively.	"PTEN	14	18	Gene_or_gene_product"	"gastric mucosa	46	60	Multi"	"gastric cancer	65	79	Cancer"	"[{""token"": ""PTEN"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric mucosa"", ""start_span"": 46, ""end_span"": 60, ""type"": ""Multi""}, {""token"": ""gastric cancer"", ""start_span"": 65, ""end_span"": 79, ""type"": ""Cancer""}]"
The positive rates of PTEN mRNA expression were 80. 4% ( 45 / 56), 45. 5% ( 5 / 11) and 32. 1% ( 18 / 56) in normal mucosa, early and advanced gastric carcinomas, respectively, while 78. 6% ( 44 / 56), 44. 5% ( 5 / 11) and 28. 6% ( 16 / 56) at the protein level.	"PTEN	22	26	Gene_or_gene_product"	"mucosa	116	122	Multi"	"gastric carcinomas	143	161	Cancer"	"[{""token"": ""PTEN"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""mucosa"", ""start_span"": 116, ""end_span"": 122, ""type"": ""Multi""}, {""token"": ""gastric carcinomas"", ""start_span"": 143, ""end_span"": 161, ""type"": ""Cancer""}]"
PTEN mRNA and protein were less frequently expressed in early and advanced gastric carcinomas than that in normal gastric mucosa ( P < 0. 05).	"PTEN	0	4	Gene_or_gene_product"	"gastric carcinomas	75	93	Cancer"	"gastric mucosa	114	128	Multi"	"[{""token"": ""PTEN"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric carcinomas"", ""start_span"": 75, ""end_span"": 93, ""type"": ""Cancer""}, {""token"": ""gastric mucosa"", ""start_span"": 114, ""end_span"": 128, ""type"": ""Multi""}]"
The expression of PTEN mRNA and protein was negatively correlated with lymph node metastasis of advanced gastric carcinomas ( P < 0. 05).	"PTEN	18	22	Gene_or_gene_product"	"lymph node	71	81	Multi"	"gastric carcinomas	105	123	Cancer"	"[{""token"": ""PTEN"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 71, ""end_span"": 81, ""type"": ""Multi""}, {""token"": ""gastric carcinomas"", ""start_span"": 105, ""end_span"": 123, ""type"": ""Cancer""}]"
3H - Cytosine arabinoside incorporation into the DNA was enhanced 1. 33 - to 18. 3 - fold over respective controls in 14 of 17 patients.	"3H - Cytosine arabinoside	0	25	Chemical"	"DNA	49	52	Cellular_component"	"patients	127	135	Organism"	"[{""token"": ""3H - Cytosine arabinoside"", ""start_span"": 0, ""end_span"": 25, ""type"": ""Chemical""}, {""token"": ""DNA"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Cellular_component""}, {""token"": ""patients"", ""start_span"": 127, ""end_span"": 135, ""type"": ""Organism""}]"
Silencing of monocarboxylate transporters via small interfering ribonucleic acid inhibits glycolysis and induces cell death in malignant glioma: an in vitro study.	"monocarboxylate transporters	13	41	Gene_or_gene_product"	"cell	113	117	Cell"	"malignant glioma	127	143	Cancer"	"[{""token"": ""monocarboxylate transporters"", ""start_span"": 13, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Cell""}, {""token"": ""malignant glioma"", ""start_span"": 127, ""end_span"": 143, ""type"": ""Cancer""}]"
Hypoxia - inducible factor - 1 ( HIF - 1) is one of the key mammalian transcription factors and shows increased levels in both protein stability and intrinsic transcriptional activity during low oxygen tension.	"Hypoxia - inducible factor - 1	0	30	Gene_or_gene_product"	"HIF - 1	33	40	Gene_or_gene_product"	"oxygen	195	201	Chemical"	"[{""token"": ""Hypoxia - inducible factor - 1"", ""start_span"": 0, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""oxygen"", ""start_span"": 195, ""end_span"": 201, ""type"": ""Chemical""}]"
Our data showed that under hypoxia the secreted sTie2 selectively inhibited tube formation and migration capacities of endothelial cells in vitro.	"sTie2	48	53	Gene_or_gene_product"	"tube	76	80	Tissue"	"endothelial cells	119	136	Cell"	"[{""token"": ""sTie2"", ""start_span"": 48, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""tube"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Tissue""}, {""token"": ""endothelial cells"", ""start_span"": 119, ""end_span"": 136, ""type"": ""Cell""}]"
Hence, we propose that the vector system, 5xHRE / SV40 / sTie2, might be a useful tool for down - regulating tumor angiogenesis under hypoxic condition.	"SV40	50	54	Gene_or_gene_product"	"sTie2	57	62	Gene_or_gene_product"	"tumor	109	114	Cancer"	"[{""token"": ""SV40"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""sTie2"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 109, ""end_span"": 114, ""type"": ""Cancer""}]"
Galpha ( 12), the alpha - subunit of the G12 family of heterotrimeric G proteins is involved in the regulation of cell proliferation and neoplastic transformation.	"G12	41	44	Gene_or_gene_product"	"heterotrimeric G proteins	55	80	Gene_or_gene_product"	"cell	114	118	Cell"	"[{""token"": ""G12"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""heterotrimeric G proteins"", ""start_span"": 55, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Cell""}]"
GTPase - deficient, constitutively activated mutant of Galpha ( 12) ( Galpha ( 12) Q229L or Galpha ( 12) QL) has been previously shown to induce oncogenic transformation of NIH3T3 cells promoting serum - and anchorage - independent growth.	"GTPase	0	6	Gene_or_gene_product"	"NIH3T3 cells	173	185	Cell"	"serum	196	201	Organism_substance"	"[{""token"": ""GTPase"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene_or_gene_product""}, {""token"": ""NIH3T3 cells"", ""start_span"": 173, ""end_span"": 185, ""type"": ""Cell""}, {""token"": ""serum"", ""start_span"": 196, ""end_span"": 201, ""type"": ""Organism_substance""}]"
Thus, our results from differential proteome analysis presented here report for the first time a role for SET in Galpha ( 12) - mediated signaling pathways and a role for Galpha ( 12) in the regulation of the leukemia - associated SET - protein expression.	"SET	106	109	Gene_or_gene_product"	"leukemia	209	217	Cancer"	"SET	231	234	Gene_or_gene_product"	"[{""token"": ""SET"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""leukemia"", ""start_span"": 209, ""end_span"": 217, ""type"": ""Cancer""}, {""token"": ""SET"", ""start_span"": 231, ""end_span"": 234, ""type"": ""Gene_or_gene_product""}]"
EXPERIMENTAL DESIGN: In the present study, we investigated the effects of 2ME2 alone and in combination with paclitaxel, an active agent in recurrent or advanced head and neck squamous cell carcinoma.	"2ME2	74	78	Chemical"	"paclitaxel	109	119	Chemical"	"head and neck squamous cell carcinoma	162	199	Cancer"	"[{""token"": ""2ME2"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Chemical""}, {""token"": ""paclitaxel"", ""start_span"": 109, ""end_span"": 119, ""type"": ""Chemical""}, {""token"": ""head and neck squamous cell carcinoma"", ""start_span"": 162, ""end_span"": 199, ""type"": ""Cancer""}]"
CONCLUSIONS: These results provide support for the use of 2ME2 in combination with paclitaxel for the treatment of recurrent or advanced head and neck squamous cell carcinoma.	"2ME2	58	62	Chemical"	"paclitaxel	83	93	Chemical"	"head and neck squamous cell carcinoma	137	174	Cancer"	"[{""token"": ""2ME2"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Chemical""}, {""token"": ""paclitaxel"", ""start_span"": 83, ""end_span"": 93, ""type"": ""Chemical""}, {""token"": ""head and neck squamous cell carcinoma"", ""start_span"": 137, ""end_span"": 174, ""type"": ""Cancer""}]"
Key players in this process are the hypoxia - inducible factors ( HIF - 1alpha to 3alpha).	"hypoxia - inducible factors	36	63	Gene_or_gene_product"	"HIF - 1alpha	66	78	Gene_or_gene_product"	"3alpha	82	88	Gene_or_gene_product"	"[{""token"": ""hypoxia - inducible factors"", ""start_span"": 36, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1alpha"", ""start_span"": 66, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""3alpha"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}]"
With regard to differentiation, hypoxic cells lost their neuronal / neuroendocrine features and gained marker gene expression associated with an immature, neural crest - like phenotype.	"hypoxic cells	32	45	Cell"	"neuronal	57	65	Cell"	"neuroendocrine	68	82	Cell"	"[{""token"": ""hypoxic cells"", ""start_span"": 32, ""end_span"": 45, ""type"": ""Cell""}, {""token"": ""neuronal"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Cell""}, {""token"": ""neuroendocrine"", ""start_span"": 68, ""end_span"": 82, ""type"": ""Cell""}]"
One such receptor, VEGFR - 2 / KDR, plays a key role in VEGF - induced angiogenesis.	"VEGFR - 2	19	28	Gene_or_gene_product"	"KDR	31	34	Gene_or_gene_product"	"VEGF	56	60	Gene_or_gene_product"	"[{""token"": ""VEGFR - 2"", ""start_span"": 19, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}]"
Here, we expressed the catalytic domain of VEGFR - 2 as a soluble active kinase using Bac - to - Bac expression system, and investigated correlations between VEGFR - 2 activity and enzyme concentration, ATP concentration, substrate concentration and divalent cation type.	"VEGFR - 2	43	52	Gene_or_gene_product"	"VEGFR - 2	158	167	Gene_or_gene_product"	"ATP	203	206	Chemical"	"[{""token"": ""VEGFR - 2"", ""start_span"": 43, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 2"", ""start_span"": 158, ""end_span"": 167, ""type"": ""Gene_or_gene_product""}, {""token"": ""ATP"", ""start_span"": 203, ""end_span"": 206, ""type"": ""Chemical""}]"
Hemostatic factors play a crucial role in generating thrombotic plugs at sites of vascular damage ( atherothrombosis).	"Hemostatic factors	0	18	Gene_or_gene_product"	"thrombotic plugs	53	69	Pathological_formation"	"vascular	82	90	Multi"	"[{""token"": ""Hemostatic factors"", ""start_span"": 0, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""thrombotic plugs"", ""start_span"": 53, ""end_span"": 69, ""type"": ""Pathological_formation""}, {""token"": ""vascular"", ""start_span"": 82, ""end_span"": 90, ""type"": ""Multi""}]"
Autopsy studies have revealed that intimal thickening represents the first stage of atherosclerosis and that lipid - rich plaque arises from such lesions.	"intimal	35	42	Tissue"	"lipid - rich plaque	109	128	Pathological_formation"	"lesions	146	153	Pathological_formation"	"[{""token"": ""intimal"", ""start_span"": 35, ""end_span"": 42, ""type"": ""Tissue""}, {""token"": ""lipid - rich plaque"", ""start_span"": 109, ""end_span"": 128, ""type"": ""Pathological_formation""}, {""token"": ""lesions"", ""start_span"": 146, ""end_span"": 153, ""type"": ""Pathological_formation""}]"
Platelets release several growth factors and bioactive agents that play a central role in development of not only thrombus but also of intimal thickening.	"Platelets	0	9	Cell"	"thrombus	114	122	Pathological_formation"	"intimal	135	142	Tissue"	"[{""token"": ""Platelets"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Cell""}, {""token"": ""thrombus"", ""start_span"": 114, ""end_span"": 122, ""type"": ""Pathological_formation""}, {""token"": ""intimal"", ""start_span"": 135, ""end_span"": 142, ""type"": ""Tissue""}]"
Factors including thrombin and fibrin, which are downstream of the coagulation cascade activated by TF, also contribute to atherosclerosis.	"thrombin	18	26	Gene_or_gene_product"	"fibrin	31	37	Gene_or_gene_product"	"TF	100	102	Gene_or_gene_product"	"[{""token"": ""thrombin"", ""start_span"": 18, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibrin"", ""start_span"": 31, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""TF"", ""start_span"": 100, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}]"
Hereditary paraganglioma / pheochromocytoma and inherited succinate dehydrogenase deficiency.	"paraganglioma	11	24	Cancer"	"pheochromocytoma	27	43	Cancer"	"succinate dehydrogenase	58	81	Gene_or_gene_product"	"[{""token"": ""paraganglioma"", ""start_span"": 11, ""end_span"": 24, ""type"": ""Cancer""}, {""token"": ""pheochromocytoma"", ""start_span"": 27, ""end_span"": 43, ""type"": ""Cancer""}, {""token"": ""succinate dehydrogenase"", ""start_span"": 58, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}]"
These discoveries have dramatically changed the work - up and genetic counseling of patients and families with paragangliomas and / or pheochromocytomas.	"patients	84	92	Organism"	"paragangliomas	111	125	Cancer"	"pheochromocytomas	135	152	Cancer"	"[{""token"": ""patients"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Organism""}, {""token"": ""paragangliomas"", ""start_span"": 111, ""end_span"": 125, ""type"": ""Cancer""}, {""token"": ""pheochromocytomas"", ""start_span"": 135, ""end_span"": 152, ""type"": ""Cancer""}]"
The INK4 family of proteins negatively regulates cell cycle progression at the G ( 1) - S transition by inhibiting cyclin - dependent kinases.	"INK4	4	8	Gene_or_gene_product"	"cell	49	53	Cell"	"cyclin - dependent kinases	115	141	Gene_or_gene_product"	"[{""token"": ""INK4"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Cell""}, {""token"": ""cyclin - dependent kinases"", ""start_span"": 115, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}]"
We conducted a retrospective medical record review of patients treated with rofecoxib for acute haemarthrosis, chronic synovitis, target joint or pain.	"patients	54	62	Organism"	"rofecoxib	76	85	Chemical"	"joint	137	142	Multi"	"[{""token"": ""patients"", ""start_span"": 54, ""end_span"": 62, ""type"": ""Organism""}, {""token"": ""rofecoxib"", ""start_span"": 76, ""end_span"": 85, ""type"": ""Chemical""}, {""token"": ""joint"", ""start_span"": 137, ""end_span"": 142, ""type"": ""Multi""}]"
Angiostatin and thalidomide both inhibited tumor growth by about 55%.	"Angiostatin	0	11	Gene_or_gene_product"	"thalidomide	16	27	Chemical"	"tumor	43	48	Cancer"	"[{""token"": ""Angiostatin"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""thalidomide"", ""start_span"": 16, ""end_span"": 27, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Cancer""}]"
BACKGROUND: The effects of a rectified semi - sinewave signal ( 15 mT amplitude, 120 pulses per second, EMF Therapeutics, Inc.) ( TEMF) alone and in combination with gamma irradiation ( IR) therapy in nude mice bearing a human MDA MB231 breast cancer xenograft were tested.	"nude mice	201	210	Organism"	"human	221	226	Organism"	"MDA MB231 breast cancer xenograft	227	260	Cancer"	"[{""token"": ""nude mice"", ""start_span"": 201, ""end_span"": 210, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 221, ""end_span"": 226, ""type"": ""Organism""}, {""token"": ""MDA MB231 breast cancer xenograft"", ""start_span"": 227, ""end_span"": 260, ""type"": ""Cancer""}]"
RESULTS: Most tumors less than 35 mm3 were white but tumors greater than 35 mm3 were pink and had a vascularized capsule.	"tumors	14	20	Cancer"	"tumors	53	59	Cancer"	"capsule	113	120	Cancer"	"[{""token"": ""tumors"", ""start_span"": 14, ""end_span"": 20, ""type"": ""Cancer""}, {""token"": ""tumors"", ""start_span"": 53, ""end_span"": 59, ""type"": ""Cancer""}, {""token"": ""capsule"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Cancer""}]"
The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.	"adenomatous polyposis coli	23	49	Gene_or_gene_product"	"mouse	62	67	Organism"	"intestinal	68	78	Organ"	"[{""token"": ""adenomatous polyposis coli"", ""start_span"": 23, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Organism""}, {""token"": ""intestinal"", ""start_span"": 68, ""end_span"": 78, ""type"": ""Organ""}]"
Although both hypomorphic heterozygotes developed intestinal polyps, tumor multiplicities were much lower than that in Apc ( Delta716) mice, heterozygotes of an Apc null allele.	"intestinal polyps	50	67	Pathological_formation"	"tumor	69	74	Cancer"	"Apc	119	122	Gene_or_gene_product"	"[{""token"": ""intestinal polyps"", ""start_span"": 50, ""end_span"": 67, ""type"": ""Pathological_formation""}, {""token"": ""tumor"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Cancer""}, {""token"": ""Apc"", ""start_span"": 119, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}]"
We further estimated the threshold of APC protein level that forms one polyp per mouse as approximately 15% of the wild type.	"APC	38	41	Gene_or_gene_product"	"polyp	71	76	Pathological_formation"	"mouse	81	86	Organism"	"[{""token"": ""APC"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""polyp"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Pathological_formation""}, {""token"": ""mouse"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Organism""}]"
Recent studies on factors involved in tumor vascular development have identified new therapeutic targets for inhibiting tumor neovascularization and thus tumor progression.	"tumor vascular	38	52	Multi"	"tumor	120	125	Cancer"	"tumor	154	159	Cancer"	"[{""token"": ""tumor vascular"", ""start_span"": 38, ""end_span"": 52, ""type"": ""Multi""}, {""token"": ""tumor"", ""start_span"": 120, ""end_span"": 125, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 154, ""end_span"": 159, ""type"": ""Cancer""}]"
However, the process of tumor blood vessel formation is complex, and each tumor exhibits unique features in its vasculature.	"tumor blood vessel	24	42	Multi"	"tumor	74	79	Cancer"	"vasculature	112	123	Multi"	"[{""token"": ""tumor blood vessel"", ""start_span"": 24, ""end_span"": 42, ""type"": ""Multi""}, {""token"": ""tumor"", ""start_span"": 74, ""end_span"": 79, ""type"": ""Cancer""}, {""token"": ""vasculature"", ""start_span"": 112, ""end_span"": 123, ""type"": ""Multi""}]"
In addition, selected novel classes of antivascular therapies, including those targeting tumor endothelial cells and other components of the tumor vasculature, are summarized.	"antivascular	39	51	Multi"	"tumor endothelial cells	89	112	Cell"	"tumor vasculature	141	158	Multi"	"[{""token"": ""antivascular"", ""start_span"": 39, ""end_span"": 51, ""type"": ""Multi""}, {""token"": ""tumor endothelial cells"", ""start_span"": 89, ""end_span"": 112, ""type"": ""Cell""}, {""token"": ""tumor vasculature"", ""start_span"": 141, ""end_span"": 158, ""type"": ""Multi""}]"
Converging studies from many investigators indicate that RUNX1 has a critical role in the correct maintenance of essential cellular functions during embryonic development and after birth.	"RUNX1	57	62	Gene_or_gene_product"	"cellular	123	131	Cell"	"embryonic	149	158	Developing_anatomical_structure"	"[{""token"": ""RUNX1"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 123, ""end_span"": 131, ""type"": ""Cell""}, {""token"": ""embryonic"", ""start_span"": 149, ""end_span"": 158, ""type"": ""Developing_anatomical_structure""}]"
The discovery that this gene is also frequently mutated in human leukemia has increased the interest in the role that RUNX1 plays in both normal and transforming pathways.	"human	59	64	Organism"	"leukemia	65	73	Cancer"	"RUNX1	118	123	Gene_or_gene_product"	"[{""token"": ""human"", ""start_span"": 59, ""end_span"": 64, ""type"": ""Organism""}, {""token"": ""leukemia"", ""start_span"": 65, ""end_span"": 73, ""type"": ""Cancer""}, {""token"": ""RUNX1"", ""start_span"": 118, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}]"
Domain 5 of cleaved high molecular weight kininogen inhibits endothelial cell migration through Akt.	"high molecular weight kininogen	20	51	Gene_or_gene_product"	"endothelial cell	61	77	Cell"	"Akt	96	99	Gene_or_gene_product"	"[{""token"": ""high molecular weight kininogen"", ""start_span"": 20, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 61, ""end_span"": 77, ""type"": ""Cell""}, {""token"": ""Akt"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}]"
Angiogenesis, new blood vessel formation, is a multistep process, precisely regulated by pro - angiogenic cytokines, which stimulate endothelial cells to migrate, proliferate and differentiate to form new capillary microvessels.	"blood vessel	18	30	Multi"	"endothelial cells	133	150	Cell"	"capillary microvessels	205	227	Tissue"	"[{""token"": ""blood vessel"", ""start_span"": 18, ""end_span"": 30, ""type"": ""Multi""}, {""token"": ""endothelial cells"", ""start_span"": 133, ""end_span"": 150, ""type"": ""Cell""}, {""token"": ""capillary microvessels"", ""start_span"": 205, ""end_span"": 227, ""type"": ""Tissue""}]"
Excessive vascular development and blood vessel remodeling appears in psoriasis, rheumatoid arthritis, diabetic retinopathy and solid tumors formation.	"vascular	10	18	Multi"	"blood vessel	35	47	Multi"	"solid tumors	128	140	Cancer"	"[{""token"": ""vascular"", ""start_span"": 10, ""end_span"": 18, ""type"": ""Multi""}, {""token"": ""blood vessel"", ""start_span"": 35, ""end_span"": 47, ""type"": ""Multi""}, {""token"": ""solid tumors"", ""start_span"": 128, ""end_span"": 140, ""type"": ""Cancer""}]"
Administration of thalidomide at the concentration of 0. 01 microM increased cell migration, while at 10 microM, it decreased cell migration.	"thalidomide	18	29	Chemical"	"cell	77	81	Cell"	"cell	126	130	Cell"	"[{""token"": ""thalidomide"", ""start_span"": 18, ""end_span"": 29, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Cell""}]"
Thalidomide in concentrations from 0. 1 microM to 10 microM did not change cell proliferation of 72 - h cell cultures.	"Thalidomide	0	11	Chemical"	"cell	75	79	Cell"	"cell cultures	104	117	Cell"	"[{""token"": ""Thalidomide"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Cell""}, {""token"": ""cell cultures"", ""start_span"": 104, ""end_span"": 117, ""type"": ""Cell""}]"
We conclude that anti - angiogenic action of thalidomide is due to direct inhibitory action on VEGF secretion and capillary microvessel formation as well as immunomodulatory influence on EA. hy 926 cells migration and adhesion.	"thalidomide	45	56	Chemical"	"VEGF	95	99	Gene_or_gene_product"	"capillary microvessel	114	135	Tissue"	"[{""token"": ""thalidomide"", ""start_span"": 45, ""end_span"": 56, ""type"": ""Chemical""}, {""token"": ""VEGF"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""capillary microvessel"", ""start_span"": 114, ""end_span"": 135, ""type"": ""Tissue""}]"
Regulation of skin microvasculature angiogenesis, cell migration, and permeability by a specific inhibitor of PKCalpha.	"skin microvasculature	14	35	Tissue"	"cell	50	54	Cell"	"PKCalpha	110	118	Gene_or_gene_product"	"[{""token"": ""skin microvasculature"", ""start_span"": 14, ""end_span"": 35, ""type"": ""Tissue""}, {""token"": ""cell"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Cell""}, {""token"": ""PKCalpha"", ""start_span"": 110, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}]"
These studies therefore indicate a specific and a regulatory role of the PKCalpha isoform in three major endothelial cell functions that are important in the maintenance of microvascular homeostasis.	"PKCalpha	73	81	Gene_or_gene_product"	"endothelial cell	105	121	Cell"	"microvascular	173	186	Tissue"	"[{""token"": ""PKCalpha"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 105, ""end_span"": 121, ""type"": ""Cell""}, {""token"": ""microvascular"", ""start_span"": 173, ""end_span"": 186, ""type"": ""Tissue""}]"
hTERT activity is associated with nodal metastases and cellular proliferation.	"hTERT	0	5	Gene_or_gene_product"	"nodal	34	39	Multi"	"cellular	55	63	Cell"	"[{""token"": ""hTERT"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""nodal"", ""start_span"": 34, ""end_span"": 39, ""type"": ""Multi""}, {""token"": ""cellular"", ""start_span"": 55, ""end_span"": 63, ""type"": ""Cell""}]"
An understanding of the molecular basis of TSP - 1 - mediated inhibition of angiogenesis and tumor progression will aid in the development of novel therapeutics for the treatment of cancer.	"TSP - 1	43	50	Gene_or_gene_product"	"tumor	93	98	Cancer"	"cancer	182	188	Cancer"	"[{""token"": ""TSP - 1"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 93, ""end_span"": 98, ""type"": ""Cancer""}, {""token"": ""cancer"", ""start_span"": 182, ""end_span"": 188, ""type"": ""Cancer""}]"
The ability of LRP - 1 to regulate expression of the factors identified here suggests a role for LRP - 1 in determining blood vessel structure and in angiogenesis.	"LRP - 1	15	22	Gene_or_gene_product"	"LRP - 1	97	104	Gene_or_gene_product"	"blood vessel	120	132	Multi"	"[{""token"": ""LRP - 1"", ""start_span"": 15, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""LRP - 1"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""blood vessel"", ""start_span"": 120, ""end_span"": 132, ""type"": ""Multi""}]"
Similarly, flow cytometric measurements revealed that leukocyte apoptosis was increased in MTX - treated animals, while L - Car reversed these effects.	"leukocyte	54	63	Cell"	"MTX	91	94	Chemical"	"L - Car	120	127	Chemical"	"[{""token"": ""leukocyte"", ""start_span"": 54, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""MTX"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Chemical""}, {""token"": ""L - Car"", ""start_span"": 120, ""end_span"": 127, ""type"": ""Chemical""}]"
Together, these findings suggest that NCAM may limit tumor cell metastasis by stabilizing the microvessel wall.	"NCAM	38	42	Gene_or_gene_product"	"tumor cell	53	63	Cell"	"microvessel wall	94	110	Tissue"	"[{""token"": ""NCAM"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cell"", ""start_span"": 53, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""microvessel wall"", ""start_span"": 94, ""end_span"": 110, ""type"": ""Tissue""}]"
NF - kappaB and IKK as therapeutic targets in cancer.	"NF - kappaB	0	11	Gene_or_gene_product"	"IKK	16	19	Gene_or_gene_product"	"cancer	46	52	Cancer"	"[{""token"": ""NF - kappaB"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""IKK"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer"", ""start_span"": 46, ""end_span"": 52, ""type"": ""Cancer""}]"
A role for NF - kappaB in cancer cells appears to involve regulation of cell proliferation, control of apoptosis, promotion of angiogenesis, and stimulation of invasion / metastasis.	"NF - kappaB	11	22	Gene_or_gene_product"	"cancer cells	26	38	Cell"	"cell	72	76	Cell"	"[{""token"": ""NF - kappaB"", ""start_span"": 11, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer cells"", ""start_span"": 26, ""end_span"": 38, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 72, ""end_span"": 76, ""type"": ""Cell""}]"
However, other experimental data indicate that NF - kappaB can play a tumor suppressor role in certain settings and that it can be important in promoting an apoptotic signal downstream of certain cancer therapy regimens.	"NF - kappaB	47	58	Gene_or_gene_product"	"tumor	70	75	Cancer"	"cancer	196	202	Cancer"	"[{""token"": ""NF - kappaB"", ""start_span"": 47, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 70, ""end_span"": 75, ""type"": ""Cancer""}, {""token"": ""cancer"", ""start_span"": 196, ""end_span"": 202, ""type"": ""Cancer""}]"
Runx2 and MYC collaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivo.	"Runx2	0	5	Gene_or_gene_product"	"MYC	10	13	Gene_or_gene_product"	"lymphoma	29	37	Cancer"	"[{""token"": ""Runx2"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""MYC"", ""start_span"": 10, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymphoma"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Cancer""}]"
As shown previously, ectopic expression of Runx2 in the thymus leads to a preneoplastic state defined by an accumulation of cells with an immature phenotype and a low proliferative rate.	"Runx2	43	48	Gene_or_gene_product"	"thymus	56	62	Organ"	"cells	124	129	Cell"	"[{""token"": ""Runx2"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""thymus"", ""start_span"": 56, ""end_span"": 62, ""type"": ""Organ""}, {""token"": ""cells"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Cell""}]"
Furthermore, the Runx2 / MYC combination overcomes the requirement for genetic inactivation of the p53 pathway in vivo.	"Runx2	17	22	Gene_or_gene_product"	"MYC	25	28	Gene_or_gene_product"	"p53	99	102	Gene_or_gene_product"	"[{""token"": ""Runx2"", ""start_span"": 17, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""MYC"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}]"
Paclitaxel, a potent anti - neoplastic agent, has been found to be effective against several tumours, including cervical cancer.	"Paclitaxel	0	10	Chemical"	"tumours	93	100	Cancer"	"cervical cancer	112	127	Cancer"	"[{""token"": ""Paclitaxel"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Chemical""}, {""token"": ""tumours"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Cancer""}, {""token"": ""cervical cancer"", ""start_span"": 112, ""end_span"": 127, ""type"": ""Cancer""}]"
The aim of this study was to investigate the molecular pathway of the cytotoxic effect of paclitaxel in human cervical cancer cell lines.	"paclitaxel	90	100	Chemical"	"human	104	109	Organism"	"cervical cancer cell lines	110	136	Cell"	"[{""token"": ""paclitaxel"", ""start_span"": 90, ""end_span"": 100, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 104, ""end_span"": 109, ""type"": ""Organism""}, {""token"": ""cervical cancer cell lines"", ""start_span"": 110, ""end_span"": 136, ""type"": ""Cell""}]"
Four human cervical cancer cell lines were treated for 24 h with various concentration of paclitaxel, and the sensitivity was analysed by an MTT assay.	"human	5	10	Organism"	"cervical cancer cell lines	11	37	Cell"	"paclitaxel	90	100	Chemical"	"[{""token"": ""human"", ""start_span"": 5, ""end_span"": 10, ""type"": ""Organism""}, {""token"": ""cervical cancer cell lines"", ""start_span"": 11, ""end_span"": 37, ""type"": ""Cell""}, {""token"": ""paclitaxel"", ""start_span"": 90, ""end_span"": 100, ""type"": ""Chemical""}]"
Our results showed that HeLa cells demonstrated the highest sensitivity to paclitaxel, whereas CaSki cells showed the lowest.	"HeLa cells	24	34	Cell"	"paclitaxel	75	85	Chemical"	"CaSki cells	95	106	Cell"	"[{""token"": ""HeLa cells"", ""start_span"": 24, ""end_span"": 34, ""type"": ""Cell""}, {""token"": ""paclitaxel"", ""start_span"": 75, ""end_span"": 85, ""type"": ""Chemical""}, {""token"": ""CaSki cells"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Cell""}]"
Another marker being investigated in the context of vascular dysfunction and coagulopathy is the endothelial microparticle ( EMP).	"vascular	52	60	Multi"	"endothelial microparticle	97	122	Cellular_component"	"EMP	125	128	Cellular_component"	"[{""token"": ""vascular"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Multi""}, {""token"": ""endothelial microparticle"", ""start_span"": 97, ""end_span"": 122, ""type"": ""Cellular_component""}, {""token"": ""EMP"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Cellular_component""}]"
GDP and AGE receptors: mechanisms of peritoneal damage.	"GDP	0	3	Chemical"	"AGE	8	11	Chemical"	"peritoneal	37	47	Multi"	"[{""token"": ""GDP"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Chemical""}, {""token"": ""AGE"", ""start_span"": 8, ""end_span"": 11, ""type"": ""Chemical""}, {""token"": ""peritoneal"", ""start_span"": 37, ""end_span"": 47, ""type"": ""Multi""}]"
Structural changes were promoted by toxicity of glucose degradation products ( GDPs) which are generated during heat sterilization in peritoneal dialysis fluids ( PDFs).	"glucose degradation products	48	76	Chemical"	"GDPs	79	83	Chemical"	"peritoneal	134	144	Multi"	"[{""token"": ""glucose degradation products"", ""start_span"": 48, ""end_span"": 76, ""type"": ""Chemical""}, {""token"": ""GDPs"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Chemical""}, {""token"": ""peritoneal"", ""start_span"": 134, ""end_span"": 144, ""type"": ""Multi""}]"
Besides their direct toxicity GDPs promote formation of advanced glycation endproducts ( AGEs).	"GDPs	30	34	Chemical"	"advanced glycation endproducts	56	86	Chemical"	"AGEs	89	93	Chemical"	"[{""token"": ""GDPs"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Chemical""}, {""token"": ""advanced glycation endproducts"", ""start_span"": 56, ""end_span"": 86, ""type"": ""Chemical""}, {""token"": ""AGEs"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Chemical""}]"
The effects of PDFs with different amounts of GDPs were compared on morphological changes in the peritoneal membrane in a RAGE - / - mouse model.	"GDPs	46	50	Chemical"	"peritoneal membrane	97	116	Multi"	"RAGE	122	126	Gene_or_gene_product"	"[{""token"": ""GDPs"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Chemical""}, {""token"": ""peritoneal membrane"", ""start_span"": 97, ""end_span"": 116, ""type"": ""Multi""}, {""token"": ""RAGE"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}]"
Hyperfibrinogenemia ( > 310 mg / dl) was independently associated with lymph node ( Odds Ratio; 2. 342, P = 0. 0032) and liver ( Odds Ratio; 2. 933, P = 0. 0147) metastasis, not with peritoneal metastasis in this series.	"lymph node	71	81	Multi"	"liver	121	126	Organ"	"peritoneal	183	193	Multi"	"[{""token"": ""lymph node"", ""start_span"": 71, ""end_span"": 81, ""type"": ""Multi""}, {""token"": ""liver"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Organ""}, {""token"": ""peritoneal"", ""start_span"": 183, ""end_span"": 193, ""type"": ""Multi""}]"
CONCLUSION: Our results might support the idea that hyperfibrinogenemia can augment lymphatic and hematogeneous metastasis of advanced gastric cancer, which is major determinant of the prognosis in T2 gastric cancer.	"lymphatic	84	93	Cell"	"gastric cancer	135	149	Cancer"	"T2 gastric cancer	198	215	Cancer"	"[{""token"": ""lymphatic"", ""start_span"": 84, ""end_span"": 93, ""type"": ""Cell""}, {""token"": ""gastric cancer"", ""start_span"": 135, ""end_span"": 149, ""type"": ""Cancer""}, {""token"": ""T2 gastric cancer"", ""start_span"": 198, ""end_span"": 215, ""type"": ""Cancer""}]"
Our aim is to verify the alterations in the HRK gene in primary central nervous system lymphomas ( PCNSLs).	"HRK	44	47	Gene_or_gene_product"	"primary central nervous system lymphomas	56	96	Cancer"	"PCNSLs	99	105	Cancer"	"[{""token"": ""HRK"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""primary central nervous system lymphomas"", ""start_span"": 56, ""end_span"": 96, ""type"": ""Cancer""}, {""token"": ""PCNSLs"", ""start_span"": 99, ""end_span"": 105, ""type"": ""Cancer""}]"
RESULTS: A total of 13 PCNSLs ( 31%) demonstrated hypermethylation in either the promoter or exon 1; loss of HRK expression was immunohistochemically observed in 9 tumors and was significantly associated with promoter methylation.	"PCNSLs	23	29	Cancer"	"HRK	109	112	Gene_or_gene_product"	"tumors	164	170	Cancer"	"[{""token"": ""PCNSLs"", ""start_span"": 23, ""end_span"": 29, ""type"": ""Cancer""}, {""token"": ""HRK"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 164, ""end_span"": 170, ""type"": ""Cancer""}]"
Comet assay revealed a late onset of DNA breaks in the presence of 2 - DG following irradiation only in spheroids, which corroborated well with the late onset of oxidative stress.	"DNA	37	40	Cellular_component"	"2 - DG	67	73	Chemical"	"spheroids	104	113	Cell"	"[{""token"": ""DNA"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Cellular_component""}, {""token"": ""2 - DG"", ""start_span"": 67, ""end_span"": 73, ""type"": ""Chemical""}, {""token"": ""spheroids"", ""start_span"": 104, ""end_span"": 113, ""type"": ""Cell""}]"
There is evidence in experimental and clinical studies that adult bone marrow - derived stem cells and endothelial progenitor cells participate in the development of new blood vessels, called neoangiogenesis or neovascularization.	"bone marrow - derived stem cells	66	98	Cell"	"endothelial progenitor cells	103	131	Cell"	"blood vessels	170	183	Multi"	"[{""token"": ""bone marrow - derived stem cells"", ""start_span"": 66, ""end_span"": 98, ""type"": ""Cell""}, {""token"": ""endothelial progenitor cells"", ""start_span"": 103, ""end_span"": 131, ""type"": ""Cell""}, {""token"": ""blood vessels"", ""start_span"": 170, ""end_span"": 183, ""type"": ""Multi""}]"
We examined the effect of distraction rate on blood vessel growth in intramembraneous ossification after vertical distraction osteogenesis in the human mandible.	"blood vessel	46	58	Multi"	"human	146	151	Organism"	"mandible	152	160	Organ"	"[{""token"": ""blood vessel"", ""start_span"": 46, ""end_span"": 58, ""type"": ""Multi""}, {""token"": ""human"", ""start_span"": 146, ""end_span"": 151, ""type"": ""Organism""}, {""token"": ""mandible"", ""start_span"": 152, ""end_span"": 160, ""type"": ""Organ""}]"
Six edentulous patients ( aged 60 + / - 9 years) with a severely atrophic mandible underwent bone augmentation with distraction osteogenesis.	"patients	15	23	Organism"	"mandible	74	82	Organ"	"bone	93	97	Tissue"	"[{""token"": ""patients"", ""start_span"": 15, ""end_span"": 23, ""type"": ""Organism""}, {""token"": ""mandible"", ""start_span"": 74, ""end_span"": 82, ""type"": ""Organ""}, {""token"": ""bone"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Tissue""}]"
For distraction of the human mandible in elderly patients, a distraction rate of 0. 5 mm / day seems beneficial.	"human	23	28	Organism"	"mandible	29	37	Organ"	"patients	49	57	Organism"	"[{""token"": ""human"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Organism""}, {""token"": ""mandible"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Organ""}, {""token"": ""patients"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Organism""}]"
AIM: To determine whether a variety of ciliary body tumours synthesise opticin to characterise further its role in ciliary body health and disease.	"ciliary body tumours	39	59	Cancer"	"opticin	71	78	Gene_or_gene_product"	"ciliary body	115	127	Multi"	"[{""token"": ""ciliary body tumours"", ""start_span"": 39, ""end_span"": 59, ""type"": ""Cancer""}, {""token"": ""opticin"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""ciliary body"", ""start_span"": 115, ""end_span"": 127, ""type"": ""Multi""}]"
Punica granatum ( pomegranate) and its potential for prevention and treatment of inflammation and cancer.	"Punica granatum	0	15	Organism"	"pomegranate	18	29	Organism"	"cancer	98	104	Cancer"	"[{""token"": ""Punica granatum"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Organism""}, {""token"": ""pomegranate"", ""start_span"": 18, ""end_span"": 29, ""type"": ""Organism""}, {""token"": ""cancer"", ""start_span"": 98, ""end_span"": 104, ""type"": ""Cancer""}]"
The pomegranate tree, Punica granatum, especially its fruit, possesses a vast ethnomedical history and represents a phytochemical reservoir of heuristic medicinal value.	"pomegranate	4	15	Organism"	"tree	16	20	Organism_subdivision"	"Punica granatum	22	37	Organism"	"[{""token"": ""pomegranate"", ""start_span"": 4, ""end_span"": 15, ""type"": ""Organism""}, {""token"": ""tree"", ""start_span"": 16, ""end_span"": 20, ""type"": ""Organism_subdivision""}, {""token"": ""Punica granatum"", ""start_span"": 22, ""end_span"": 37, ""type"": ""Organism""}]"
These data suggest that inhibition of B16F10 melanoma metastasis by rk - 2 was caused by inhibition of neovascularization and reduction of matrix metalloproteinase expression.	"B16F10 melanoma	38	53	Cancer"	"rk - 2	68	74	Gene_or_gene_product"	"matrix metalloproteinase	139	163	Gene_or_gene_product"	"[{""token"": ""B16F10 melanoma"", ""start_span"": 38, ""end_span"": 53, ""type"": ""Cancer""}, {""token"": ""rk - 2"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix metalloproteinase"", ""start_span"": 139, ""end_span"": 163, ""type"": ""Gene_or_gene_product""}]"
WIT003, as well as pure 20 - HETE, stimulated EC proliferation by approximately 40%.	"WIT003	0	6	Chemical"	"20 - HETE	24	33	Chemical"	"EC	46	48	Cell"	"[{""token"": ""WIT003"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Chemical""}, {""token"": ""20 - HETE"", ""start_span"": 24, ""end_span"": 33, ""type"": ""Chemical""}, {""token"": ""EC"", ""start_span"": 46, ""end_span"": 48, ""type"": ""Cell""}]"
We have reported important benefits and survival with an immunotherapy schedule in patients with endocrine - dependent breast cancer and distant metastases.	"patients	83	91	Organism"	"endocrine	97	106	Anatomical_system"	"breast cancer	119	132	Cancer"	"[{""token"": ""patients"", ""start_span"": 83, ""end_span"": 91, ""type"": ""Organism""}, {""token"": ""endocrine"", ""start_span"": 97, ""end_span"": 106, ""type"": ""Anatomical_system""}, {""token"": ""breast cancer"", ""start_span"": 119, ""end_span"": 132, ""type"": ""Cancer""}]"
Furthermore, Trib1 by itself is a novel myeloid oncogene, enhancing phosphorylation of ERK, resulting in inhibition of apoptosis.	"Trib1	13	18	Gene_or_gene_product"	"myeloid	40	47	Cell"	"ERK	87	90	Gene_or_gene_product"	"[{""token"": ""Trib1"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""myeloid"", ""start_span"": 40, ""end_span"": 47, ""type"": ""Cell""}, {""token"": ""ERK"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}]"
Organic peroxides, widely used in the chemical and pharmaceutical industries, can act as skin tumor promoters and cause epidermal hyperplasia.	"Organic peroxides	0	17	Chemical"	"skin tumor	89	99	Cancer"	"epidermal hyperplasia	120	141	Pathological_formation"	"[{""token"": ""Organic peroxides"", ""start_span"": 0, ""end_span"": 17, ""type"": ""Chemical""}, {""token"": ""skin tumor"", ""start_span"": 89, ""end_span"": 99, ""type"": ""Cancer""}, {""token"": ""epidermal hyperplasia"", ""start_span"": 120, ""end_span"": 141, ""type"": ""Pathological_formation""}]"
Hyperforin ( Hyp), a polyphenol - derivative of St.	"Hyperforin	0	10	Chemical"	"Hyp	13	16	Chemical"	"polyphenol	21	31	Chemical"	"[{""token"": ""Hyperforin"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Chemical""}, {""token"": ""Hyp"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Chemical""}, {""token"": ""polyphenol"", ""start_span"": 21, ""end_span"": 31, ""type"": ""Chemical""}]"
OBJECTIVES: This study sought to assess the cellular and histologic basis of irreversible pulmonary hypertension ( PHT) in the clinical setting of congenital heart disease ( CHD).	"cellular	44	52	Cell"	"pulmonary	90	99	Organ"	"heart	158	163	Organ"	"[{""token"": ""cellular"", ""start_span"": 44, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""pulmonary"", ""start_span"": 90, ""end_span"": 99, ""type"": ""Organ""}, {""token"": ""heart"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Organ""}]"
Immunostaining for endothelial nitric oxide synthase, vascular endothelial growth factor, and CD34 ( markers of vasoactivity and neoangiogenesis) was also performed.	"endothelial nitric oxide synthase	19	52	Gene_or_gene_product"	"vascular endothelial growth factor	54	88	Gene_or_gene_product"	"CD34	94	98	Gene_or_gene_product"	"[{""token"": ""endothelial nitric oxide synthase"", ""start_span"": 19, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 54, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD34"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}]"
RESULTS: The antiapoptotic protein Bcl - 2 was highly expressed by pulmonary endothelial cells in all cases of irreversible PHT but in no cases of reversible PHT, nor in control patients ( p less than 0. 001).	"Bcl - 2	35	42	Gene_or_gene_product"	"pulmonary endothelial cells	67	94	Cell"	"patients	178	186	Organism"	"[{""token"": ""Bcl - 2"", ""start_span"": 35, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""pulmonary endothelial cells"", ""start_span"": 67, ""end_span"": 94, ""type"": ""Cell""}, {""token"": ""patients"", ""start_span"": 178, ""end_span"": 186, ""type"": ""Organism""}]"
Irreversible PHT cases were also more likely to show compensatory upregulation of vascular endothelial growth factor and new small vessel formation at the sites of native vessel stenosis or occlusion ( p less than 0. 001).	"vascular endothelial growth factor	82	116	Gene_or_gene_product"	"vessel	131	137	Multi"	"vessel	171	177	Multi"	"[{""token"": ""vascular endothelial growth factor"", ""start_span"": 82, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""vessel"", ""start_span"": 131, ""end_span"": 137, ""type"": ""Multi""}, {""token"": ""vessel"", ""start_span"": 171, ""end_span"": 177, ""type"": ""Multi""}]"
These changes are associated with intimal proliferation and vessel narrowing, and thereby may contribute to clinical outcomes associated with pulmonary hypertension.	"intimal	34	41	Tissue"	"vessel	60	66	Multi"	"pulmonary	142	151	Organ"	"[{""token"": ""intimal"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Tissue""}, {""token"": ""vessel"", ""start_span"": 60, ""end_span"": 66, ""type"": ""Multi""}, {""token"": ""pulmonary"", ""start_span"": 142, ""end_span"": 151, ""type"": ""Organ""}]"
Inhibition of Dll4 - mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion.	"Dll4	14	18	Gene_or_gene_product"	"vessels	74	81	Multi"	"tissue	102	108	Tissue"	"[{""token"": ""Dll4"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""vessels"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Multi""}, {""token"": ""tissue"", ""start_span"": 102, ""end_span"": 108, ""type"": ""Tissue""}]"
Dll4 is one of the Notch ligands that regulates arterial specification and maturation events.	"Dll4	0	4	Gene_or_gene_product"	"Notch	19	24	Gene_or_gene_product"	"arterial	48	56	Multi"	"[{""token"": ""Dll4"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""Notch"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""arterial"", ""start_span"": 48, ""end_span"": 56, ""type"": ""Multi""}]"
SWAP - 70 is a phosphatidylinositol trisphosphate ( PtdIns ( 3, 4, 5) P ( 3)) binding protein, which acts in F - actin rearrangement.	"SWAP - 70	0	9	Gene_or_gene_product"	"phosphatidylinositol trisphosphate	15	49	Chemical"	"F - actin	109	118	Gene_or_gene_product"	"[{""token"": ""SWAP - 70"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""phosphatidylinositol trisphosphate"", ""start_span"": 15, ""end_span"": 49, ""type"": ""Chemical""}, {""token"": ""F - actin"", ""start_span"": 109, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}]"
In this study, we show that Tsg101 is highly expressed in a subset of invasive human breast cancers.	"Tsg101	28	34	Gene_or_gene_product"	"human	79	84	Organism"	"breast cancers	85	99	Cancer"	"[{""token"": ""Tsg101"", ""start_span"": 28, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Organism""}, {""token"": ""breast cancers"", ""start_span"": 85, ""end_span"": 99, ""type"": ""Cancer""}]"
The overexpression of Tsg101 resulted in increased phosphorylation of the epidermal growth factor receptor and downstream activation of MAP kinases.	"Tsg101	22	28	Gene_or_gene_product"	"epidermal growth factor receptor	74	106	Gene_or_gene_product"	"MAP kinases	136	147	Gene_or_gene_product"	"[{""token"": ""Tsg101"", ""start_span"": 22, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""epidermal growth factor receptor"", ""start_span"": 74, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""MAP kinases"", ""start_span"": 136, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}]"
However, owing to the long latency of tumor formation and the sporadic occurrence of bona fide mammary cancers, we conclude that the Tsg101 protein has only weak oncogenic properties.	"tumor	38	43	Cancer"	"mammary cancers	95	110	Cancer"	"Tsg101	133	139	Gene_or_gene_product"	"[{""token"": ""tumor"", ""start_span"": 38, ""end_span"": 43, ""type"": ""Cancer""}, {""token"": ""mammary cancers"", ""start_span"": 95, ""end_span"": 110, ""type"": ""Cancer""}, {""token"": ""Tsg101"", ""start_span"": 133, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}]"
Instead of cancer initiation, it is therefore likely that Tsg101 plays a more predominant role in the progression of a subset of spontaneously arising breast cancers.	"cancer	11	17	Cancer"	"Tsg101	58	64	Gene_or_gene_product"	"breast cancers	151	165	Cancer"	"[{""token"": ""cancer"", ""start_span"": 11, ""end_span"": 17, ""type"": ""Cancer""}, {""token"": ""Tsg101"", ""start_span"": 58, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancers"", ""start_span"": 151, ""end_span"": 165, ""type"": ""Cancer""}]"
Analysis of associations among studied proteins revealed positive correlation between Bcl - xL and Bax in primary tumors ( P < 0. 03, r = 0. 307).	"Bcl - xL	86	94	Gene_or_gene_product"	"Bax	99	102	Gene_or_gene_product"	"tumors	114	120	Cancer"	"[{""token"": ""Bcl - xL"", ""start_span"": 86, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bax"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 114, ""end_span"": 120, ""type"": ""Cancer""}]"
An antibody directed against PDGF receptor beta enhances the antitumor and the anti - angiogenic activities of an anti - VEGF receptor 2 antibody.	"antibody directed against PDGF receptor beta	3	47	Gene_or_gene_product"	"antitumor	61	70	Cancer"	"anti - VEGF receptor 2 antibody	114	145	Gene_or_gene_product"	"[{""token"": ""antibody directed against PDGF receptor beta"", ""start_span"": 3, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""antitumor"", ""start_span"": 61, ""end_span"": 70, ""type"": ""Cancer""}, {""token"": ""anti - VEGF receptor 2 antibody"", ""start_span"": 114, ""end_span"": 145, ""type"": ""Gene_or_gene_product""}]"
Here we produced a neutralizing antibody, 1B3, directed against mouse PDGFRbeta.	"1B3	42	45	Chemical"	"mouse	64	69	Organism"	"PDGFRbeta	70	79	Gene_or_gene_product"	"[{""token"": ""1B3"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Chemical""}, {""token"": ""mouse"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Organism""}, {""token"": ""PDGFRbeta"", ""start_span"": 70, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}]"
1B3 binds to PDGFRbeta with high affinity ( 9x10 ( - 11) M) and blocks PDGF - BB from binding to the receptor with an IC ( 50) of approximately 1. 2 nM.	"1B3	0	3	Chemical"	"PDGFRbeta	13	22	Gene_or_gene_product"	"PDGF - BB	71	80	Gene_or_gene_product"	"[{""token"": ""1B3"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Chemical""}, {""token"": ""PDGFRbeta"", ""start_span"": 13, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""PDGF - BB"", ""start_span"": 71, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}]"
Taken together, these results lend great support to use PDGFRbeta antagonists in combinations with other antitumor and / or anti - angiogenic agents in the treatment of a variety of cancers.	"PDGFRbeta antagonists	56	77	Gene_or_gene_product"	"antitumor	105	114	Cancer"	"cancers	182	189	Cancer"	"[{""token"": ""PDGFRbeta antagonists"", ""start_span"": 56, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""antitumor"", ""start_span"": 105, ""end_span"": 114, ""type"": ""Cancer""}, {""token"": ""cancers"", ""start_span"": 182, ""end_span"": 189, ""type"": ""Cancer""}]"
Conditioned media prepared from colon cells treated with an adenosine analog increased human umbilical vein endothelial cell migration.	"colon cells	32	43	Cell"	"adenosine	60	69	Chemical"	"human umbilical vein endothelial cell	87	124	Cell"	"[{""token"": ""colon cells"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Cell""}, {""token"": ""adenosine"", ""start_span"": 60, ""end_span"": 69, ""type"": ""Chemical""}, {""token"": ""human umbilical vein endothelial cell"", ""start_span"": 87, ""end_span"": 124, ""type"": ""Cell""}]"
To confirm the role of lymphangiogenesis in mediating metastasis, the low - metastatic LAPC - 9 tumor cells were engineered to overexpress VEGF - C, and the development of metastases was evaluated.	"LAPC - 9 tumor cells	87	107	Cell"	"VEGF - C	139	147	Gene_or_gene_product"	"metastases	172	182	Cancer"	"[{""token"": ""LAPC - 9 tumor cells"", ""start_span"": 87, ""end_span"": 107, ""type"": ""Cell""}, {""token"": ""VEGF - C"", ""start_span"": 139, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""metastases"", ""start_span"": 172, ""end_span"": 182, ""type"": ""Cancer""}]"
Taken together, our studies, based on a molecular imaging approach for semiquantitative detection of micrometastases, point to an important role of tumor lymphatics in the metastatic process of human prostate cancer.	"tumor lymphatics	148	164	Multi"	"human	194	199	Organism"	"prostate cancer	200	215	Cancer"	"[{""token"": ""tumor lymphatics"", ""start_span"": 148, ""end_span"": 164, ""type"": ""Multi""}, {""token"": ""human"", ""start_span"": 194, ""end_span"": 199, ""type"": ""Organism""}, {""token"": ""prostate cancer"", ""start_span"": 200, ""end_span"": 215, ""type"": ""Cancer""}]"
A validated assay in human fat tissue is needed to study the role of angiogenesis in human obesity.	"human	21	26	Organism"	"fat tissue	27	37	Tissue"	"human	85	90	Organism"	"[{""token"": ""human"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Organism""}, {""token"": ""fat tissue"", ""start_span"": 27, ""end_span"": 37, ""type"": ""Tissue""}, {""token"": ""human"", ""start_span"": 85, ""end_span"": 90, ""type"": ""Organism""}]"
Taxol at 10 ( - 6) and 10 ( - 7) M completely inhibited angiogenesis, while Taxol 10 ( - 8) and 10 ( - 9) M and the heparin - steroid partially inhibited angiogenesis.	"Taxol	0	5	Chemical"	"Taxol	76	81	Chemical"	"heparin - steroid	116	133	Chemical"	"[{""token"": ""Taxol"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Chemical""}, {""token"": ""Taxol"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Chemical""}, {""token"": ""heparin - steroid"", ""start_span"": 116, ""end_span"": 133, ""type"": ""Chemical""}]"
The vessels are derived from quiescient vessels within the fat.	"vessels	4	11	Multi"	"quiescient vessels	29	47	Multi"	"fat	59	62	Tissue"	"[{""token"": ""vessels"", ""start_span"": 4, ""end_span"": 11, ""type"": ""Multi""}, {""token"": ""quiescient vessels"", ""start_span"": 29, ""end_span"": 47, ""type"": ""Multi""}, {""token"": ""fat"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Tissue""}]"
In oral cancers, cytoplasmic BAG - 1 overexpression is a marker of poor prognosis.	"oral cancers	3	15	Cancer"	"cytoplasmic	17	28	Organism_substance"	"BAG - 1	29	36	Gene_or_gene_product"	"[{""token"": ""oral cancers"", ""start_span"": 3, ""end_span"": 15, ""type"": ""Cancer""}, {""token"": ""cytoplasmic"", ""start_span"": 17, ""end_span"": 28, ""type"": ""Organism_substance""}, {""token"": ""BAG - 1"", ""start_span"": 29, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}]"
By contrast to the cytoplasmic BAG - 1 isoforms, BAG - 1L may act to suppress tumorigenesis.	"cytoplasmic	19	30	Organism_substance"	"BAG - 1	31	38	Gene_or_gene_product"	"BAG - 1L	49	57	Gene_or_gene_product"	"[{""token"": ""cytoplasmic"", ""start_span"": 19, ""end_span"": 30, ""type"": ""Organism_substance""}, {""token"": ""BAG - 1"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""BAG - 1L"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}]"
Liver tissue spaces, investigated with multiple indicator dilution technique in liver perfusion studies, were unchanged at week 3 after tumor induction.	"Liver tissue	0	12	Tissue"	"liver	80	85	Organ"	"tumor	136	141	Cancer"	"[{""token"": ""Liver tissue"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Tissue""}, {""token"": ""liver"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Organ""}, {""token"": ""tumor"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Cancer""}]"
These observations suggest that stem / progenitor cells in the mammary gland may be especially susceptible to oncogenic transformation.	"stem	32	36	Cell"	"progenitor cells	39	55	Cell"	"mammary gland	63	76	Organ"	"[{""token"": ""stem"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Cell""}, {""token"": ""progenitor cells"", ""start_span"": 39, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""mammary gland"", ""start_span"": 63, ""end_span"": 76, ""type"": ""Organ""}]"
Whether more differentiated cells may also be transformed by particular oncogenes is actively debated; it is presently unclear whether stem cells or differentiated mammary cells are more susceptible to transformation by individual oncogenes.	"cells	28	33	Cell"	"stem cells	135	145	Cell"	"mammary cells	164	177	Cell"	"[{""token"": ""cells"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Cell""}, {""token"": ""stem cells"", ""start_span"": 135, ""end_span"": 145, ""type"": ""Cell""}, {""token"": ""mammary cells"", ""start_span"": 164, ""end_span"": 177, ""type"": ""Cell""}]"
In damaged and inflamed tissue, LL - 37 functions as a chemoattractant, mitogen and pro - angiogenic factor suggesting that the peptide may potentiate tumor progression.	"tissue	24	30	Tissue"	"LL - 37	32	39	Gene_or_gene_product"	"tumor	151	156	Cancer"	"[{""token"": ""tissue"", ""start_span"": 24, ""end_span"": 30, ""type"": ""Tissue""}, {""token"": ""LL - 37"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 151, ""end_span"": 156, ""type"": ""Cancer""}]"
Protein expression was statistically compared to the degree of immune cell infiltration and microvessel density in epithelial - derived ovarian tumors and a significant correlation was observed for both.	"immune cell	63	74	Cell"	"microvessel	92	103	Tissue"	"epithelial - derived ovarian tumors	115	150	Cancer"	"[{""token"": ""immune cell"", ""start_span"": 63, ""end_span"": 74, ""type"": ""Cell""}, {""token"": ""microvessel"", ""start_span"": 92, ""end_span"": 103, ""type"": ""Tissue""}, {""token"": ""epithelial - derived ovarian tumors"", ""start_span"": 115, ""end_span"": 150, ""type"": ""Cancer""}]"
Treatment of ovarian cancer cell lines with recombinant LL - 37 stimulated proliferation, chemotaxis, invasion and matrix metalloproteinase expression.	"ovarian cancer cell lines	13	38	Cell"	"LL - 37	56	63	Gene_or_gene_product"	"matrix metalloproteinase	115	139	Gene_or_gene_product"	"[{""token"": ""ovarian cancer cell lines"", ""start_span"": 13, ""end_span"": 38, ""type"": ""Cell""}, {""token"": ""LL - 37"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix metalloproteinase"", ""start_span"": 115, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}]"
To grow, invade and metastasize, a treacherous society between cancer and host cells must be formed, and this association provides novel and effective clinical targets for cancer control and prevention.	"cancer	63	69	Cancer"	"host cells	74	84	Cell"	"cancer	172	178	Cancer"	"[{""token"": ""cancer"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Cancer""}, {""token"": ""host cells"", ""start_span"": 74, ""end_span"": 84, ""type"": ""Cell""}, {""token"": ""cancer"", ""start_span"": 172, ""end_span"": 178, ""type"": ""Cancer""}]"
An increase of atrophy over the Retinal Pigment Epithelium ( RPE) was observed in another patient.	"Retinal Pigment Epithelium	32	58	Tissue"	"RPE	61	64	Tissue"	"patient	90	97	Organism"	"[{""token"": ""Retinal Pigment Epithelium"", ""start_span"": 32, ""end_span"": 58, ""type"": ""Tissue""}, {""token"": ""RPE"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Tissue""}, {""token"": ""patient"", ""start_span"": 90, ""end_span"": 97, ""type"": ""Organism""}]"
CONCLUSIONS: PDT can reduce the clinical signs of activity, such as choroidal hyperpermeability or neurosensorial retinal detachment, in patients affected by chronic CSC.	"choroidal	68	77	Multi"	"retinal	114	121	Multi"	"patients	137	145	Organism"	"[{""token"": ""choroidal"", ""start_span"": 68, ""end_span"": 77, ""type"": ""Multi""}, {""token"": ""retinal"", ""start_span"": 114, ""end_span"": 121, ""type"": ""Multi""}, {""token"": ""patients"", ""start_span"": 137, ""end_span"": 145, ""type"": ""Organism""}]"
This ultimately deprives VEGF receptors of an essential molecule required for promoting the disruption of endothelial cell - cell contacts and paracellular permeability.	"VEGF	25	29	Gene_or_gene_product"	"endothelial	106	117	Cell"	"paracellular	143	155	Immaterial_anatomical_entity"	"[{""token"": ""VEGF"", ""start_span"": 25, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial"", ""start_span"": 106, ""end_span"": 117, ""type"": ""Cell""}, {""token"": ""paracellular"", ""start_span"": 143, ""end_span"": 155, ""type"": ""Immaterial_anatomical_entity""}]"
We did not found any mutation in de novo BCR - ABL + ALLs or lymphoid BC CML.	"BCR	41	44	Gene_or_gene_product"	"ABL	47	50	Gene_or_gene_product"	"lymphoid BC CML	61	76	Cancer"	"[{""token"": ""BCR"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""ABL"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymphoid BC CML"", ""start_span"": 61, ""end_span"": 76, ""type"": ""Cancer""}]"
The therapeutic efficacy of rAAV2 / 5 - VAS was determined by monitoring tumor volume, survival rate, and degree of neovascularization after treatment in these models.	"rAAV2	28	33	Organism"	"5 - VAS	36	43	Organism"	"tumor	73	78	Cancer"	"[{""token"": ""rAAV2"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Organism""}, {""token"": ""5 - VAS"", ""start_span"": 36, ""end_span"": 43, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 73, ""end_span"": 78, ""type"": ""Cancer""}]"
Radiation retinopathy is treatable with anti - vascular endothelial growth factor bevacizumab ( Avastin).	"anti - vascular endothelial growth factor	40	81	Gene_or_gene_product"	"bevacizumab	82	93	Chemical"	"Avastin	96	103	Chemical"	"[{""token"": ""anti - vascular endothelial growth factor"", ""start_span"": 40, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""bevacizumab"", ""start_span"": 82, ""end_span"": 93, ""type"": ""Chemical""}, {""token"": ""Avastin"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Chemical""}]"
PATIENTS AND METHODS: Twenty - one patients with radiation retinopathy ( edema, hemorrhages, capillary dropout, and neovascularization) and a subjective or objective loss of vision were treated.	"patients	35	43	Organism"	"edema	73	78	Pathological_formation"	"capillary	93	102	Tissue"	"[{""token"": ""patients"", ""start_span"": 35, ""end_span"": 43, ""type"": ""Organism""}, {""token"": ""edema"", ""start_span"": 73, ""end_span"": 78, ""type"": ""Pathological_formation""}, {""token"": ""capillary"", ""start_span"": 93, ""end_span"": 102, ""type"": ""Tissue""}]"
RESULTS: Bevacizumab treatment was followed by reductions in retinal hemorrhage, exudation, and edema.	"Bevacizumab	9	20	Chemical"	"retinal	61	68	Multi"	"edema	96	101	Pathological_formation"	"[{""token"": ""Bevacizumab"", ""start_span"": 9, ""end_span"": 20, ""type"": ""Chemical""}, {""token"": ""retinal"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Multi""}, {""token"": ""edema"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Pathological_formation""}]"
Western blots confirmed that LeTx treatment reduced the levels of phosphorylated extracellular signal - regulated kinase and p38 MAPK in vitro.	"LeTx	29	33	Chemical"	"extracellular signal - regulated kinase	81	120	Gene_or_gene_product"	"p38 MAPK	125	133	Gene_or_gene_product"	"[{""token"": ""LeTx"", ""start_span"": 29, ""end_span"": 33, ""type"": ""Chemical""}, {""token"": ""extracellular signal - regulated kinase"", ""start_span"": 81, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""p38 MAPK"", ""start_span"": 125, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}]"
Although short treatments with LeTx only modestly affected cell proliferation, sustained treatment markedly reduced cell numbers.	"LeTx	31	35	Chemical"	"cell	59	63	Cell"	"cell	116	120	Cell"	"[{""token"": ""LeTx"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Cell""}]"
In vivo, LeTx decreased MAPK activity and blocked fibrosarcoma growth.	"LeTx	9	13	Chemical"	"MAPK	24	28	Gene_or_gene_product"	"fibrosarcoma	50	62	Cancer"	"[{""token"": ""LeTx"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Chemical""}, {""token"": ""MAPK"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibrosarcoma"", ""start_span"": 50, ""end_span"": 62, ""type"": ""Cancer""}]"
We have detected transforming activity by a tumorigenicity assay using NIH3T3 cells transfected with DNA from a chronic myeloproliferative disorder patient.	"NIH3T3 cells	71	83	Cell"	"DNA	101	104	Cellular_component"	"patient	148	155	Organism"	"[{""token"": ""NIH3T3 cells"", ""start_span"": 71, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""DNA"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Cellular_component""}, {""token"": ""patient"", ""start_span"": 148, ""end_span"": 155, ""type"": ""Organism""}]"
The predicted UFO protein exhibits characteristic features of a transmembrane receptor with associated tyrosine kinase activity.	"UFO	14	17	Gene_or_gene_product"	"transmembrane	64	77	Cellular_component"	"tyrosine	103	111	Amino_acid"	"[{""token"": ""UFO"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""transmembrane"", ""start_span"": 64, ""end_span"": 77, ""type"": ""Cellular_component""}, {""token"": ""tyrosine"", ""start_span"": 103, ""end_span"": 111, ""type"": ""Amino_acid""}]"
CONTEXT: Nasopharyngeal carcinoma ( NPC), common in southern China and North Africa, has a complex etiology involving interplay between viral, environmental, and hereditary factors and is almost constantly associated with the Epstein - Barr virus.	"Nasopharyngeal carcinoma	9	33	Cancer"	"NPC	36	39	Cancer"	"Epstein - Barr virus	226	246	Organism"	"[{""token"": ""Nasopharyngeal carcinoma"", ""start_span"": 9, ""end_span"": 33, ""type"": ""Cancer""}, {""token"": ""NPC"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Cancer""}, {""token"": ""Epstein - Barr virus"", ""start_span"": 226, ""end_span"": 246, ""type"": ""Organism""}]"
After confirmation by immunocytochemical staining, their expression in patient samples was measured using 40 pairs of undifferentiated NPCs together with their adjacent normal epithelia.	"patient	71	78	Organism"	"NPCs	135	139	Cell"	"normal epithelia	169	185	Tissue"	"[{""token"": ""patient"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Organism""}, {""token"": ""NPCs"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Cell""}, {""token"": ""normal epithelia"", ""start_span"": 169, ""end_span"": 185, ""type"": ""Tissue""}]"
Finally, annexin II down - regulation was positively associated with lymph node metastasis, suggesting that it may be a prognostic factor in NPC.	"annexin II	9	19	Gene_or_gene_product"	"lymph node	69	79	Multi"	"NPC	141	144	Cancer"	"[{""token"": ""annexin II"", ""start_span"": 9, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 69, ""end_span"": 79, ""type"": ""Multi""}, {""token"": ""NPC"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Cancer""}]"
In this study, the role of the proprotein convertase furin in PLAG1 proto - oncogene - induced salivary gland tumorigenesis was investigated.	"furin	53	58	Gene_or_gene_product"	"PLAG1	62	67	Gene_or_gene_product"	"salivary gland	95	109	Multi"	"[{""token"": ""furin"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""PLAG1"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""salivary gland"", ""start_span"": 95, ""end_span"": 109, ""type"": ""Multi""}]"
Moreover, the lymph nodes close to the salivary glands were enlarged, and histology showed that they had activated follicles.	"lymph nodes	14	25	Multi"	"salivary glands	39	54	Organ"	"follicles	115	124	Multi"	"[{""token"": ""lymph nodes"", ""start_span"": 14, ""end_span"": 25, ""type"": ""Multi""}, {""token"": ""salivary glands"", ""start_span"": 39, ""end_span"": 54, ""type"": ""Organ""}, {""token"": ""follicles"", ""start_span"": 115, ""end_span"": 124, ""type"": ""Multi""}]"
Moreover, the M2 - PK - binding peptide aptamers also reduced the proliferation rate of human U - 2 OS osteosarcoma cells.	"M2 - PK	14	21	Gene_or_gene_product"	"human	88	93	Organism"	"U - 2 OS osteosarcoma cells	94	121	Cell"	"[{""token"": ""M2 - PK"", ""start_span"": 14, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Organism""}, {""token"": ""U - 2 OS osteosarcoma cells"", ""start_span"": 94, ""end_span"": 121, ""type"": ""Cell""}]"
Hematogenous metastasis in gastric cancer requires isolated tumor cells and expression of vascular endothelial growth factor receptor - 1.	"gastric cancer	27	41	Cancer"	"isolated tumor cells	51	71	Cell"	"vascular endothelial growth factor receptor - 1	90	137	Gene_or_gene_product"	"[{""token"": ""gastric cancer"", ""start_span"": 27, ""end_span"": 41, ""type"": ""Cancer""}, {""token"": ""isolated tumor cells"", ""start_span"": 51, ""end_span"": 71, ""type"": ""Cell""}, {""token"": ""vascular endothelial growth factor receptor - 1"", ""start_span"": 90, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}]"
Gastric cancer metastasized when ITCs were observed in the presence of VEGFR - 1.	"Gastric cancer	0	14	Cancer"	"ITCs	33	37	Cell"	"VEGFR - 1	71	80	Gene_or_gene_product"	"[{""token"": ""Gastric cancer"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Cancer""}, {""token"": ""ITCs"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Cell""}, {""token"": ""VEGFR - 1"", ""start_span"": 71, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}]"
In the 380 patients who were ITC negative and showed low VEGFR - 1 expression, synchronous ( at the time of surgery) and heterochronous ( recurrent) metastases were not observed.	"patients	11	19	Organism"	"ITC	29	32	Cell"	"VEGFR - 1	57	66	Gene_or_gene_product"	"[{""token"": ""patients"", ""start_span"": 11, ""end_span"": 19, ""type"": ""Organism""}, {""token"": ""ITC"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Cell""}, {""token"": ""VEGFR - 1"", ""start_span"": 57, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}]"
This study indicates that the simultaneous presence of ITC and VEGFR - 1 expression at premetastatic sites is clinically significant for disease progression.	"ITC	55	58	Cell"	"VEGFR - 1	63	72	Gene_or_gene_product"	"premetastatic sites	87	106	Multi"	"[{""token"": ""ITC"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Cell""}, {""token"": ""VEGFR - 1"", ""start_span"": 63, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""premetastatic sites"", ""start_span"": 87, ""end_span"": 106, ""type"": ""Multi""}]"
Together, the data establish that acute ethanol exposure significantly impairs angiogenesis and suggest that this effect is mediated by changes in endothelial cell responsiveness to both VEGF and hypoxia.	"ethanol	40	47	Chemical"	"endothelial cell	147	163	Cell"	"VEGF	187	191	Gene_or_gene_product"	"[{""token"": ""ethanol"", ""start_span"": 40, ""end_span"": 47, ""type"": ""Chemical""}, {""token"": ""endothelial cell"", ""start_span"": 147, ""end_span"": 163, ""type"": ""Cell""}, {""token"": ""VEGF"", ""start_span"": 187, ""end_span"": 191, ""type"": ""Gene_or_gene_product""}]"
Histological examination revealed cystic or angiomatoid spaces of various sizes lined by cuboidal, low - columnar, or flattened epithelioid cells with vacuolated cytoplasm and round to oval nuclei.	"epithelioid cells	128	145	Cell"	"vacuolated cytoplasm	151	171	Organism_substance"	"nuclei	190	196	Cellular_component"	"[{""token"": ""epithelioid cells"", ""start_span"": 128, ""end_span"": 145, ""type"": ""Cell""}, {""token"": ""vacuolated cytoplasm"", ""start_span"": 151, ""end_span"": 171, ""type"": ""Organism_substance""}, {""token"": ""nuclei"", ""start_span"": 190, ""end_span"": 196, ""type"": ""Cellular_component""}]"
The role of platelet - derived endothelial cell growth factor / thymidine phosphorylase in tumor behavior.	"platelet - derived endothelial cell growth factor	12	61	Gene_or_gene_product"	"thymidine phosphorylase	64	87	Gene_or_gene_product"	"tumor	91	96	Cancer"	"[{""token"": ""platelet - derived endothelial cell growth factor"", ""start_span"": 12, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""thymidine phosphorylase"", ""start_span"": 64, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Cancer""}]"
A high TP expression at tumor sites is correlated with tumor growth, induction of angiogenesis, and metastasis.	"TP	7	9	Gene_or_gene_product"	"tumor	24	29	Cancer"	"tumor	55	60	Cancer"	"[{""token"": ""TP"", ""start_span"": 7, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 24, ""end_span"": 29, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 55, ""end_span"": 60, ""type"": ""Cancer""}]"
The latter in its parent form or in its sugar form, deoxyribose ( dR) may play a role in the induction of angiogenesis.	"sugar	40	45	Chemical"	"deoxyribose	52	63	Chemical"	"dR	66	68	Chemical"	"[{""token"": ""sugar"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Chemical""}, {""token"": ""deoxyribose"", ""start_span"": 52, ""end_span"": 63, ""type"": ""Chemical""}, {""token"": ""dR"", ""start_span"": 66, ""end_span"": 68, ""type"": ""Chemical""}]"
The mechanism of TP induction is not yet completely clear, but TNF, IL10 and other cytokines have been clearly shown to induce its expression.	"TP	17	19	Gene_or_gene_product"	"TNF	63	66	Gene_or_gene_product"	"IL10	68	72	Gene_or_gene_product"	"[{""token"": ""TP"", ""start_span"": 17, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""TNF"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL10"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}]"
The various complex interactions of TP give it an essential role in cellular functioning and, hence, it is an ideal target in cancer therapy.	"TP	36	38	Gene_or_gene_product"	"cellular	68	76	Cell"	"cancer	126	132	Cancer"	"[{""token"": ""TP"", ""start_span"": 36, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 68, ""end_span"": 76, ""type"": ""Cell""}, {""token"": ""cancer"", ""start_span"": 126, ""end_span"": 132, ""type"": ""Cancer""}]"
Substantial studies have demonstrated that PTEN can inhibit cell proliferation, migration and invasion of many cancer cells.	"PTEN	43	47	Gene_or_gene_product"	"cell	60	64	Cell"	"cancer cells	111	123	Cell"	"[{""token"": ""PTEN"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Cell""}, {""token"": ""cancer cells"", ""start_span"": 111, ""end_span"": 123, ""type"": ""Cell""}]"
CONCLUSION: These results demonstrated that PTEN had played an important role in the cell proliferation, cell migration and invasion dependent on its phosphatase activity.	"PTEN	44	48	Gene_or_gene_product"	"cell	85	89	Cell"	"cell	105	109	Cell"	"[{""token"": ""PTEN"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 105, ""end_span"": 109, ""type"": ""Cell""}]"
Allogeneic injection of fetal membrane - derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia.	"fetal membrane - derived mesenchymal stem cells	24	71	Cell"	"rat	110	113	Organism"	"hind limb	123	132	Organism_subdivision"	"[{""token"": ""fetal membrane - derived mesenchymal stem cells"", ""start_span"": 24, ""end_span"": 71, ""type"": ""Cell""}, {""token"": ""rat"", ""start_span"": 110, ""end_span"": 113, ""type"": ""Organism""}, {""token"": ""hind limb"", ""start_span"": 123, ""end_span"": 132, ""type"": ""Organism_subdivision""}]"
FM - MSC were obtained from Lewis rats and had surface antigen expression and multipotent potential partly similar to those of BM - MSC.	"FM - MSC	0	8	Cell"	"rats	34	38	Organism"	"BM - MSC	127	135	Cell"	"[{""token"": ""FM - MSC"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Cell""}, {""token"": ""rats"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Organism""}, {""token"": ""BM - MSC"", ""start_span"": 127, ""end_span"": 135, ""type"": ""Cell""}]"
Malignancy in cancer is associated with aerobic glycolysis ( Warburg effect) evidenced by increased trapping of [ ( 18) F] deoxyglucose ( FdG) in patients imaged by positron emission tomography ( PET).	"cancer	14	20	Cancer"	"FdG	138	141	Chemical"	"patients	146	154	Organism"	"[{""token"": ""cancer"", ""start_span"": 14, ""end_span"": 20, ""type"": ""Cancer""}, {""token"": ""FdG"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Chemical""}, {""token"": ""patients"", ""start_span"": 146, ""end_span"": 154, ""type"": ""Organism""}]"
We have previously reported in established breast lines that HIF - 1alpha levels in the presence of oxygen leads to the Warburg effect.	"breast lines	43	55	Cell"	"HIF - 1alpha	61	73	Gene_or_gene_product"	"oxygen	100	106	Chemical"	"[{""token"": ""breast lines"", ""start_span"": 43, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""HIF - 1alpha"", ""start_span"": 61, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""oxygen"", ""start_span"": 100, ""end_span"": 106, ""type"": ""Chemical""}]"
Two of 12 cell lines formed xenografts in mice.	"cell lines	10	20	Cell"	"xenografts	28	38	Cancer"	"mice	42	46	Organism"	"[{""token"": ""cell lines"", ""start_span"": 10, ""end_span"": 20, ""type"": ""Cell""}, {""token"": ""xenografts"", ""start_span"": 28, ""end_span"": 38, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Organism""}]"
Both were positive for HIF - 1alpha and phosphorylated c - Myc, and only one was positive for pAkt.	"HIF - 1alpha	23	35	Gene_or_gene_product"	"c - Myc	55	62	Gene_or_gene_product"	"pAkt	94	98	Gene_or_gene_product"	"[{""token"": ""HIF - 1alpha"", ""start_span"": 23, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - Myc"", ""start_span"": 55, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""pAkt"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}]"
These findings suggest that c - Myc and / or HIF - 1alpha activities are both involved in the regulation of glycolysis in breast cancers.	"c - Myc	28	35	Gene_or_gene_product"	"HIF - 1alpha	45	57	Gene_or_gene_product"	"breast cancers	122	136	Cancer"	"[{""token"": ""c - Myc"", ""start_span"": 28, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1alpha"", ""start_span"": 45, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancers"", ""start_span"": 122, ""end_span"": 136, ""type"": ""Cancer""}]"
Following implantation within the striatum, the volume of the primary fibroblast grafts, stained immunohistochemically for fibronectin, does not differ significantly at 3 and 8 weeks.	"striatum	34	42	Multi"	"fibroblast grafts	70	87	Tissue"	"fibronectin	123	134	Gene_or_gene_product"	"[{""token"": ""striatum"", ""start_span"": 34, ""end_span"": 42, ""type"": ""Multi""}, {""token"": ""fibroblast grafts"", ""start_span"": 70, ""end_span"": 87, ""type"": ""Tissue""}, {""token"": ""fibronectin"", ""start_span"": 123, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}]"
The graft size is dependent on the density of the cell suspension, but not dependent on either the number of passages the cells are taken through in culture prior to grafting or on the postoperative survival period.	"graft	4	9	Tissue"	"cell	50	54	Cell"	"cells	122	127	Cell"	"[{""token"": ""graft"", ""start_span"": 4, ""end_span"": 9, ""type"": ""Tissue""}, {""token"": ""cell"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Cell""}]"
Reactive astrocytic processes and phagocytic cells are also present in the grafts.	"astrocytic processes	9	29	Cellular_component"	"phagocytic cells	34	50	Cell"	"grafts	75	81	Tissue"	"[{""token"": ""astrocytic processes"", ""start_span"": 9, ""end_span"": 29, ""type"": ""Cellular_component""}, {""token"": ""phagocytic cells"", ""start_span"": 34, ""end_span"": 50, ""type"": ""Cell""}, {""token"": ""grafts"", ""start_span"": 75, ""end_span"": 81, ""type"": ""Tissue""}]"
Also, the grafts maintain a constant volume between 3 and 8 weeks, thereby indicating that primary skin fibroblasts do not produce tumors.	"grafts	10	16	Tissue"	"skin fibroblasts	99	115	Cell"	"tumors	131	137	Cancer"	"[{""token"": ""grafts"", ""start_span"": 10, ""end_span"": 16, ""type"": ""Tissue""}, {""token"": ""skin fibroblasts"", ""start_span"": 99, ""end_span"": 115, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 131, ""end_span"": 137, ""type"": ""Cancer""}]"
Angiogenesis associated with visceral and subcutaneous adipose tissue in severe human obesity.	"visceral	29	37	Tissue"	"subcutaneous adipose tissue	42	69	Tissue"	"human	80	85	Organism"	"[{""token"": ""visceral"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Tissue""}, {""token"": ""subcutaneous adipose tissue"", ""start_span"": 42, ""end_span"": 69, ""type"": ""Tissue""}, {""token"": ""human"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Organism""}]"
This model highlighted the role of VEGF in angiogenesis in both SAT and VAT.	"VEGF	35	39	Gene_or_gene_product"	"SAT	64	67	Tissue"	"VAT	72	75	Tissue"	"[{""token"": ""VEGF"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""SAT"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Tissue""}, {""token"": ""VAT"", ""start_span"": 72, ""end_span"": 75, ""type"": ""Tissue""}]"
BACKGROUND: M - CSF recruits mononuclear phagocytes which regulate processes such as angiogenesis and metastases in tumors.	"M - CSF	12	19	Gene_or_gene_product"	"mononuclear phagocytes	29	51	Cell"	"tumors	116	122	Cancer"	"[{""token"": ""M - CSF"", ""start_span"": 12, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""mononuclear phagocytes"", ""start_span"": 29, ""end_span"": 51, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 116, ""end_span"": 122, ""type"": ""Cancer""}]"
VEGF is a potent activator of angiogenesis as it promotes endothelial cell proliferation and new blood vessel formation.	"VEGF	0	4	Gene_or_gene_product"	"endothelial cell	58	74	Cell"	"blood vessel	97	109	Multi"	"[{""token"": ""VEGF"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 58, ""end_span"": 74, ""type"": ""Cell""}, {""token"": ""blood vessel"", ""start_span"": 97, ""end_span"": 109, ""type"": ""Multi""}]"
Importantly, the addition of a neutralizing VEGF antibody abolished M - CSF - induced blood vessel formation.	"VEGF antibody	44	57	Gene_or_gene_product"	"M - CSF	68	75	Gene_or_gene_product"	"blood vessel	86	98	Multi"	"[{""token"": ""VEGF antibody"", ""start_span"": 44, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""M - CSF"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""blood vessel"", ""start_span"": 86, ""end_span"": 98, ""type"": ""Multi""}]"
BACKGROUND: Bone morphogenetic proteins ( BMPs) exert osteoinductive effects in prostate cancer ( PC) via uncharacterized mechanisms.	"Bone	12	16	Organ"	"prostate cancer	80	95	Cancer"	"PC	98	100	Cancer"	"[{""token"": ""Bone"", ""start_span"": 12, ""end_span"": 16, ""type"": ""Organ""}, {""token"": ""prostate cancer"", ""start_span"": 80, ""end_span"": 95, ""type"": ""Cancer""}, {""token"": ""PC"", ""start_span"": 98, ""end_span"": 100, ""type"": ""Cancer""}]"
METHODS: NF - kappaB inhibition was achieved by IkappaBalpha super - repressor adenoviral vector and activation was monitored by EMSA and reporter assays.	"NF - kappaB	9	20	Gene_or_gene_product"	"IkappaBalpha	48	60	Gene_or_gene_product"	"adenoviral	79	89	Organism"	"[{""token"": ""NF - kappaB"", ""start_span"": 9, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""IkappaBalpha"", ""start_span"": 48, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""adenoviral"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Organism""}]"
Smad1 / 5 / 8 phosphorylation was measured by Western blot analysis.	"Smad1	0	5	Gene_or_gene_product"	"5	8	9	Gene_or_gene_product"	"8	12	13	Gene_or_gene_product"	"[{""token"": ""Smad1"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""5"", ""start_span"": 8, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""8"", ""start_span"": 12, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}]"
A novel peptide ligand, A5 - 1 ( VILVLF), with high affinity to integrin alpha5beta1 was identified from the hexapeptide libraries with this chip - based screening method on the basis of a competitive inhibition assay.	"A5 - 1	24	30	Gene_or_gene_product"	"VILVLF	33	39	Gene_or_gene_product"	"integrin alpha5beta1	64	84	Gene_or_gene_product"	"[{""token"": ""A5 - 1"", ""start_span"": 24, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""VILVLF"", ""start_span"": 33, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""integrin alpha5beta1"", ""start_span"": 64, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}]"
A5 - 1 inhibits the integrin - fibronectin interaction in a dose - dependent manner ( IC ( 50); 1. 56 + / - 0. 28 microM.	"A5 - 1	0	6	Gene_or_gene_product"	"integrin	20	28	Gene_or_gene_product"	"fibronectin	31	42	Gene_or_gene_product"	"[{""token"": ""A5 - 1"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene_or_gene_product""}, {""token"": ""integrin"", ""start_span"": 20, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibronectin"", ""start_span"": 31, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}]"
Evaluation of electrical stimulation for ischemic wound therapy: a feasibility study using the lapine wound model.	"wound	50	55	Pathological_formation"	"lapine	95	101	Organism"	"wound	102	107	Pathological_formation"	"[{""token"": ""wound"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Pathological_formation""}, {""token"": ""lapine"", ""start_span"": 95, ""end_span"": 101, ""type"": ""Organism""}, {""token"": ""wound"", ""start_span"": 102, ""end_span"": 107, ""type"": ""Pathological_formation""}]"
A feasibility study was carried out to develop the Ahn / Mustoe lapine wound model for systematic investigation of the effects of electrical stimulation on ischemic wound therapy.	"lapine	64	70	Organism"	"wound	71	76	Pathological_formation"	"wound	165	170	Pathological_formation"	"[{""token"": ""lapine"", ""start_span"": 64, ""end_span"": 70, ""type"": ""Organism""}, {""token"": ""wound"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Pathological_formation""}, {""token"": ""wound"", ""start_span"": 165, ""end_span"": 170, ""type"": ""Pathological_formation""}]"
Both COL - I and COL - V showed statistically significant ( P less than 0. 05) increased activity between day 7 and day 14 for pattern A, potentially indicating a continued effect on matrix remodeling.	"COL - I	5	12	Gene_or_gene_product"	"COL - V	17	24	Gene_or_gene_product"	"matrix	183	189	Cellular_component"	"[{""token"": ""COL - I"", ""start_span"": 5, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""COL - V"", ""start_span"": 17, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix"", ""start_span"": 183, ""end_span"": 189, ""type"": ""Cellular_component""}]"
Vascular endothelial growth factor ( VEGF), one of the most potent angiogenic factors, stimulates endothelial cell proliferation and induces the angiogenesis.	"Vascular endothelial growth factor	0	34	Gene_or_gene_product"	"VEGF	37	41	Gene_or_gene_product"	"endothelial cell	98	114	Cell"	"[{""token"": ""Vascular endothelial growth factor"", ""start_span"": 0, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 98, ""end_span"": 114, ""type"": ""Cell""}]"
The scope of the present review is to discuss from a clinical point of view the potential interactions between VEGF and angiopoietins in the asthmatic airways, and focus on the therapeutic implications targeting for these angiogenic factors.	"VEGF	111	115	Gene_or_gene_product"	"angiopoietins	120	133	Gene_or_gene_product"	"airways	151	158	Multi"	"[{""token"": ""VEGF"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""angiopoietins"", ""start_span"": 120, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""airways"", ""start_span"": 151, ""end_span"": 158, ""type"": ""Multi""}]"
The present study was designed to investigate the effect of transplanted MSCs from rats of different ages on the improvement of heart function after AMI.	"MSCs	73	77	Cell"	"rats	83	87	Organism"	"heart	128	133	Organ"	"[{""token"": ""MSCs"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Cell""}, {""token"": ""rats"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Organism""}, {""token"": ""heart"", ""start_span"": 128, ""end_span"": 133, ""type"": ""Organ""}]"
The transplantation of old donor - derived MSCs attenuated apoptosis of cardiomyocytes in the peri - infarct region compared with the control group and the effect was elevated in young donor - derived MSCs ( P less than 0. 05).	"MSCs	43	47	Cell"	"cardiomyocytes	72	86	Cell"	"MSCs	201	205	Cell"	"[{""token"": ""MSCs"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Cell""}, {""token"": ""cardiomyocytes"", ""start_span"": 72, ""end_span"": 86, ""type"": ""Cell""}, {""token"": ""MSCs"", ""start_span"": 201, ""end_span"": 205, ""type"": ""Cell""}]"
CONCLUSIONS: Young donor - derived MSCs can improve heart function significantly through angiogenesis and decreasing cardiomyocyte apoptosis when transplanted to the infarcted area.	"MSCs	35	39	Cell"	"heart	52	57	Organ"	"cardiomyocyte	117	130	Cell"	"[{""token"": ""MSCs"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Cell""}, {""token"": ""heart"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Organ""}, {""token"": ""cardiomyocyte"", ""start_span"": 117, ""end_span"": 130, ""type"": ""Cell""}]"
Clinical significance of chicken ovalbumin upstream promoter - transcription factor II expression in human colorectal cancer.	"chicken ovalbumin upstream promoter - transcription factor II	25	86	Gene_or_gene_product"	"human	101	106	Organism"	"colorectal cancer	107	124	Cancer"	"[{""token"": ""chicken ovalbumin upstream promoter - transcription factor II"", ""start_span"": 25, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Organism""}, {""token"": ""colorectal cancer"", ""start_span"": 107, ""end_span"": 124, ""type"": ""Cancer""}]"
A previous study showed that the expression of COUP - TFII enhanced invasiveness of human lung carcinoma cells.	"COUP - TFII	47	58	Gene_or_gene_product"	"human	84	89	Organism"	"lung carcinoma cells	90	110	Cell"	"[{""token"": ""COUP - TFII"", ""start_span"": 47, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 84, ""end_span"": 89, ""type"": ""Organism""}, {""token"": ""lung carcinoma cells"", ""start_span"": 90, ""end_span"": 110, ""type"": ""Cell""}]"
The 3 - year disease - free survival ( DFS) and overall survival ( OS) of patients with tumors expressing different levels of COUP - TFII were evaluated by the Kaplan - Meier method.	"patients	74	82	Organism"	"tumors	88	94	Cancer"	"COUP - TFII	126	137	Gene_or_gene_product"	"[{""token"": ""patients"", ""start_span"": 74, ""end_span"": 82, ""type"": ""Organism""}, {""token"": ""tumors"", ""start_span"": 88, ""end_span"": 94, ""type"": ""Cancer""}, {""token"": ""COUP - TFII"", ""start_span"": 126, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}]"
The p53 tumor suppressor plays pivotal role in the organism by supervising strict compliance of individual cells to needs of the whole organisms.	"p53	4	7	Gene_or_gene_product"	"tumor	8	13	Cancer"	"cells	107	112	Cell"	"[{""token"": ""p53"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 8, ""end_span"": 13, ""type"": ""Cancer""}, {""token"": ""cells"", ""start_span"": 107, ""end_span"": 112, ""type"": ""Cell""}]"
Additional activities of p53 in non - stressed cells tune up the antioxidant defense mechanisms reducing the probability of mutations caused by DNA oxidation under conditions of daily stresses.	"p53	25	28	Gene_or_gene_product"	"cells	47	52	Cell"	"DNA	144	147	Cellular_component"	"[{""token"": ""p53"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""DNA"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Cellular_component""}]"
BACKGROUND AND PURPOSE: Cerebral cavernous malformations ( CCMs) are prevalent cerebral vascular lesions involving aberrant angiogenesis.	"Cerebral cavernous malformations	24	56	Pathological_formation"	"CCMs	59	63	Pathological_formation"	"cerebral vascular lesions	79	104	Pathological_formation"	"[{""token"": ""Cerebral cavernous malformations"", ""start_span"": 24, ""end_span"": 56, ""type"": ""Pathological_formation""}, {""token"": ""CCMs"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Pathological_formation""}, {""token"": ""cerebral vascular lesions"", ""start_span"": 79, ""end_span"": 104, ""type"": ""Pathological_formation""}]"
Phosphatase and tension homolog deleted on chromosome 10 ( PTEN), a tumor suppressor, is frequently deficient in various pathologies due to mutation or epigenetic alterations.	"Phosphatase and tension homolog deleted on chromosome 10	0	56	Gene_or_gene_product"	"PTEN	59	63	Gene_or_gene_product"	"tumor	68	73	Cancer"	"[{""token"": ""Phosphatase and tension homolog deleted on chromosome 10"", ""start_span"": 0, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTEN"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 68, ""end_span"": 73, ""type"": ""Cancer""}]"
In addition, PTEN promoter methylation appeared more frequently in multiple CCMs, including familial cases ( 46. 7%), than that in single - lesioned CCMs ( 11. 8%; P < 0. 05).	"PTEN	13	17	Gene_or_gene_product"	"CCMs	76	80	Pathological_formation"	"CCMs	149	153	Pathological_formation"	"[{""token"": ""PTEN"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""CCMs"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Pathological_formation""}, {""token"": ""CCMs"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Pathological_formation""}]"
The identification of Erk1, 2 as triggered signaling in the lesions may be valuable for the development of effective therapy for this disease.	"Erk1	22	26	Gene_or_gene_product"	"2	28	29	Gene_or_gene_product"	"lesions	60	67	Pathological_formation"	"[{""token"": ""Erk1"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""2"", ""start_span"": 28, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""lesions"", ""start_span"": 60, ""end_span"": 67, ""type"": ""Pathological_formation""}]"
Multiple studies are ongoing to determine the clinical benefits of aflibercept in cancer patients.	"aflibercept	67	78	Chemical"	"cancer	82	88	Cancer"	"patients	89	97	Organism"	"[{""token"": ""aflibercept"", ""start_span"": 67, ""end_span"": 78, ""type"": ""Chemical""}, {""token"": ""cancer"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 89, ""end_span"": 97, ""type"": ""Organism""}]"
The effect of perfluorocarbon - based artificial oxygen carriers on tissue - engineered trachea.	"perfluorocarbon	14	29	Chemical"	"oxygen	49	55	Chemical"	"tissue - engineered trachea	68	95	Multi"	"[{""token"": ""perfluorocarbon"", ""start_span"": 14, ""end_span"": 29, ""type"": ""Chemical""}, {""token"": ""oxygen"", ""start_span"": 49, ""end_span"": 55, ""type"": ""Chemical""}, {""token"": ""tissue - engineered trachea"", ""start_span"": 68, ""end_span"": 95, ""type"": ""Multi""}]"
The semaphorin 7A receptor Plexin C1 is lost during melanoma metastasis.	"semaphorin 7A	4	17	Gene_or_gene_product"	"Plexin C1	27	36	Gene_or_gene_product"	"melanoma	52	60	Cancer"	"[{""token"": ""semaphorin 7A"", ""start_span"": 4, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""Plexin C1"", ""start_span"": 27, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""melanoma"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Cancer""}]"
The transformation of normal melanocytes, or melanocyte stem cells, to melanoma, is a complex process involving multiple mechanisms.	"melanocytes	29	40	Cell"	"melanocyte stem cells	45	66	Cell"	"melanoma	71	79	Cancer"	"[{""token"": ""melanocytes"", ""start_span"": 29, ""end_span"": 40, ""type"": ""Cell""}, {""token"": ""melanocyte stem cells"", ""start_span"": 45, ""end_span"": 66, ""type"": ""Cell""}, {""token"": ""melanoma"", ""start_span"": 71, ""end_span"": 79, ""type"": ""Cancer""}]"
In this report, we analyzed the expression of Plexin C1 using immunohistochemistry on sections of primary and matched metastatic lesions from 19 subjects and in a large melanoma tumor microarray.	"Plexin C1	46	55	Gene_or_gene_product"	"metastatic lesions	118	136	Cancer"	"melanoma tumor	169	183	Cancer"	"[{""token"": ""Plexin C1"", ""start_span"": 46, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""metastatic lesions"", ""start_span"": 118, ""end_span"": 136, ""type"": ""Cancer""}, {""token"": ""melanoma tumor"", ""start_span"": 169, ""end_span"": 183, ""type"": ""Cancer""}]"
The coagulative parameters including the prothrombin time, activated partial thromboplastin time, and fibrinogen levels were collected and studied retrospectively.	"prothrombin	41	52	Gene_or_gene_product"	"thromboplastin	77	91	Gene_or_gene_product"	"fibrinogen	102	112	Gene_or_gene_product"	"[{""token"": ""prothrombin"", ""start_span"": 41, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""thromboplastin"", ""start_span"": 77, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibrinogen"", ""start_span"": 102, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}]"
CONCLUSIONS: The level of fibrinogen in patients with pancreatic carcinoma was elevated.	"fibrinogen	26	36	Gene_or_gene_product"	"patients	40	48	Organism"	"pancreatic carcinoma	54	74	Cancer"	"[{""token"": ""fibrinogen"", ""start_span"": 26, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 40, ""end_span"": 48, ""type"": ""Organism""}, {""token"": ""pancreatic carcinoma"", ""start_span"": 54, ""end_span"": 74, ""type"": ""Cancer""}]"
In addition, TNFalpha treatment alone led to increased malignant transformation of mouse embryo fibroblasts, which could be partially suppressed by antioxidants.	"TNFalpha	13	21	Gene_or_gene_product"	"mouse	83	88	Organism"	"embryo fibroblasts	89	107	Cell"	"[{""token"": ""TNFalpha"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 83, ""end_span"": 88, ""type"": ""Organism""}, {""token"": ""embryo fibroblasts"", ""start_span"": 89, ""end_span"": 107, ""type"": ""Cell""}]"
PTTG induced S100A4 and galectin - 1 mRNA and protein expression as assessed by Western blot and reverse transcription - PCR.	"PTTG	0	4	Gene_or_gene_product"	"S100A4	13	19	Gene_or_gene_product"	"galectin - 1	24	36	Gene_or_gene_product"	"[{""token"": ""PTTG"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""S100A4"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""galectin - 1"", ""start_span"": 24, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}]"
Chromatin immunoprecipitation assays further confirmed specific c - Myc binding to galectin - 1 promoter.	"Chromatin	0	9	Cellular_component"	"c - Myc	64	71	Gene_or_gene_product"	"galectin - 1	83	95	Gene_or_gene_product"	"[{""token"": ""Chromatin"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Cellular_component""}, {""token"": ""c - Myc"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""galectin - 1"", ""start_span"": 83, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}]"
The cells subsequently proliferate and differentiate to form endothelial tubes and capillary - like structures.	"cells	4	9	Cell"	"endothelial tubes	61	78	Tissue"	"capillary - like structures	83	110	Tissue"	"[{""token"": ""cells"", ""start_span"": 4, ""end_span"": 9, ""type"": ""Cell""}, {""token"": ""endothelial tubes"", ""start_span"": 61, ""end_span"": 78, ""type"": ""Tissue""}, {""token"": ""capillary - like structures"", ""start_span"": 83, ""end_span"": 110, ""type"": ""Tissue""}]"
We studied the metabolic changes of endothelial cell activation by growth factors using human umbilical vein endothelial cells ( HUVECs), [ 1, 2 - ( 13) C ( 2)] - glucose and mass isotopomer distribution analysis.	"endothelial cell	36	52	Cell"	"human umbilical vein endothelial cells	88	126	Cell"	"HUVECs	129	135	Cell"	"[{""token"": ""endothelial cell"", ""start_span"": 36, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""human umbilical vein endothelial cells"", ""start_span"": 88, ""end_span"": 126, ""type"": ""Cell""}, {""token"": ""HUVECs"", ""start_span"": 129, ""end_span"": 135, ""type"": ""Cell""}]"
A specific VEGF receptor - 2 inhibitor demonstrated the importance of glycogen metabolism and pentose cycle pathway.	"VEGF receptor - 2	11	28	Gene_or_gene_product"	"glycogen	70	78	Chemical"	"pentose	94	101	Chemical"	"[{""token"": ""VEGF receptor - 2"", ""start_span"": 11, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""glycogen"", ""start_span"": 70, ""end_span"": 78, ""type"": ""Chemical""}, {""token"": ""pentose"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Chemical""}]"
Finally, we demonstrated that direct inhibition of key enzymes to glycogen metabolism and pentose phosphate pathways reduced HUVEC viability and migration.	"glycogen	66	74	Chemical"	"pentose	90	97	Chemical"	"HUVEC	125	130	Cell"	"[{""token"": ""glycogen"", ""start_span"": 66, ""end_span"": 74, ""type"": ""Chemical""}, {""token"": ""pentose"", ""start_span"": 90, ""end_span"": 97, ""type"": ""Chemical""}, {""token"": ""HUVEC"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Cell""}]"
Rab GTPase regulation of VEGFR2 trafficking and signaling in endothelial cells.	"Rab	0	3	Gene_or_gene_product"	"VEGFR2	25	31	Gene_or_gene_product"	"endothelial cells	61	78	Cell"	"[{""token"": ""Rab"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR2"", ""start_span"": 25, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 61, ""end_span"": 78, ""type"": ""Cell""}]"
OBJECTIVE: Vascular endothelial growth factor receptor 2 ( VEGFR2) is a receptor tyrosine kinase that regulates vascular physiology.	"Vascular endothelial growth factor receptor 2	11	56	Gene_or_gene_product"	"VEGFR2	59	65	Gene_or_gene_product"	"vascular	112	120	Multi"	"[{""token"": ""Vascular endothelial growth factor receptor 2"", ""start_span"": 11, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR2"", ""start_span"": 59, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular"", ""start_span"": 112, ""end_span"": 120, ""type"": ""Multi""}]"
Here, we have tested endocytic Rab GTPases for regulation of VEGFR2 trafficking and signaling linked to endothelial cell migration.	"Rab	31	34	Gene_or_gene_product"	"VEGFR2	61	67	Gene_or_gene_product"	"endothelial cell	104	120	Cell"	"[{""token"": ""Rab"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR2"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 104, ""end_span"": 120, ""type"": ""Cell""}]"
Manipulation of Rab7a GTPase activity associated with late endosomes using overexpression of wild - type or mutant proteins blocks activated VEGFR2 trafficking and degradation.	"Rab7a	16	21	Gene_or_gene_product"	"late endosomes	54	68	Cellular_component"	"VEGFR2	141	147	Gene_or_gene_product"	"[{""token"": ""Rab7a"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""late endosomes"", ""start_span"": 54, ""end_span"": 68, ""type"": ""Cellular_component""}, {""token"": ""VEGFR2"", ""start_span"": 141, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}]"
Endothelial cell migration was increased by Rab5a depletion but decreased by Rab7a depletion.	"Endothelial cell	0	16	Cell"	"Rab5a	44	49	Gene_or_gene_product"	"Rab7a	77	82	Gene_or_gene_product"	"[{""token"": ""Endothelial cell"", ""start_span"": 0, ""end_span"": 16, ""type"": ""Cell""}, {""token"": ""Rab5a"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rab7a"", ""start_span"": 77, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}]"
We recently observed that FOXO3a gene inactivation occurs frequently in carcinogen - induced lung adenocarcinoma ( LAC).	"FOXO3a	26	32	Gene_or_gene_product"	"lung adenocarcinoma	93	112	Cancer"	"LAC	115	118	Cancer"	"[{""token"": ""FOXO3a"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""lung adenocarcinoma"", ""start_span"": 93, ""end_span"": 112, ""type"": ""Cancer""}, {""token"": ""LAC"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Cancer""}]"
Genes most significantly represented in this program are those with roles in cell growth and proliferation > protein synthesis > gene expression > cell death > cell cycle.	"cell	77	81	Cell"	"cell	147	151	Cell"	"cell	160	164	Cell"	"[{""token"": ""cell"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 160, ""end_span"": 164, ""type"": ""Cell""}]"
We hypothesized that Erbb2 activation contributes to UV - induced skin tumorigenesis by suppressing cell cycle arrest.	"Erbb2	21	26	Gene_or_gene_product"	"skin	66	70	Organ"	"cell	100	104	Cell"	"[{""token"": ""Erbb2"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""skin"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Organ""}, {""token"": ""cell"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Cell""}]"
A small GTPase Arf6 primarily regulates recycling of plasma membrane components.	"Arf6	15	19	Gene_or_gene_product"	"plasma	53	59	Organism_substance"	"membrane components	60	79	Cellular_component"	"[{""token"": ""Arf6"", ""start_span"": 15, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""plasma"", ""start_span"": 53, ""end_span"": 59, ""type"": ""Organism_substance""}, {""token"": ""membrane components"", ""start_span"": 60, ""end_span"": 79, ""type"": ""Cellular_component""}]"
Met amplification and tumor progression in Cdkn2a - deficient melanocytes.	"Met	0	3	Gene_or_gene_product"	"tumor	22	27	Cancer"	"Cdkn2a	43	49	Gene_or_gene_product"	"[{""token"": ""Met"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Cancer""}, {""token"": ""Cdkn2a"", ""start_span"": 43, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}]"
This study validates a role for Met activation in melanoma tumor progression in the context of Cdkn2a deficiency.	"Met	32	35	Gene_or_gene_product"	"melanoma tumor	50	64	Cancer"	"Cdkn2a	95	101	Gene_or_gene_product"	"[{""token"": ""Met"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""melanoma tumor"", ""start_span"": 50, ""end_span"": 64, ""type"": ""Cancer""}, {""token"": ""Cdkn2a"", ""start_span"": 95, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}]"
Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis.	"platelets	10	19	Cell"	"ovarian cancer cell	28	47	Cell"	"cellular	62	70	Cell"	"[{""token"": ""platelets"", ""start_span"": 10, ""end_span"": 19, ""type"": ""Cell""}, {""token"": ""ovarian cancer cell"", ""start_span"": 28, ""end_span"": 47, ""type"": ""Cell""}, {""token"": ""cellular"", ""start_span"": 62, ""end_span"": 70, ""type"": ""Cell""}]"
TRAP - activated platelets stimulated a dose - dependent increase in SKOV3 cell invasion.	"TRAP	0	4	Gene_or_gene_product"	"platelets	17	26	Cell"	"SKOV3 cell	69	79	Cell"	"[{""token"": ""TRAP"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""platelets"", ""start_span"": 17, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""SKOV3 cell"", ""start_span"": 69, ""end_span"": 79, ""type"": ""Cell""}]"
Exposure to activated platelet membranes and to soluble proteins contained in activated platelet releasate both contributed to the observed increase in invasion.	"platelet	22	30	Cell"	"membranes	31	40	Cellular_component"	"platelet	88	96	Cell"	"[{""token"": ""platelet"", ""start_span"": 22, ""end_span"": 30, ""type"": ""Cell""}, {""token"": ""membranes"", ""start_span"": 31, ""end_span"": 40, ""type"": ""Cellular_component""}, {""token"": ""platelet"", ""start_span"": 88, ""end_span"": 96, ""type"": ""Cell""}]"
The inhibition of platelet activation with prostaglandin E1 ( PGE ( 1)) attenuated the invasive capacity of SKOV3 cells.	"platelet	18	26	Cell"	"prostaglandin E1	43	59	Chemical"	"SKOV3 cells	108	119	Cell"	"[{""token"": ""platelet"", ""start_span"": 18, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""prostaglandin E1"", ""start_span"": 43, ""end_span"": 59, ""type"": ""Chemical""}, {""token"": ""SKOV3 cells"", ""start_span"": 108, ""end_span"": 119, ""type"": ""Cell""}]"
If generalizable to additional cell lines and human disease, this observation may partially explain the adverse prognosis associated with thrombocytosis in ovarian cancer.	"cell lines	31	41	Cell"	"human	46	51	Organism"	"ovarian cancer	156	170	Cancer"	"[{""token"": ""cell lines"", ""start_span"": 31, ""end_span"": 41, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Organism""}, {""token"": ""ovarian cancer"", ""start_span"": 156, ""end_span"": 170, ""type"": ""Cancer""}]"
Platelets, therefore, may represent a potential target for therapeutic intervention in human ovarian cancer.	"Platelets	0	9	Cell"	"human	87	92	Organism"	"ovarian cancer	93	107	Cancer"	"[{""token"": ""Platelets"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 87, ""end_span"": 92, ""type"": ""Organism""}, {""token"": ""ovarian cancer"", ""start_span"": 93, ""end_span"": 107, ""type"": ""Cancer""}]"
Mice with EC - specific deletion of Dicer, a key enzyme for generating miRNAs, display defective postnatal angiogenesis.	"Mice	0	4	Organism"	"EC	10	12	Cell"	"Dicer	36	41	Gene_or_gene_product"	"[{""token"": ""Mice"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Organism""}, {""token"": ""EC"", ""start_span"": 10, ""end_span"": 12, ""type"": ""Cell""}, {""token"": ""Dicer"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}]"
miRNA - 126, an EC - restricted miRNA, regulates vascular integrity and developmental angiogenesis.	"miRNA - 126	0	11	Gene_or_gene_product"	"EC	16	18	Cell"	"vascular	49	57	Multi"	"[{""token"": ""miRNA - 126"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 16, ""end_span"": 18, ""type"": ""Cell""}, {""token"": ""vascular"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Multi""}]"
We tested this possibility with in vitro assays using human endothelial cells, as well as in a rodent hindlimb ischemia model.	"human	54	59	Organism"	"endothelial cells	60	77	Cell"	"hindlimb	102	110	Organism_subdivision"	"[{""token"": ""human"", ""start_span"": 54, ""end_span"": 59, ""type"": ""Organism""}, {""token"": ""endothelial cells"", ""start_span"": 60, ""end_span"": 77, ""type"": ""Cell""}, {""token"": ""hindlimb"", ""start_span"": 102, ""end_span"": 110, ""type"": ""Organism_subdivision""}]"
OBJECTIVE: To study the activation of sterol regulatory element binding protein ( SREBP) and its critical role in endothelial cell migration.	"sterol regulatory element binding protein	38	79	Gene_or_gene_product"	"SREBP	82	87	Gene_or_gene_product"	"endothelial cell	114	130	Cell"	"[{""token"": ""sterol regulatory element binding protein"", ""start_span"": 38, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""SREBP"", ""start_span"": 82, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 114, ""end_span"": 130, ""type"": ""Cell""}]"
METHODS: Bovine aortic endothelial cells ( ECs) were cultured.	"Bovine	9	15	Organism"	"aortic endothelial cells	16	40	Cell"	"ECs	43	46	Cell"	"[{""token"": ""Bovine"", ""start_span"": 9, ""end_span"": 15, ""type"": ""Organism""}, {""token"": ""aortic endothelial cells"", ""start_span"": 16, ""end_span"": 40, ""type"": ""Cell""}, {""token"": ""ECs"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Cell""}]"
Fibroblast growth factor receptor 2 - positive fibroblasts provide a suitable microenvironment for tumor development and progression in esophageal carcinoma.	"Fibroblast growth factor receptor 2	0	35	Gene_or_gene_product"	"tumor	99	104	Cancer"	"esophageal carcinoma	136	156	Cancer"	"[{""token"": ""Fibroblast growth factor receptor 2"", ""start_span"": 0, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Cancer""}, {""token"": ""esophageal carcinoma"", ""start_span"": 136, ""end_span"": 156, ""type"": ""Cancer""}]"
RESULTS: About 43% ( 126 of 292) of known deregulated genes in TFs were associated with cell proliferation, extracellular matrix remodeling, and immune response.	"TFs	63	66	Cell"	"cell	88	92	Cell"	"extracellular matrix	108	128	Cellular_component"	"[{""token"": ""TFs"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Cell""}, {""token"": ""extracellular matrix"", ""start_span"": 108, ""end_span"": 128, ""type"": ""Cellular_component""}]"
The paper reviews the data available in the literature on a role of the tumor suppressor ARF in oncogenesis and considers the structure of a gene encoding ARF protein.	"tumor	72	77	Cancer"	"ARF	89	92	Gene_or_gene_product"	"ARF	155	158	Gene_or_gene_product"	"[{""token"": ""tumor"", ""start_span"": 72, ""end_span"": 77, ""type"": ""Cancer""}, {""token"": ""ARF"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""ARF"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}]"
The importance of this tumor suppressor in the mechanisms of carcinogenesis is beyond question as the inactivation of ARF suppressor activity leads to the rapid growth of neoplasia.	"tumor	23	28	Cancer"	"ARF	118	121	Gene_or_gene_product"	"neoplasia	171	180	Cancer"	"[{""token"": ""tumor"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Cancer""}, {""token"": ""ARF"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}, {""token"": ""neoplasia"", ""start_span"": 171, ""end_span"": 180, ""type"": ""Cancer""}]"
Taken together, these data suggest that signal - controlled activation of SRF, MRTF - A, and CBP provides a novel connection between mechanical stimuli and angiogenic gene expression.	"SRF	74	77	Gene_or_gene_product"	"MRTF - A	79	87	Gene_or_gene_product"	"CBP	93	96	Gene_or_gene_product"	"[{""token"": ""SRF"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""MRTF - A"", ""start_span"": 79, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""CBP"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}]"
Studies were therefore performed with PECAM - 1 - null mice to further define the involvement of PECAM - 1 in blood vessel formation.	"PECAM - 1	38	47	Gene_or_gene_product"	"PECAM - 1	97	106	Gene_or_gene_product"	"blood vessel	110	122	Multi"	"[{""token"": ""PECAM - 1"", ""start_span"": 38, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""PECAM - 1"", ""start_span"": 97, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""blood vessel"", ""start_span"": 110, ""end_span"": 122, ""type"": ""Multi""}]"
In vitro wound migration and single - cell motility by PECAM - 1 - null endothelial cells were also compromised.	"wound	9	14	Pathological_formation"	"cell	38	42	Cell"	"PECAM - 1	55	64	Gene_or_gene_product"	"[{""token"": ""wound"", ""start_span"": 9, ""end_span"": 14, ""type"": ""Pathological_formation""}, {""token"": ""cell"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Cell""}, {""token"": ""PECAM - 1"", ""start_span"": 55, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}]"
Although, the growth of all three cell lines was suppressed by DMI, it was more effective in Ca3 / 7 cells.	"cell lines	34	44	Cell"	"DMI	63	66	Chemical"	"Ca3 / 7 cells	93	106	Cell"	"[{""token"": ""cell lines"", ""start_span"": 34, ""end_span"": 44, ""type"": ""Cell""}, {""token"": ""DMI"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Chemical""}, {""token"": ""Ca3 / 7 cells"", ""start_span"": 93, ""end_span"": 106, ""type"": ""Cell""}]"
The translocation of GR was induced by FA alone, DMI alone, and combination of both agents.	"GR	21	23	Gene_or_gene_product"	"FA	39	41	Chemical"	"DMI	49	52	Chemical"	"[{""token"": ""GR"", ""start_span"": 21, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""FA"", ""start_span"": 39, ""end_span"": 41, ""type"": ""Chemical""}, {""token"": ""DMI"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Chemical""}]"
However, DMI inhibited FA - induced, GR - mediated transcription when both agents were given together.	"DMI	9	12	Chemical"	"FA	23	25	Chemical"	"GR	37	39	Gene_or_gene_product"	"[{""token"": ""DMI"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Chemical""}, {""token"": ""FA"", ""start_span"": 23, ""end_span"": 25, ""type"": ""Chemical""}, {""token"": ""GR"", ""start_span"": 37, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}]"
DMI is suggested to inhibit the growth of Ca3 / 7 cells and to affect GR - mediated transcription.	"DMI	0	3	Chemical"	"Ca3 / 7 cells	42	55	Cell"	"GR	70	72	Gene_or_gene_product"	"[{""token"": ""DMI"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Chemical""}, {""token"": ""Ca3 / 7 cells"", ""start_span"": 42, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""GR"", ""start_span"": 70, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}]"
Using a retroviral gene transfer approach, we found that constitutive activation of MEK5 / ERK5 signaling strongly inhibits EC migration and results in massive morphological changes.	"MEK5	84	88	Gene_or_gene_product"	"ERK5	91	95	Gene_or_gene_product"	"EC	124	126	Cell"	"[{""token"": ""MEK5"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK5"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 124, ""end_span"": 126, ""type"": ""Cell""}]"
This phenotype was most likely based on decreased focal contact turnover caused by reduced expression of p130Cas, a key player in directed cell migration.	"focal contact	50	63	Cellular_component"	"p130Cas	105	112	Gene_or_gene_product"	"cell	139	143	Cell"	"[{""token"": ""focal contact"", ""start_span"": 50, ""end_span"": 63, ""type"": ""Cellular_component""}, {""token"": ""p130Cas"", ""start_span"": 105, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 139, ""end_span"": 143, ""type"": ""Cell""}]"
We demonstrate for the first time that ERK5 signaling not only is involved in EC survival and stress response but also controls migration and morphology of EC.	"ERK5	39	43	Gene_or_gene_product"	"EC	78	80	Cell"	"EC	156	158	Cell"	"[{""token"": ""ERK5"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 78, ""end_span"": 80, ""type"": ""Cell""}, {""token"": ""EC"", ""start_span"": 156, ""end_span"": 158, ""type"": ""Cell""}]"
EPOX inhibits angiogenesis by degradation of Mcl - 1 through ERK inactivation.	"EPOX	0	4	Chemical"	"Mcl - 1	45	52	Gene_or_gene_product"	"ERK	61	64	Gene_or_gene_product"	"[{""token"": ""EPOX"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Chemical""}, {""token"": ""Mcl - 1"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}]"
RESULTS: EPOX induced endothelial cell apoptosis in association with proteasome - dependent Mcl - 1 degradation.	"EPOX	9	13	Chemical"	"endothelial cell	22	38	Cell"	"Mcl - 1	92	99	Gene_or_gene_product"	"[{""token"": ""EPOX"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Chemical""}, {""token"": ""endothelial cell"", ""start_span"": 22, ""end_span"": 38, ""type"": ""Cell""}, {""token"": ""Mcl - 1"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}]"
Although anti - VEGF therapies have clearly demonstrated antitumor efficacy in various malignancies, especially when combined with conventional cytotoxic chemotherapy, their mechanism of action is not fully understood.	"anti - VEGF	9	20	Gene_or_gene_product"	"antitumor	57	66	Cancer"	"malignancies	87	99	Cancer"	"[{""token"": ""anti - VEGF"", ""start_span"": 9, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""antitumor"", ""start_span"": 57, ""end_span"": 66, ""type"": ""Cancer""}, {""token"": ""malignancies"", ""start_span"": 87, ""end_span"": 99, ""type"": ""Cancer""}]"
Nonetheless, anti - VEGF therapy has enhanced the arsenal of anticancer therapies and has provided new insights into the biology of malignancy.	"anti - VEGF	13	24	Gene_or_gene_product"	"anticancer	61	71	Cancer"	"malignancy	132	142	Cancer"	"[{""token"": ""anti - VEGF"", ""start_span"": 13, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""anticancer"", ""start_span"": 61, ""end_span"": 71, ""type"": ""Cancer""}, {""token"": ""malignancy"", ""start_span"": 132, ""end_span"": 142, ""type"": ""Cancer""}]"
The review is focused on the participation of polymorphonuclear granulocytes ( neutrophils) in development and spreading of a tumor.	"polymorphonuclear granulocytes	46	76	Cell"	"neutrophils	79	90	Cell"	"tumor	126	131	Cancer"	"[{""token"": ""polymorphonuclear granulocytes"", ""start_span"": 46, ""end_span"": 76, ""type"": ""Cell""}, {""token"": ""neutrophils"", ""start_span"": 79, ""end_span"": 90, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Cancer""}]"
We consider both the well known functions of neutrophils ( degranulation, production of reactive oxygen species ( ROS)) and the recently shown one ( presentation of an antigene).	"neutrophils	45	56	Cell"	"reactive oxygen species	88	111	Chemical"	"ROS	114	117	Chemical"	"[{""token"": ""neutrophils"", ""start_span"": 45, ""end_span"": 56, ""type"": ""Cell""}, {""token"": ""reactive oxygen species"", ""start_span"": 88, ""end_span"": 111, ""type"": ""Chemical""}, {""token"": ""ROS"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Chemical""}]"
Endothelial cell migration and vascular endothelial growth factor expression are the result of loss of breast tissue polarity.	"Endothelial cell	0	16	Cell"	"vascular endothelial growth factor	31	65	Gene_or_gene_product"	"breast tissue	103	116	Tissue"	"[{""token"": ""Endothelial cell"", ""start_span"": 0, ""end_span"": 16, ""type"": ""Cell""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 31, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast tissue"", ""start_span"": 103, ""end_span"": 116, ""type"": ""Tissue""}]"
In a three - dimensional model of breast carcinogenesis, disorganized, proliferative transformed breast epithelial cells express significantly higher expression of angiogenic genes compared with their polarized, growth - arrested nonmalignant counterparts.	"breast	34	40	Organism_subdivision"	"breast epithelial cells	97	120	Cell"	"nonmalignant counterparts	230	255	Cell"	"[{""token"": ""breast"", ""start_span"": 34, ""end_span"": 40, ""type"": ""Organism_subdivision""}, {""token"": ""breast epithelial cells"", ""start_span"": 97, ""end_span"": 120, ""type"": ""Cell""}, {""token"": ""nonmalignant counterparts"", ""start_span"": 230, ""end_span"": 255, ""type"": ""Cell""}]"
In unchallenged endothelial cells, fibrillar collagen induced robust capillary morphogenesis.	"endothelial cells	16	33	Cell"	"fibrillar collagen	35	53	Gene_or_gene_product"	"capillary	69	78	Tissue"	"[{""token"": ""endothelial cells"", ""start_span"": 16, ""end_span"": 33, ""type"": ""Cell""}, {""token"": ""fibrillar collagen"", ""start_span"": 35, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""capillary"", ""start_span"": 69, ""end_span"": 78, ""type"": ""Tissue""}]"
We further characterized zebrafish alpha2 integrin and discovered that this integrin is highly conserved, especially the I domain.	"zebrafish	25	34	Organism"	"alpha2 integrin	35	50	Gene_or_gene_product"	"integrin	76	84	Gene_or_gene_product"	"[{""token"": ""zebrafish"", ""start_span"": 25, ""end_span"": 34, ""type"": ""Organism""}, {""token"": ""alpha2 integrin"", ""start_span"": 35, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""integrin"", ""start_span"": 76, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}]"
Islet endothelial activation and oxidative stress gene expression is reduced by IL - 1Ra treatment in the type 2 diabetic GK rat.	"Islet endothelial	0	17	Cell"	"IL - 1Ra	80	88	Chemical"	"GK rat	122	128	Organism"	"[{""token"": ""Islet endothelial"", ""start_span"": 0, ""end_span"": 17, ""type"": ""Cell""}, {""token"": ""IL - 1Ra"", ""start_span"": 80, ""end_span"": 88, ""type"": ""Chemical""}, {""token"": ""GK rat"", ""start_span"": 122, ""end_span"": 128, ""type"": ""Organism""}]"
We also examined islet endotheliuml / oxidative stress ( OS) / inflammation - related gene expression, islet vascularization and fibrosis after treatment with the interleukin - 1 ( IL - 1) receptor antagonist ( IL - 1Ra).	"islet endotheliuml	17	35	Tissue"	"islet	103	108	Multi"	"IL - 1Ra	211	219	Chemical"	"[{""token"": ""islet endotheliuml"", ""start_span"": 17, ""end_span"": 35, ""type"": ""Tissue""}, {""token"": ""islet"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Multi""}, {""token"": ""IL - 1Ra"", ""start_span"": 211, ""end_span"": 219, ""type"": ""Chemical""}]"
METHODOLOGY / PRINCIPAL FINDINGS: Gene expression was analyzed by quantitative RT - PCR on islets isolated from 10 - week - old diabetic GK and control Wistar rats.	"islets	91	97	Multi"	"GK	137	139	Organism"	"Wistar rats	152	163	Organism"	"[{""token"": ""islets"", ""start_span"": 91, ""end_span"": 97, ""type"": ""Multi""}, {""token"": ""GK"", ""start_span"": 137, ""end_span"": 139, ""type"": ""Organism""}, {""token"": ""Wistar rats"", ""start_span"": 152, ""end_span"": 163, ""type"": ""Organism""}]"
CONCLUSIONS / SIGNIFICANCE: GK rat islets have increased mRNA expression of markers of early islet endothelial cell activation, possibly triggered by several metabolic factors, and also some defense mechanisms.	"GK rat	28	34	Organism"	"islets	35	41	Multi"	"islet endothelial cell	93	115	Cell"	"[{""token"": ""GK rat"", ""start_span"": 28, ""end_span"": 34, ""type"": ""Organism""}, {""token"": ""islets"", ""start_span"": 35, ""end_span"": 41, ""type"": ""Multi""}, {""token"": ""islet endothelial cell"", ""start_span"": 93, ""end_span"": 115, ""type"": ""Cell""}]"
AVE8062: a new combretastatin derivative vascular disrupting agent.	"AVE8062	0	7	Chemical"	"combretastatin	15	29	Chemical"	"vascular	41	49	Multi"	"[{""token"": ""AVE8062"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""combretastatin"", ""start_span"": 15, ""end_span"": 29, ""type"": ""Chemical""}, {""token"": ""vascular"", ""start_span"": 41, ""end_span"": 49, ""type"": ""Multi""}]"
The tumor vascular network is the result of pro - angiogenic and inhibitory factors as well as of the interaction between endothelial cells and extracellular matrix.	"tumor vascular network	4	26	Multi"	"endothelial cells	122	139	Cell"	"extracellular matrix	144	164	Cellular_component"	"[{""token"": ""tumor vascular network"", ""start_span"": 4, ""end_span"": 26, ""type"": ""Multi""}, {""token"": ""endothelial cells"", ""start_span"": 122, ""end_span"": 139, ""type"": ""Cell""}, {""token"": ""extracellular matrix"", ""start_span"": 144, ""end_span"": 164, ""type"": ""Cellular_component""}]"
Different antiangiogenic therapeutics have been developed to improve tumor control through vascular - targeting agents ( VTA).	"tumor	69	74	Cancer"	"vascular - targeting agents	91	118	Chemical"	"VTA	121	124	Chemical"	"[{""token"": ""tumor"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Cancer""}, {""token"": ""vascular - targeting agents"", ""start_span"": 91, ""end_span"": 118, ""type"": ""Chemical""}, {""token"": ""VTA"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Chemical""}]"
In this review we will discuss the mechanism of action, as well as the preclinical and clinical results, of one of the most promising antitubulin agents: the combretastatin A4 - phosphate derivative, AVE8062A.	"antitubulin agents	134	152	Chemical"	"combretastatin A4 - phosphate derivative	158	198	Chemical"	"AVE8062A	200	208	Chemical"	"[{""token"": ""antitubulin agents"", ""start_span"": 134, ""end_span"": 152, ""type"": ""Chemical""}, {""token"": ""combretastatin A4 - phosphate derivative"", ""start_span"": 158, ""end_span"": 198, ""type"": ""Chemical""}, {""token"": ""AVE8062A"", ""start_span"": 200, ""end_span"": 208, ""type"": ""Chemical""}]"
Tumor necrosis factor - alpha ( TNF - alpha) was first isolated two decades ago as a macrophageproduced protein that can effectively kill tumor cells.	"Tumor necrosis factor - alpha	0	29	Gene_or_gene_product"	"TNF - alpha	32	43	Gene_or_gene_product"	"tumor cells	138	149	Cell"	"[{""token"": ""Tumor necrosis factor - alpha"", ""start_span"": 0, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""TNF - alpha"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cells"", ""start_span"": 138, ""end_span"": 149, ""type"": ""Cell""}]"
[ Effect of osteopontin silencing by lentivirus - mediated delivery of siRNA on glioma cell invasion and apoptosis].	"osteopontin	12	23	Gene_or_gene_product"	"lentivirus	37	47	Organism"	"glioma cell	80	91	Cell"	"[{""token"": ""osteopontin"", ""start_span"": 12, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""lentivirus"", ""start_span"": 37, ""end_span"": 47, ""type"": ""Organism""}, {""token"": ""glioma cell"", ""start_span"": 80, ""end_span"": 91, ""type"": ""Cell""}]"
METHODS: The invasion, apoptosis and levels of uPA, MMP - 2 and MMP - 9 were determined by invasion assay, flow cytometry, Western blot and real - time fluorescence quantitative PCR respectively.	"uPA	47	50	Gene_or_gene_product"	"MMP - 2	52	59	Gene_or_gene_product"	"MMP - 9	64	71	Gene_or_gene_product"	"[{""token"": ""uPA"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 2"", ""start_span"": 52, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 9"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}]"
It suggests that osteopontin plays an important role in human glioma progression.	"osteopontin	17	28	Gene_or_gene_product"	"human	56	61	Organism"	"glioma	62	68	Cancer"	"[{""token"": ""osteopontin"", ""start_span"": 17, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Organism""}, {""token"": ""glioma"", ""start_span"": 62, ""end_span"": 68, ""type"": ""Cancer""}]"
AKT2 is a downstream target of metabotropic glutamate receptor 1 ( Grm1).	"AKT2	0	4	Gene_or_gene_product"	"glutamate receptor 1	44	64	Gene_or_gene_product"	"Grm1	67	71	Gene_or_gene_product"	"[{""token"": ""AKT2"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""glutamate receptor 1"", ""start_span"": 44, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""Grm1"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}]"
We also detected strong activation of AKT in allograft tumors specifically AKT2 as the predominant isoform involved.	"AKT	38	41	Gene_or_gene_product"	"allograft tumors	45	61	Cancer"	"AKT2	75	79	Gene_or_gene_product"	"[{""token"": ""AKT"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""allograft tumors"", ""start_span"": 45, ""end_span"": 61, ""type"": ""Cancer""}, {""token"": ""AKT2"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}]"
Hormonal regulation and distinct functions of semaphorin - 3B and semaphorin - 3F in ovarian cancer.	"semaphorin - 3B	46	61	Gene_or_gene_product"	"semaphorin - 3F	66	81	Gene_or_gene_product"	"ovarian cancer	85	99	Cancer"	"[{""token"": ""semaphorin - 3B"", ""start_span"": 46, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""semaphorin - 3F"", ""start_span"": 66, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian cancer"", ""start_span"": 85, ""end_span"": 99, ""type"": ""Cancer""}]"
We examined the status and regulation of semaphorins and their receptors in human ovarian cancer cells.	"semaphorins	41	52	Gene_or_gene_product"	"human	76	81	Organism"	"ovarian cancer cells	82	102	Cell"	"[{""token"": ""semaphorins"", ""start_span"": 41, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Organism""}, {""token"": ""ovarian cancer cells"", ""start_span"": 82, ""end_span"": 102, ""type"": ""Cell""}]"
Forced expression of SEMA3B, but not SEMA3F, inhibited viability of ovarian cancer cells.	"SEMA3B	21	27	Gene_or_gene_product"	"SEMA3F	37	43	Gene_or_gene_product"	"ovarian cancer cells	68	88	Cell"	"[{""token"": ""SEMA3B"", ""start_span"": 21, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""SEMA3F"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian cancer cells"", ""start_span"": 68, ""end_span"": 88, ""type"": ""Cell""}]"
The aim of the present study was to investigate the effects of doxorubicin in Hct - 116 human colon carcinoma cells in order to clarify if a time / concentration range for optimal doxorubicin - induced apoptosis exists.	"doxorubicin	63	74	Chemical"	"Hct - 116 human colon carcinoma cells	78	115	Cell"	"doxorubicin	180	191	Chemical"	"[{""token"": ""doxorubicin"", ""start_span"": 63, ""end_span"": 74, ""type"": ""Chemical""}, {""token"": ""Hct - 116 human colon carcinoma cells"", ""start_span"": 78, ""end_span"": 115, ""type"": ""Cell""}, {""token"": ""doxorubicin"", ""start_span"": 180, ""end_span"": 191, ""type"": ""Chemical""}]"
We compared a treatment schedule were cells were bolus incubated for 3h with doxorubicin followed by 24h in drug - free medium, with a continuous doxorubicin treatment schedule for 24h.	"cells	38	43	Cell"	"doxorubicin	77	88	Chemical"	"doxorubicin	146	157	Chemical"	"[{""token"": ""cells"", ""start_span"": 38, ""end_span"": 43, ""type"": ""Cell""}, {""token"": ""doxorubicin"", ""start_span"": 77, ""end_span"": 88, ""type"": ""Chemical""}, {""token"": ""doxorubicin"", ""start_span"": 146, ""end_span"": 157, ""type"": ""Chemical""}]"
In contrast, continuous ( 24h) treatment with doxorubicin reduced the number of living cells with no parallel raise in the amount of dead cells.	"doxorubicin	46	57	Chemical"	"cells	87	92	Cell"	"cells	138	143	Cell"	"[{""token"": ""doxorubicin"", ""start_span"": 46, ""end_span"": 57, ""type"": ""Chemical""}, {""token"": ""cells"", ""start_span"": 87, ""end_span"": 92, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 138, ""end_span"": 143, ""type"": ""Cell""}]"
Lactate - dehydrogenase 5 is overexpressed in non - small cell lung cancer and correlates with the expression of the transketolase - like protein 1.	"Lactate - dehydrogenase 5	0	25	Gene_or_gene_product"	"non - small cell lung cancer	46	74	Cancer"	"transketolase - like protein 1	117	147	Gene_or_gene_product"	"[{""token"": ""Lactate - dehydrogenase 5"", ""start_span"": 0, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""non - small cell lung cancer"", ""start_span"": 46, ""end_span"": 74, ""type"": ""Cancer""}, {""token"": ""transketolase - like protein 1"", ""start_span"": 117, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}]"
LDH5 overexpression in cancer cells induces an upregulated glycolytic metabolism and reduced dependence on the presence of oxygen.	"LDH5	0	4	Gene_or_gene_product"	"cancer cells	23	35	Cell"	"oxygen	123	129	Chemical"	"[{""token"": ""LDH5"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer cells"", ""start_span"": 23, ""end_span"": 35, ""type"": ""Cell""}, {""token"": ""oxygen"", ""start_span"": 123, ""end_span"": 129, ""type"": ""Chemical""}]"
Here we analyzed LDH5 protein expression in a well characterized large cohort of primary lung cancers in correlation to clinico - pathological data and its possible impact on patient survival.	"LDH5	17	21	Gene_or_gene_product"	"primary lung cancers	81	101	Cancer"	"patient	175	182	Organism"	"[{""token"": ""LDH5"", ""start_span"": 17, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""primary lung cancers"", ""start_span"": 81, ""end_span"": 101, ""type"": ""Cancer""}, {""token"": ""patient"", ""start_span"": 175, ""end_span"": 182, ""type"": ""Organism""}]"
In addition, the results of the previously tested transketolase like 1 protein ( TKTL1) expression were correlated to LDH5 expression.	"transketolase like 1	50	70	Gene_or_gene_product"	"TKTL1	81	86	Gene_or_gene_product"	"LDH5	118	122	Gene_or_gene_product"	"[{""token"": ""transketolase like 1"", ""start_span"": 50, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""TKTL1"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""LDH5"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}]"
A significant correlation between LDH5 and TKTL1 within each histologic tumortype could not be revealed.	"LDH5	34	38	Gene_or_gene_product"	"TKTL1	43	48	Gene_or_gene_product"	"tumortype	72	81	Cancer"	"[{""token"": ""LDH5"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""TKTL1"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumortype"", ""start_span"": 72, ""end_span"": 81, ""type"": ""Cancer""}]"
During lymphomagenesis, induction of persistent telomerase expression and activity may occur before or after telomere shortening, as a consequence of the different mechanisms through which transforming factors / agents may activate telomerase.	"telomerase	48	58	Gene_or_gene_product"	"telomere	109	117	Cellular_component"	"telomerase	232	242	Gene_or_gene_product"	"[{""token"": ""telomerase"", ""start_span"": 48, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""telomere"", ""start_span"": 109, ""end_span"": 117, ""type"": ""Cellular_component""}, {""token"": ""telomerase"", ""start_span"": 232, ""end_span"": 242, ""type"": ""Gene_or_gene_product""}]"
We further investigated the mechanism of anticancer activity by betulin, using HeLa cells as an experimental model.	"anticancer	41	51	Cancer"	"betulin	64	71	Chemical"	"HeLa cells	79	89	Cell"	"[{""token"": ""anticancer"", ""start_span"": 41, ""end_span"": 51, ""type"": ""Cancer""}, {""token"": ""betulin"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Chemical""}, {""token"": ""HeLa cells"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Cell""}]"
Taken together, the lines of evidence demonstrate that betulin triggers apoptosis of human cancer cells through the intrinsic apoptotic pathway.	"betulin	55	62	Chemical"	"human	85	90	Organism"	"cancer cells	91	103	Cell"	"[{""token"": ""betulin"", ""start_span"": 55, ""end_span"": 62, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 85, ""end_span"": 90, ""type"": ""Organism""}, {""token"": ""cancer cells"", ""start_span"": 91, ""end_span"": 103, ""type"": ""Cell""}]"
Histone deacetylase inhibitors ( HDACi) are potent anti - cancer agents for variety of cancer types.	"Histone deacetylase	0	19	Gene_or_gene_product"	"cancer	58	64	Cancer"	"cancer	87	93	Cancer"	"[{""token"": ""Histone deacetylase"", ""start_span"": 0, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer"", ""start_span"": 58, ""end_span"": 64, ""type"": ""Cancer""}, {""token"": ""cancer"", ""start_span"": 87, ""end_span"": 93, ""type"": ""Cancer""}]"
Suberoylanilide hydroxamic acid ( SAHA) has been approved as a drug to treat cutaneous T cell lymphoma, and the combination of HDACi and other agents have been actively tested in many clinical trials.	"Suberoylanilide hydroxamic acid	0	31	Chemical"	"SAHA	34	38	Chemical"	"T cell lymphoma	87	102	Cancer"	"[{""token"": ""Suberoylanilide hydroxamic acid"", ""start_span"": 0, ""end_span"": 31, ""type"": ""Chemical""}, {""token"": ""SAHA"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Chemical""}, {""token"": ""T cell lymphoma"", ""start_span"": 87, ""end_span"": 102, ""type"": ""Cancer""}]"
Here, we showed that proapoptotic activity of HDACi was robustly enhanced by E1A in multiple cancer cells, but not in normal cells.	"E1A	77	80	Gene_or_gene_product"	"multiple cancer cells	84	105	Cell"	"cells	125	130	Cell"	"[{""token"": ""E1A"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""multiple cancer cells"", ""start_span"": 84, ""end_span"": 105, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Cell""}]"
Together, our results provide not only a novel insight into the mechanisms underlying anti - tumor activity of E1A, but also a rationale for the combined HDACi and E1A gene therapy in future clinical trials.	"tumor	93	98	Cancer"	"E1A	111	114	Gene_or_gene_product"	"E1A	164	167	Gene_or_gene_product"	"[{""token"": ""tumor"", ""start_span"": 93, ""end_span"": 98, ""type"": ""Cancer""}, {""token"": ""E1A"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""E1A"", ""start_span"": 164, ""end_span"": 167, ""type"": ""Gene_or_gene_product""}]"
Conversely, knockdown of endogenous FOXO3a expression reduced PI3K / Akt activity.	"FOXO3a	36	42	Gene_or_gene_product"	"PI3K	62	66	Gene_or_gene_product"	"Akt	69	72	Gene_or_gene_product"	"[{""token"": ""FOXO3a"", ""start_span"": 36, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}]"
Thus, our results suggest that sustained FOXO3a activation can enhance hyperactivation of the PI3K / Akt pathway.	"FOXO3a	41	47	Gene_or_gene_product"	"PI3K	94	98	Gene_or_gene_product"	"Akt	101	104	Gene_or_gene_product"	"[{""token"": ""FOXO3a"", ""start_span"": 41, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}]"
This perspective places the report by Villani et al. that appears in this issue of the journal ( beginning on page 1222) in the context of recent work showing an intersection between two important developmental pathways implicated in oncogenesis: the hedgehog and insulin - like growth factor ( IGF) pathways.	"hedgehog	251	259	Gene_or_gene_product"	"insulin - like growth factor	264	292	Gene_or_gene_product"	"IGF	295	298	Gene_or_gene_product"	"[{""token"": ""hedgehog"", ""start_span"": 251, ""end_span"": 259, ""type"": ""Gene_or_gene_product""}, {""token"": ""insulin - like growth factor"", ""start_span"": 264, ""end_span"": 292, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF"", ""start_span"": 295, ""end_span"": 298, ""type"": ""Gene_or_gene_product""}]"
Brk1 is required for cell proliferation and cell transformation by oncogenes.	"Brk1	0	4	Gene_or_gene_product"	"cell	21	25	Cell"	"cell	44	48	Cell"	"[{""token"": ""Brk1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 21, ""end_span"": 25, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Cell""}]"
In addition, Brk1 downregulation results in defective directional migration and invasive growth in renal cell carcinoma cells as well as in other tumor cell types.	"Brk1	13	17	Gene_or_gene_product"	"renal cell carcinoma cells	99	125	Cell"	"tumor cell	146	156	Cell"	"[{""token"": ""Brk1"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""renal cell carcinoma cells"", ""start_span"": 99, ""end_span"": 125, ""type"": ""Cell""}, {""token"": ""tumor cell"", ""start_span"": 146, ""end_span"": 156, ""type"": ""Cell""}]"
Finally, genetic ablation of Brk1 results in dramatic defects in embryo compaction and development, suggesting an essential role for this protein in actin dynamics.	"Brk1	29	33	Gene_or_gene_product"	"embryo	65	71	Developing_anatomical_structure"	"actin	149	154	Gene_or_gene_product"	"[{""token"": ""Brk1"", ""start_span"": 29, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""embryo"", ""start_span"": 65, ""end_span"": 71, ""type"": ""Developing_anatomical_structure""}, {""token"": ""actin"", ""start_span"": 149, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}]"
Thus, genetic loss or inhibition of BRK1 is likely to be protective against tumor development due to proliferation and motility defects in affected cells.	"BRK1	36	40	Gene_or_gene_product"	"tumor	76	81	Cancer"	"cells	148	153	Cell"	"[{""token"": ""BRK1"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Cancer""}, {""token"": ""cells"", ""start_span"": 148, ""end_span"": 153, ""type"": ""Cell""}]"
METHODS: Gene silencing and over - expression techniques were used to modulate RASSF1C expression in human breast cancer cells.	"RASSF1C	79	86	Gene_or_gene_product"	"human	101	106	Organism"	"breast cancer cells	107	126	Cell"	"[{""token"": ""RASSF1C"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Organism""}, {""token"": ""breast cancer cells"", ""start_span"": 107, ""end_span"": 126, ""type"": ""Cell""}]"
Affymetrix - microarray analysis was performed using T47D cells over - expressing RASSF1C to identify RASSF1C target genes.	"T47D cells	53	63	Cell"	"RASSF1C	82	89	Gene_or_gene_product"	"RASSF1C	102	109	Gene_or_gene_product"	"[{""token"": ""T47D cells"", ""start_span"": 53, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""RASSF1C"", ""start_span"": 82, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""RASSF1C"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}]"
RESULTS: In this article, we report the effects of altering RASSF1C expression in human breast cancer cells.	"RASSF1C	60	67	Gene_or_gene_product"	"human	82	87	Organism"	"breast cancer cells	88	107	Cell"	"[{""token"": ""RASSF1C"", ""start_span"": 60, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 82, ""end_span"": 87, ""type"": ""Organism""}, {""token"": ""breast cancer cells"", ""start_span"": 88, ""end_span"": 107, ""type"": ""Cell""}]"
RASSF1C down - regulates several pro - apoptotic and tumor suppressor genes and up - regulates several growth promoting genes in breast cancer cells.	"RASSF1C	0	7	Gene_or_gene_product"	"tumor	53	58	Cancer"	"breast cancer cells	129	148	Cell"	"[{""token"": ""RASSF1C"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Cancer""}, {""token"": ""breast cancer cells"", ""start_span"": 129, ""end_span"": 148, ""type"": ""Cell""}]"
We quantified the expression of alpha - SMA as a marker of myofibroblasts in the invasive breast cancer.	"alpha - SMA	32	43	Gene_or_gene_product"	"myofibroblasts	59	73	Cell"	"breast cancer	90	103	Cancer"	"[{""token"": ""alpha - SMA"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""myofibroblasts"", ""start_span"": 59, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""breast cancer"", ""start_span"": 90, ""end_span"": 103, ""type"": ""Cancer""}]"
When the patients were divided into two groups according to their alpha - SMA expression using a cutoff point at the mean value of 8. 48%, the high alpha - SMA group had a significantly poorer overall survival rate ( p < 0. 001).	"patients	9	17	Organism"	"alpha - SMA	66	77	Gene_or_gene_product"	"alpha - SMA	148	159	Gene_or_gene_product"	"[{""token"": ""patients"", ""start_span"": 9, ""end_span"": 17, ""type"": ""Organism""}, {""token"": ""alpha - SMA"", ""start_span"": 66, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""alpha - SMA"", ""start_span"": 148, ""end_span"": 159, ""type"": ""Gene_or_gene_product""}]"
CONCLUSION: Myofibroblasts represent an important prognostic factor for invasive growth that is translated into a poor clinical prognosis for patients with invasive breast cancer.	"Myofibroblasts	12	26	Cell"	"patients	142	150	Organism"	"invasive breast cancer	156	178	Cancer"	"[{""token"": ""Myofibroblasts"", ""start_span"": 12, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""patients"", ""start_span"": 142, ""end_span"": 150, ""type"": ""Organism""}, {""token"": ""invasive breast cancer"", ""start_span"": 156, ""end_span"": 178, ""type"": ""Cancer""}]"
During these processes, proteolytic activities of tumor and stromal cells modify the extracellular matrix to produce a microenvironment suitable for their growth and migration.	"tumor	50	55	Cell"	"stromal cells	60	73	Cell"	"extracellular matrix	85	105	Cellular_component"	"[{""token"": ""tumor"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""stromal cells"", ""start_span"": 60, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""extracellular matrix"", ""start_span"": 85, ""end_span"": 105, ""type"": ""Cellular_component""}]"
In contrast, cancer cells depend mostly on glycolysis, the aerobic breakdown of glucose into ATP.	"cancer cells	13	25	Cell"	"glucose	80	87	Chemical"	"ATP	93	96	Chemical"	"[{""token"": ""cancer cells"", ""start_span"": 13, ""end_span"": 25, ""type"": ""Cell""}, {""token"": ""glucose"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Chemical""}, {""token"": ""ATP"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Chemical""}]"
A thorough understanding of the unique metabolism of cancer cells will help to design of more effective drugs targeting metabolic pathways, which will greatly impact the capacity to effectively treat cancer patients.	"cancer cells	53	65	Cell"	"cancer	200	206	Cancer"	"patients	207	215	Organism"	"[{""token"": ""cancer cells"", ""start_span"": 53, ""end_span"": 65, ""type"": ""Cell""}, {""token"": ""cancer"", ""start_span"": 200, ""end_span"": 206, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 207, ""end_span"": 215, ""type"": ""Organism""}]"
MTSS1 ( metastasis suppressor - 1) was first identified as a metastasis suppressor missing in metastatic bladder carcinoma cell lines.	"MTSS1	0	5	Gene_or_gene_product"	"metastasis suppressor - 1	8	33	Gene_or_gene_product"	"bladder carcinoma cell lines	105	133	Cell"	"[{""token"": ""MTSS1"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""metastasis suppressor - 1"", ""start_span"": 8, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""bladder carcinoma cell lines"", ""start_span"": 105, ""end_span"": 133, ""type"": ""Cell""}]"
The down - regulation of MTSS1 that may be caused by DNA methylation was also observed in many other types of cancer.	"MTSS1	25	30	Gene_or_gene_product"	"DNA	53	56	Cellular_component"	"cancer	110	116	Cancer"	"[{""token"": ""MTSS1"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Cellular_component""}, {""token"": ""cancer"", ""start_span"": 110, ""end_span"": 116, ""type"": ""Cancer""}]"
As determined by ELISA and immunoblot assays, ras p21 in the serum increased with increased tumor growth.	"ras p21	46	53	Gene_or_gene_product"	"serum	61	66	Organism_substance"	"tumor	92	97	Cancer"	"[{""token"": ""ras p21"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""serum"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Organism_substance""}, {""token"": ""tumor"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Cancer""}]"
Serum soluble vascular adhesion protein - 1 is a valuable prognostic marker in gastric cancer.	"Serum	0	5	Organism_substance"	"vascular adhesion protein - 1	14	43	Gene_or_gene_product"	"gastric cancer	79	93	Cancer"	"[{""token"": ""Serum"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Organism_substance""}, {""token"": ""vascular adhesion protein - 1"", ""start_span"": 14, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric cancer"", ""start_span"": 79, ""end_span"": 93, ""type"": ""Cancer""}]"
BACKGROUND: Vascular adhesion protein - 1 ( VAP - 1) regulates leukocyte tissue infiltration.	"Vascular adhesion protein - 1	12	41	Gene_or_gene_product"	"VAP - 1	44	51	Gene_or_gene_product"	"leukocyte tissue	63	79	Cell"	"[{""token"": ""Vascular adhesion protein - 1"", ""start_span"": 12, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""VAP - 1"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""leukocyte tissue"", ""start_span"": 63, ""end_span"": 79, ""type"": ""Cell""}]"
Elevated serum soluble VAP - 1 ( sVAP - 1) levels occur in certain diseases having an inflammatory component.	"serum	9	14	Organism_substance"	"VAP - 1	23	30	Gene_or_gene_product"	"sVAP - 1	33	41	Gene_or_gene_product"	"[{""token"": ""serum"", ""start_span"": 9, ""end_span"": 14, ""type"": ""Organism_substance""}, {""token"": ""VAP - 1"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""sVAP - 1"", ""start_span"": 33, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}]"
This study determines the relationship between preoperative serum sVAP - 1 levels and clinicopathological features and prognosis in gastric cancer.	"serum	60	65	Organism_substance"	"sVAP - 1	66	74	Gene_or_gene_product"	"gastric cancer	132	146	Cancer"	"[{""token"": ""serum"", ""start_span"": 60, ""end_span"": 65, ""type"": ""Organism_substance""}, {""token"": ""sVAP - 1"", ""start_span"": 66, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric cancer"", ""start_span"": 132, ""end_span"": 146, ""type"": ""Cancer""}]"
METHODS: Preoperative serum was collected from 107 gastric cancer patients and 33 normal controls.	"serum	22	27	Organism_substance"	"gastric cancer	51	65	Cancer"	"patients	66	74	Organism"	"[{""token"": ""serum"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Organism_substance""}, {""token"": ""gastric cancer"", ""start_span"": 51, ""end_span"": 65, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 66, ""end_span"": 74, ""type"": ""Organism""}]"
We are increasingly aware that cellular metabolism plays a vital role in diseases such as cancer, and that p53 is an important regulator of metabolic pathways.	"cellular	31	39	Cell"	"cancer	90	96	Cancer"	"p53	107	110	Gene_or_gene_product"	"[{""token"": ""cellular"", ""start_span"": 31, ""end_span"": 39, ""type"": ""Cell""}, {""token"": ""cancer"", ""start_span"": 90, ""end_span"": 96, ""type"": ""Cancer""}, {""token"": ""p53"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}]"
A better understanding of how p53 coordinates metabolic adaptation will facilitate the identification of novel therapeutic targets and will also illuminate the wider role of p53 in human biology.	"p53	30	33	Gene_or_gene_product"	"p53	174	177	Gene_or_gene_product"	"human	181	186	Organism"	"[{""token"": ""p53"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 174, ""end_span"": 177, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 181, ""end_span"": 186, ""type"": ""Organism""}]"
RAF265 inhibited 2 - deoxy - 2 - [ ( 18) F] fluoro - d - glucose ( FDG) accumulation in cell culture at 28 hours in a dose - dependent manner.	"RAF265	0	6	Chemical"	"FDG	67	70	Chemical"	"cell	88	92	Cell"	"[{""token"": ""RAF265"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Chemical""}, {""token"": ""FDG"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Cell""}]"
RAF265 also inhibited FDG accumulation in tumor xenografts after 1 day of drug treatment.	"RAF265	0	6	Chemical"	"FDG	22	25	Chemical"	"tumor xenografts	42	58	Cancer"	"[{""token"": ""RAF265"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Chemical""}, {""token"": ""FDG"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Chemical""}, {""token"": ""tumor xenografts"", ""start_span"": 42, ""end_span"": 58, ""type"": ""Cancer""}]"
Our results support the use of FDG PET in clinical trials with RAF265 to assess early tumor response.	"FDG	31	34	Chemical"	"RAF265	63	69	Chemical"	"tumor	86	91	Cancer"	"[{""token"": ""FDG"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Chemical""}, {""token"": ""RAF265"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Cancer""}]"
DNA microarray analysis allows for analysis of drug effects on multiple pathways linked to cancer and can suggest corresponding imaging tracers for further analysis as biomarkers of tumor response.	"DNA	0	3	Cellular_component"	"cancer	91	97	Cancer"	"tumor	182	187	Cancer"	"[{""token"": ""DNA"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Cellular_component""}, {""token"": ""cancer"", ""start_span"": 91, ""end_span"": 97, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 182, ""end_span"": 187, ""type"": ""Cancer""}]"
The heat shock proteins ( HSPs) centered and NF - kappaB centered networks were also enriched in the result, which may imply the key function of inflaming on metastasis.	"heat shock proteins	4	23	Gene_or_gene_product"	"HSPs	26	30	Gene_or_gene_product"	"NF - kappaB	45	56	Gene_or_gene_product"	"[{""token"": ""heat shock proteins"", ""start_span"": 4, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""HSPs"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 45, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}]"
Similarly to other members of this family, Id - 1 is involved in the repression of cell differentiation and activation of cell growth.	"Id - 1	43	49	Gene_or_gene_product"	"cell	83	87	Cell"	"cell	122	126	Cell"	"[{""token"": ""Id - 1"", ""start_span"": 43, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Cell""}]"
"In addition, FGF - 2 has been described to induce "" neuronal - like "" differentiation and trigger apoptosis in neuroblastoma SK - N - MC cells."	"FGF - 2	13	20	Gene_or_gene_product"	"neuronal	52	60	Cell"	"neuroblastoma SK - N - MC cells	111	142	Cell"	"[{""token"": ""FGF - 2"", ""start_span"": 13, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuronal"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Cell""}, {""token"": ""neuroblastoma SK - N - MC cells"", ""start_span"": 111, ""end_span"": 142, ""type"": ""Cell""}]"
Although regulation of Id - 1 protein by several mitogenic factors is well - established, little is known about the role of FGF - 2 in the regulation of Id - 1.	"Id - 1	23	29	Gene_or_gene_product"	"FGF - 2	124	131	Gene_or_gene_product"	"Id - 1	153	159	Gene_or_gene_product"	"[{""token"": ""Id - 1"", ""start_span"": 23, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGF - 2"", ""start_span"": 124, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}, {""token"": ""Id - 1"", ""start_span"": 153, ""end_span"": 159, ""type"": ""Gene_or_gene_product""}]"
We also demonstrate direct interaction of Egr - 1 with Id - 1 promoter in vitro and in cell culture.	"Egr - 1	42	49	Gene_or_gene_product"	"Id - 1	55	61	Gene_or_gene_product"	"cell culture	87	99	Cell"	"[{""token"": ""Egr - 1"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""Id - 1"", ""start_span"": 55, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell culture"", ""start_span"": 87, ""end_span"": 99, ""type"": ""Cell""}]"
Coexpression of keratin and vimentin was found in approximately 20% of the tumors regardless of menopausal status.	"keratin	16	23	Gene_or_gene_product"	"vimentin	28	36	Gene_or_gene_product"	"tumors	75	81	Cancer"	"[{""token"": ""keratin"", ""start_span"": 16, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""vimentin"", ""start_span"": 28, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 75, ""end_span"": 81, ""type"": ""Cancer""}]"
Vimentin was expressed preferentially in tumor cells of high - grade ductal breast carcinomas ( 15 of 28 histologic grade 3 vs. 0 of 40 grades 1 and 2).	"Vimentin	0	8	Gene_or_gene_product"	"tumor cells	41	52	Cell"	"high - grade ductal breast carcinomas	56	93	Cancer"	"[{""token"": ""Vimentin"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cells"", ""start_span"": 41, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""high - grade ductal breast carcinomas"", ""start_span"": 56, ""end_span"": 93, ""type"": ""Cancer""}]"
More than 50% of the tumor cells coexpressed vimentin and keratin.	"tumor cells	21	32	Cell"	"vimentin	45	53	Gene_or_gene_product"	"keratin	58	65	Gene_or_gene_product"	"[{""token"": ""tumor cells"", ""start_span"": 21, ""end_span"": 32, ""type"": ""Cell""}, {""token"": ""vimentin"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""keratin"", ""start_span"": 58, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}]"
Thus, vimentin expression may be helpful in identifying a substantial subset of ER - independent breast carcinomas with poor prognostic indicators.	"vimentin	6	14	Gene_or_gene_product"	"ER	80	82	Gene_or_gene_product"	"breast carcinomas	97	114	Cancer"	"[{""token"": ""vimentin"", ""start_span"": 6, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""ER"", ""start_span"": 80, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast carcinomas"", ""start_span"": 97, ""end_span"": 114, ""type"": ""Cancer""}]"
OBJECTIVE: To determine the expression and clinical significance of Merlin protein in non - small cell lung cancer ( NSCLC).	"Merlin	68	74	Gene_or_gene_product"	"non - small cell lung cancer	86	114	Cancer"	"NSCLC	117	122	Cancer"	"[{""token"": ""Merlin"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""non - small cell lung cancer"", ""start_span"": 86, ""end_span"": 114, ""type"": ""Cancer""}, {""token"": ""NSCLC"", ""start_span"": 117, ""end_span"": 122, ""type"": ""Cancer""}]"
RESULTS: The expression rates of Merlin protein in NSCLC and normal lung tissue sections were 73. 33% and 15. 56%, respectively ( P < 0. 05).	"Merlin	33	39	Gene_or_gene_product"	"NSCLC	51	56	Cancer"	"lung tissue sections	68	88	Multi"	"[{""token"": ""Merlin"", ""start_span"": 33, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""NSCLC"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Cancer""}, {""token"": ""lung tissue sections"", ""start_span"": 68, ""end_span"": 88, ""type"": ""Multi""}]"
Recombinants that lacked miR - BHRF1 - 2 or miR - BHRF1 - 3 displayed enhanced EBNA expression initiated at the Cp and Wp promoters.	"miR - BHRF1 - 2	25	40	Gene_or_gene_product"	"miR - BHRF1 - 3	44	59	Gene_or_gene_product"	"EBNA	79	83	Gene_or_gene_product"	"[{""token"": ""miR - BHRF1 - 2"", ""start_span"": 25, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""miR - BHRF1 - 3"", ""start_span"": 44, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""EBNA"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}]"
Interestingly, we find that the deletion of miR - BHRF1 - 2 reduced the expression level of miR - BHRF1 - 3 and possibly that of miR - BHRF1 - 1, demonstrating that the expression of one miRNA can potentiate the expression of other miRNAs located in the same cluster.	"miR - BHRF1 - 2	44	59	Gene_or_gene_product"	"miR - BHRF1 - 3	92	107	Gene_or_gene_product"	"miR - BHRF1 - 1	129	144	Gene_or_gene_product"	"[{""token"": ""miR - BHRF1 - 2"", ""start_span"": 44, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""miR - BHRF1 - 3"", ""start_span"": 92, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""miR - BHRF1 - 1"", ""start_span"": 129, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}]"
Therefore, the phenotypic traits of the miR - BHRF1 - 2 null mutant could result partly from reduced miR - BHRF1 - 1 and miR - BHRF1 - 3 expression levels.	"miR - BHRF1 - 2	40	55	Gene_or_gene_product"	"miR - BHRF1 - 1	101	116	Gene_or_gene_product"	"miR - BHRF1 - 3	121	136	Gene_or_gene_product"	"[{""token"": ""miR - BHRF1 - 2"", ""start_span"": 40, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""miR - BHRF1 - 1"", ""start_span"": 101, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""miR - BHRF1 - 3"", ""start_span"": 121, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}]"
Development of a mouse model for lymph node metastasis with endometrial cancer.	"mouse	17	22	Organism"	"lymph node	33	43	Multi"	"endometrial cancer	60	78	Cancer"	"[{""token"": ""mouse"", ""start_span"": 17, ""end_span"": 22, ""type"": ""Organism""}, {""token"": ""lymph node"", ""start_span"": 33, ""end_span"": 43, ""type"": ""Multi""}, {""token"": ""endometrial cancer"", ""start_span"": 60, ""end_span"": 78, ""type"": ""Cancer""}]"
Lymph node metastasis is one of the most important prognostic factors in various types of cancers, including endometrial cancer.	"Lymph node	0	10	Multi"	"cancers	90	97	Cancer"	"endometrial cancer	109	127	Cancer"	"[{""token"": ""Lymph node"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Multi""}, {""token"": ""cancers"", ""start_span"": 90, ""end_span"": 97, ""type"": ""Cancer""}, {""token"": ""endometrial cancer"", ""start_span"": 109, ""end_span"": 127, ""type"": ""Cancer""}]"
Vascular endothelial growth factor - C ( VEGF - C) plays a crucial role in lymphangiogenesis, and is implicated to play an important role in lymph node metastasis.	"Vascular endothelial growth factor - C	0	38	Gene_or_gene_product"	"VEGF - C	41	49	Gene_or_gene_product"	"lymph node	141	151	Multi"	"[{""token"": ""Vascular endothelial growth factor - C"", ""start_span"": 0, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C"", ""start_span"": 41, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 141, ""end_span"": 151, ""type"": ""Multi""}]"
The number of lymph node metastases was significantly higher in HEC1A / VEGF - C cells than in HEC1A cells ( 3. 2 vs 1. 1 nodes / animal, respectively).	"lymph node	14	24	Multi"	"VEGF	72	76	Gene_or_gene_product"	"HEC1A cells	95	106	Cell"	"[{""token"": ""lymph node"", ""start_span"": 14, ""end_span"": 24, ""type"": ""Multi""}, {""token"": ""VEGF"", ""start_span"": 72, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""HEC1A cells"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Cell""}]"
These results indicate that VEGF - C plays a critical role in lymph node metastasis, in addition to serving as a platform to test the efficacy of various therapeutic modalities against lymph node metastasis.	"VEGF - C	28	36	Gene_or_gene_product"	"lymph node	62	72	Multi"	"lymph node	185	195	Multi"	"[{""token"": ""VEGF - C"", ""start_span"": 28, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 62, ""end_span"": 72, ""type"": ""Multi""}, {""token"": ""lymph node"", ""start_span"": 185, ""end_span"": 195, ""type"": ""Multi""}]"
IL - 17F deficiency inhibits small intestinal tumorigenesis in ApcMin / + mice.	"IL - 17F	0	8	Gene_or_gene_product"	"small intestinal	29	45	Organ"	"ApcMin	63	69	Gene_or_gene_product"	"[{""token"": ""IL - 17F"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""small intestinal"", ""start_span"": 29, ""end_span"": 45, ""type"": ""Organ""}, {""token"": ""ApcMin"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}]"
It was recently reported for its anticancer effect on several types of cancer cells in vitro however, the molecular mechanisms of this anticancer effect are not fully understood.	"anticancer	33	43	Cancer"	"cancer cells	71	83	Cell"	"anticancer	135	145	Cancer"	"[{""token"": ""anticancer"", ""start_span"": 33, ""end_span"": 43, ""type"": ""Cancer""}, {""token"": ""cancer cells"", ""start_span"": 71, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""anticancer"", ""start_span"": 135, ""end_span"": 145, ""type"": ""Cancer""}]"
In the present study, we evaluated the effects of curcumin on human mammary epithelial carcinoma MCF - 7 cells.	"curcumin	50	58	Chemical"	"human	62	67	Organism"	"mammary epithelial carcinoma MCF - 7 cells	68	110	Cell"	"[{""token"": ""curcumin"", ""start_span"": 50, ""end_span"": 58, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Organism""}, {""token"": ""mammary epithelial carcinoma MCF - 7 cells"", ""start_span"": 68, ""end_span"": 110, ""type"": ""Cell""}]"
Cells were treated with curcumin and examined for cell viability by MTT assay.	"Cells	0	5	Cell"	"curcumin	24	32	Chemical"	"cell	50	54	Cell"	"[{""token"": ""Cells"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Cell""}, {""token"": ""curcumin"", ""start_span"": 24, ""end_span"": 32, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Cell""}]"
Although tumor cells can exploit cytokine signaling to promote growth, invasion, and metastasis, the response of normal and premalignant epithelial cells to cytokines present in a developing tumor microenvironment remains unclear.	"tumor cells	9	20	Cell"	"premalignant epithelial cells	124	153	Cell"	"tumor	191	196	Cancer"	"[{""token"": ""tumor cells"", ""start_span"": 9, ""end_span"": 20, ""type"": ""Cell""}, {""token"": ""premalignant epithelial cells"", ""start_span"": 124, ""end_span"": 153, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 191, ""end_span"": 196, ""type"": ""Cancer""}]"
Paradoxically, OSM can also suppress the growth of normal cells and certain tumor - derived cell lines.	"OSM	15	18	Gene_or_gene_product"	"cells	58	63	Cell"	"certain tumor - derived cell lines	68	102	Cell"	"[{""token"": ""OSM"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""certain tumor - derived cell lines"", ""start_span"": 68, ""end_span"": 102, ""type"": ""Cell""}]"
In addition, expression of c - MYC from a constitutive promoter also abrogated the STAT3 - mediated arrest, and strikingly, cooperated with OSM to promote anchorage - independent growth ( AIG), a property associated with malignant transformation.	"c - MYC	27	34	Gene_or_gene_product"	"STAT3	83	88	Gene_or_gene_product"	"OSM	140	143	Gene_or_gene_product"	"[{""token"": ""c - MYC"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""STAT3"", ""start_span"": 83, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""OSM"", ""start_span"": 140, ""end_span"": 143, ""type"": ""Gene_or_gene_product""}]"
PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target.	"PTHrP	0	5	Gene_or_gene_product"	"breast tumor	13	25	Cancer"	"mice	69	73	Organism"	"[{""token"": ""PTHrP"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast tumor"", ""start_span"": 13, ""end_span"": 25, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 69, ""end_span"": 73, ""type"": ""Organism""}]"
PTHrP is also associated with the progression of skeletal metastases, and its dysregulated expression in advanced cancers causes malignancy - associated hypercalcemia.	"PTHrP	0	5	Gene_or_gene_product"	"skeletal	49	57	Organ"	"cancers	114	121	Cancer"	"[{""token"": ""PTHrP"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""skeletal"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Organ""}, {""token"": ""cancers"", ""start_span"": 114, ""end_span"": 121, ""type"": ""Cancer""}]"
Importantly, PTHrP - specific neutralizing antibodies slowed the progression and metastasis of human breast cancer xenografts.	"PTHrP	13	18	Gene_or_gene_product"	"human	95	100	Organism"	"breast cancer xenografts	101	125	Cancer"	"[{""token"": ""PTHrP"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Organism""}, {""token"": ""breast cancer xenografts"", ""start_span"": 101, ""end_span"": 125, ""type"": ""Cancer""}]"
Our data identify what we believe to be new functions for PTHrP in several key steps of breast cancer and suggest that PTHrP may constitute a novel target for therapeutic intervention.	"PTHrP	58	63	Gene_or_gene_product"	"breast cancer	88	101	Cancer"	"PTHrP	119	124	Gene_or_gene_product"	"[{""token"": ""PTHrP"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer"", ""start_span"": 88, ""end_span"": 101, ""type"": ""Cancer""}, {""token"": ""PTHrP"", ""start_span"": 119, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}]"
However, little is known about the function of AQPs in human breast cancer.	"AQPs	47	51	Gene_or_gene_product"	"human	55	60	Organism"	"breast cancer	61	74	Cancer"	"[{""token"": ""AQPs"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 55, ""end_span"": 60, ""type"": ""Organism""}, {""token"": ""breast cancer"", ""start_span"": 61, ""end_span"": 74, ""type"": ""Cancer""}]"
The aim of this study was to investigate the expression profile of AQPs in human breast cancer and its significance.	"AQPs	67	71	Gene_or_gene_product"	"human	75	80	Organism"	"breast cancer	81	94	Cancer"	"[{""token"": ""AQPs"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Organism""}, {""token"": ""breast cancer"", ""start_span"": 81, ""end_span"": 94, ""type"": ""Cancer""}]"
METHODS: In this study, we screened the expression profile of AQP0 - 12 in breast cancer tissues and corresponding normal tissues by RT - PCR, Western blotting and immunohistochemistry.	"AQP0 - 12	62	71	Gene_or_gene_product"	"breast cancer tissues	75	96	Tissue"	"normal tissues	115	129	Tissue"	"[{""token"": ""AQP0 - 12"", ""start_span"": 62, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer tissues"", ""start_span"": 75, ""end_span"": 96, ""type"": ""Tissue""}, {""token"": ""normal tissues"", ""start_span"": 115, ""end_span"": 129, ""type"": ""Tissue""}]"
Expression of AQP5 was associated with cellular differentiation, lymph node invasion, and clinicopathological staging.	"AQP5	14	18	Gene_or_gene_product"	"cellular	39	47	Cell"	"lymph node	65	75	Multi"	"[{""token"": ""AQP5"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 39, ""end_span"": 47, ""type"": ""Cell""}, {""token"": ""lymph node"", ""start_span"": 65, ""end_span"": 75, ""type"": ""Multi""}]"
CONCLUSIONS: These observations suggested that several subtypes of the AQP family play a role in human breast carcinogenesis.	"AQP	71	74	Gene_or_gene_product"	"human	97	102	Organism"	"breast	103	109	Organism_subdivision"	"[{""token"": ""AQP"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Organism""}, {""token"": ""breast"", ""start_span"": 103, ""end_span"": 109, ""type"": ""Organism_subdivision""}]"
Research and discovery of the first human cancer virus, HTLV - 1.	"human	36	41	Organism"	"cancer	42	48	Cancer"	"HTLV - 1	56	64	Organism"	"[{""token"": ""human"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Organism""}, {""token"": ""cancer"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Cancer""}, {""token"": ""HTLV - 1"", ""start_span"": 56, ""end_span"": 64, ""type"": ""Organism""}]"
Selective inhibition of nuclear factor - kappaB by nuclear factor - kappaB essential modulator - binding domain peptide suppresses the metastasis of highly metastatic oral squamous cell carcinoma.	"nuclear factor - kappaB	24	47	Gene_or_gene_product"	"nuclear factor - kappaB essential modulator - binding domain peptide	51	119	Chemical"	"oral squamous cell carcinoma	167	195	Cancer"	"[{""token"": ""nuclear factor - kappaB"", ""start_span"": 24, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""nuclear factor - kappaB essential modulator - binding domain peptide"", ""start_span"": 51, ""end_span"": 119, ""type"": ""Chemical""}, {""token"": ""oral squamous cell carcinoma"", ""start_span"": 167, ""end_span"": 195, ""type"": ""Cancer""}]"
In vitro migration and invasion were assessed in these cells, and the NF - kappaB activities and expression of NF - kappaB - regulated metastasis - related molecules were also examined.	"cells	55	60	Cell"	"NF - kappaB	70	81	Gene_or_gene_product"	"NF - kappaB	111	122	Gene_or_gene_product"	"[{""token"": ""cells"", ""start_span"": 55, ""end_span"": 60, ""type"": ""Cell""}, {""token"": ""NF - kappaB"", ""start_span"": 70, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 111, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}]"
Our results suggest that the selective inhibition of NF - kappaB activation by NBD peptide may provide an effective approach for the treatment of highly metastatic OSCC.	"NF - kappaB	53	64	Gene_or_gene_product"	"NBD peptide	79	90	Chemical"	"OSCC	164	168	Cancer"	"[{""token"": ""NF - kappaB"", ""start_span"": 53, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""NBD peptide"", ""start_span"": 79, ""end_span"": 90, ""type"": ""Chemical""}, {""token"": ""OSCC"", ""start_span"": 164, ""end_span"": 168, ""type"": ""Cancer""}]"
BACKGROUND: Compound targeting histone deacetylase ( HDAC) represents a new era in molecular cancer therapeutics.	"histone deacetylase	31	50	Gene_or_gene_product"	"HDAC	53	57	Gene_or_gene_product"	"cancer	93	99	Cancer"	"[{""token"": ""histone deacetylase"", ""start_span"": 31, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""HDAC"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer"", ""start_span"": 93, ""end_span"": 99, ""type"": ""Cancer""}]"
METHODOLOGY / PRINCIPAL FINDINGS: Here, we propose a novel HDAC inhibitor, N - Hydroxy - 4 - ( 4 - phenylbutyryl - amino) benzamide ( HTPB), as a potential chemotherapeutic drug for solid tumors.	"HDAC	59	63	Gene_or_gene_product"	"HTPB	134	138	Chemical"	"solid tumors	182	194	Cancer"	"[{""token"": ""HDAC"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""HTPB"", ""start_span"": 134, ""end_span"": 138, ""type"": ""Chemical""}, {""token"": ""solid tumors"", ""start_span"": 182, ""end_span"": 194, ""type"": ""Cancer""}]"
The HDAC inhibition of HTPB was confirmed using HDAC activity assay.	"HDAC	4	8	Gene_or_gene_product"	"HTPB	23	27	Chemical"	"HDAC	48	52	Gene_or_gene_product"	"[{""token"": ""HDAC"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""HTPB"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Chemical""}, {""token"": ""HDAC"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}]"
Mice with tumor xenograft and experimental metastasis model were used to evaluate effects on tumor growth and metastasis.	"Mice	0	4	Organism"	"tumor xenograft	10	25	Cancer"	"tumor	93	98	Cancer"	"[{""token"": ""Mice"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Organism""}, {""token"": ""tumor xenograft"", ""start_span"": 10, ""end_span"": 25, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 93, ""end_span"": 98, ""type"": ""Cancer""}]"
Upon HTPB treatment, cell cycle arrest was induced and subsequently led to mitochondria - mediated apoptosis.	"HTPB	5	9	Chemical"	"cell	21	25	Cell"	"mitochondria	75	87	Cellular_component"	"[{""token"": ""HTPB"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 21, ""end_span"": 25, ""type"": ""Cell""}, {""token"": ""mitochondria"", ""start_span"": 75, ""end_span"": 87, ""type"": ""Cellular_component""}]"
HTPB disrupted F - actin dynamics via downregulating RhoA activity.	"HTPB	0	4	Chemical"	"F - actin	15	24	Gene_or_gene_product"	"RhoA	53	57	Gene_or_gene_product"	"[{""token"": ""HTPB"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Chemical""}, {""token"": ""F - actin"", ""start_span"": 15, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""RhoA"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}]"
HTPB delayed lung metastasis of 4T1 mouse breast cancer cells.	"HTPB	0	4	Chemical"	"lung	13	17	Organ"	"mouse	36	41	Organism"	"[{""token"": ""HTPB"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Chemical""}, {""token"": ""lung"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Organ""}, {""token"": ""mouse"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Organism""}]"
CONCLUSIONS / SIGNIFICANCE: These results suggested that intrinsic apoptotic pathway may involve in anti - tumor growth effects of HTPB in lung cancer cells.	"tumor	107	112	Cancer"	"HTPB	131	135	Chemical"	"lung cancer cells	139	156	Cell"	"[{""token"": ""tumor"", ""start_span"": 107, ""end_span"": 112, ""type"": ""Cancer""}, {""token"": ""HTPB"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Chemical""}, {""token"": ""lung cancer cells"", ""start_span"": 139, ""end_span"": 156, ""type"": ""Cell""}]"
We have provided convincing preclinical evidence that HTPB is a potent HDAC targeted inhibitor and is thus a promising candidate for lung cancer chemotherapy.	"HTPB	54	58	Chemical"	"HDAC	71	75	Gene_or_gene_product"	"lung cancer	133	144	Cancer"	"[{""token"": ""HTPB"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Chemical""}, {""token"": ""HDAC"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""lung cancer"", ""start_span"": 133, ""end_span"": 144, ""type"": ""Cancer""}]"
RESULTS: HER2 receptor protein was absent in adenomas and in normal gallbladder epithelium.	"HER2 receptor	9	22	Gene_or_gene_product"	"adenomas	45	53	Cancer"	"gallbladder epithelium	68	90	Tissue"	"[{""token"": ""HER2 receptor"", ""start_span"": 9, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""adenomas"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Cancer""}, {""token"": ""gallbladder epithelium"", ""start_span"": 68, ""end_span"": 90, ""type"": ""Tissue""}]"
Expression of basic fibroblast growth factor in normal human tissues.	"basic fibroblast growth factor	14	44	Gene_or_gene_product"	"human	55	60	Organism"	"tissues	61	68	Tissue"	"[{""token"": ""basic fibroblast growth factor"", ""start_span"": 14, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 55, ""end_span"": 60, ""type"": ""Organism""}, {""token"": ""tissues"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Tissue""}]"
Intensity and patterns of localization in blood vessels was consistent in various tissues, but varied among different regions of the vascular bed.	"blood vessels	42	55	Multi"	"tissues	82	89	Tissue"	"vascular bed	133	145	Multi"	"[{""token"": ""blood vessels"", ""start_span"": 42, ""end_span"": 55, ""type"": ""Multi""}, {""token"": ""tissues"", ""start_span"": 82, ""end_span"": 89, ""type"": ""Tissue""}, {""token"": ""vascular bed"", ""start_span"": 133, ""end_span"": 145, ""type"": ""Multi""}]"
The presence of bFGF in the extracellular compartment of a diverse variety of organs may play a role in angiogenesis.	"bFGF	16	20	Gene_or_gene_product"	"extracellular compartment	28	53	Immaterial_anatomical_entity"	"organs	78	84	Organ"	"[{""token"": ""bFGF"", ""start_span"": 16, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""extracellular compartment"", ""start_span"": 28, ""end_span"": 53, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""organs"", ""start_span"": 78, ""end_span"": 84, ""type"": ""Organ""}]"
Some human cancer cells have been found to overexpress eph mRNAs without gene amplification.	"human	5	10	Organism"	"cancer cells	11	23	Cell"	"eph	55	58	Gene_or_gene_product"	"[{""token"": ""human"", ""start_span"": 5, ""end_span"": 10, ""type"": ""Organism""}, {""token"": ""cancer cells"", ""start_span"": 11, ""end_span"": 23, ""type"": ""Cell""}, {""token"": ""eph"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}]"
We show here that NIH3T3 cells acquire tumorigenic ability in nude mice and make colonies in soft agar with a viral LTR ( Long Terminal Repeat) - driven artificial expression of the eph gene to a high level.	"NIH3T3 cells	18	30	Cell"	"nude mice	62	71	Organism"	"eph	182	185	Gene_or_gene_product"	"[{""token"": ""NIH3T3 cells"", ""start_span"": 18, ""end_span"": 30, ""type"": ""Cell""}, {""token"": ""nude mice"", ""start_span"": 62, ""end_span"": 71, ""type"": ""Organism""}, {""token"": ""eph"", ""start_span"": 182, ""end_span"": 185, ""type"": ""Gene_or_gene_product""}]"
Energy supply of the mitotic cell cycle and the Na + / H + - antiport in ascites tumors.	"Na +	48	52	Chemical"	"H +	55	58	Chemical"	"ascites tumors	73	87	Cancer"	"[{""token"": ""Na +"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Chemical""}, {""token"": ""H +"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Chemical""}, {""token"": ""ascites tumors"", ""start_span"": 73, ""end_span"": 87, ""type"": ""Cancer""}]"
Experimental results and theoretical calculations suggest that in glucose - containing medium the Na + transport increases from 0. 75 to 1. 78 pmol / hour per cell.	"glucose	66	73	Chemical"	"Na +	98	102	Chemical"	"cell	159	163	Cell"	"[{""token"": ""glucose"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Chemical""}, {""token"": ""Na +"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 159, ""end_span"": 163, ""type"": ""Cell""}]"
The permeability of plasma membranes for K + increases 2. 75 fold, while the passive flux of Na + diminishes.	"plasma membranes	20	36	Cellular_component"	"K +	41	44	Chemical"	"Na +	93	97	Chemical"	"[{""token"": ""plasma membranes"", ""start_span"": 20, ""end_span"": 36, ""type"": ""Cellular_component""}, {""token"": ""K +"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Chemical""}, {""token"": ""Na +"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Chemical""}]"
The inhibition of fibrinolysis or proteases decreased the primary tumor growth and pulmonary metastasis, whereas the activation of fibrinolysis or proteases increased the number of metastatic foci in the lung.	"tumor	66	71	Cancer"	"pulmonary	83	92	Organ"	"lung	204	208	Organ"	"[{""token"": ""tumor"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Cancer""}, {""token"": ""pulmonary"", ""start_span"": 83, ""end_span"": 92, ""type"": ""Organ""}, {""token"": ""lung"", ""start_span"": 204, ""end_span"": 208, ""type"": ""Organ""}]"
Differences in polyphosphoinositide metabolism have been reported for ras - transformed cells.	"polyphosphoinositide	15	35	Chemical"	"ras	70	73	Gene_or_gene_product"	"cells	88	93	Cell"	"[{""token"": ""polyphosphoinositide"", ""start_span"": 15, ""end_span"": 35, ""type"": ""Chemical""}, {""token"": ""ras"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Cell""}]"
The basal phosphorylation of protein kinase C substrate of relative molecular mass ( Mr) 80, 000 ( 80K) is significantly increased in all the ras - transformed cell lines.	"protein kinase C	29	45	Gene_or_gene_product"	"ras	142	145	Gene_or_gene_product"	"cell lines	160	170	Cell"	"[{""token"": ""protein kinase C"", ""start_span"": 29, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""ras"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell lines"", ""start_span"": 160, ""end_span"": 170, ""type"": ""Cell""}]"
Glutamine and glucose as energy substrates for Ehrlich ascites tumour cells.	"Glutamine	0	9	Amino_acid"	"glucose	14	21	Chemical"	"Ehrlich ascites tumour cells	47	75	Cell"	"[{""token"": ""Glutamine"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Amino_acid""}, {""token"": ""glucose"", ""start_span"": 14, ""end_span"": 21, ""type"": ""Chemical""}, {""token"": ""Ehrlich ascites tumour cells"", ""start_span"": 47, ""end_span"": 75, ""type"": ""Cell""}]"
Energy metabolism of freshly harvested Ehrlich ascites tumour cells in the presence of 5 mM glucose and / or 0. 5 mM glutamine was studied.	"Ehrlich ascites tumour cells	39	67	Cell"	"glucose	92	99	Chemical"	"glutamine	117	126	Amino_acid"	"[{""token"": ""Ehrlich ascites tumour cells"", ""start_span"": 39, ""end_span"": 67, ""type"": ""Cell""}, {""token"": ""glucose"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Chemical""}, {""token"": ""glutamine"", ""start_span"": 117, ""end_span"": 126, ""type"": ""Amino_acid""}]"
The rate of oxygen utilization was not altered by the addition of 0. 5 mM glutamine; 5 mM glucose induced an inhibition of respiration.	"oxygen	12	18	Chemical"	"glutamine	74	83	Amino_acid"	"glucose	90	97	Chemical"	"[{""token"": ""oxygen"", ""start_span"": 12, ""end_span"": 18, ""type"": ""Chemical""}, {""token"": ""glutamine"", ""start_span"": 74, ""end_span"": 83, ""type"": ""Amino_acid""}, {""token"": ""glucose"", ""start_span"": 90, ""end_span"": 97, ""type"": ""Chemical""}]"
Growth state - dependent regulation of protein kinase C in normal and transformed murine cells.	"protein kinase C	39	55	Gene_or_gene_product"	"murine	82	88	Organism"	"cells	89	94	Cell"	"[{""token"": ""protein kinase C"", ""start_span"": 39, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""murine"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Organism""}, {""token"": ""cells"", ""start_span"": 89, ""end_span"": 94, ""type"": ""Cell""}]"
We determined whether growth state can influence the action of protein kinase C by measuring protein kinase C activity in growing and stationary cultures of normal and transformed cells.	"protein kinase C	63	79	Gene_or_gene_product"	"protein kinase C	93	109	Gene_or_gene_product"	"cells	180	185	Cell"	"[{""token"": ""protein kinase C"", ""start_span"": 63, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""protein kinase C"", ""start_span"": 93, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 180, ""end_span"": 185, ""type"": ""Cell""}]"
In contrast, the response of cells to long - term treatment with PDBu was significantly different depending upon the initial growth state of the cells.	"cells	29	34	Cell"	"PDBu	65	69	Chemical"	"cells	145	150	Cell"	"[{""token"": ""cells"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Cell""}, {""token"": ""PDBu"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Chemical""}, {""token"": ""cells"", ""start_span"": 145, ""end_span"": 150, ""type"": ""Cell""}]"
These results suggest that prolonged treatment with tumor promoters alters the sensitivity of cells to activators of protein kinase C in a growth state - dependent manner.	"tumor	52	57	Cancer"	"cells	94	99	Cell"	"protein kinase C	117	133	Gene_or_gene_product"	"[{""token"": ""tumor"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Cancer""}, {""token"": ""cells"", ""start_span"": 94, ""end_span"": 99, ""type"": ""Cell""}, {""token"": ""protein kinase C"", ""start_span"": 117, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}]"
Tumorigenic hybrid derivatives contained lower numbers of chromosomes than the tetraploid parental hybrids.	"hybrid derivatives	12	30	Cell"	"chromosomes	58	69	Cellular_component"	"parental hybrids	90	106	Cell"	"[{""token"": ""hybrid derivatives"", ""start_span"": 12, ""end_span"": 30, ""type"": ""Cell""}, {""token"": ""chromosomes"", ""start_span"": 58, ""end_span"": 69, ""type"": ""Cellular_component""}, {""token"": ""parental hybrids"", ""start_span"": 90, ""end_span"": 106, ""type"": ""Cell""}]"
Normal cells contain suppressor gene ( s) which safeguard these cells against transformation by the product of the transforming Ha - ras - 1 oncogene.	"Normal cells	0	12	Cell"	"cells	64	69	Cell"	"Ha - ras - 1	128	140	Gene_or_gene_product"	"[{""token"": ""Normal cells"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Cell""}, {""token"": ""Ha - ras - 1"", ""start_span"": 128, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}]"
Mast cells were found to be unique among the peritoneal leukocytes by virtue of their capacity to enhance profoundly the proliferation of a variety of tumors in vitro.	"Mast cells	0	10	Cell"	"peritoneal leukocytes	45	66	Cell"	"tumors	151	157	Cancer"	"[{""token"": ""Mast cells"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Cell""}, {""token"": ""peritoneal leukocytes"", ""start_span"": 45, ""end_span"": 66, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 151, ""end_span"": 157, ""type"": ""Cancer""}]"
The growth factor was found to reside in mast cell granules and was identified as heparin by sequential purification and enzymatic degradation.	"mast cell	41	50	Cell"	"granules	51	59	Organism_substance"	"heparin	82	89	Chemical"	"[{""token"": ""mast cell"", ""start_span"": 41, ""end_span"": 50, ""type"": ""Cell""}, {""token"": ""granules"", ""start_span"": 51, ""end_span"": 59, ""type"": ""Organism_substance""}, {""token"": ""heparin"", ""start_span"": 82, ""end_span"": 89, ""type"": ""Chemical""}]"
Cells transformed by Rous sarcoma virus release transforming growth factors.	"Cells	0	5	Cell"	"Rous sarcoma virus	21	39	Organism"	"transforming growth factors	48	75	Gene_or_gene_product"	"[{""token"": ""Cells"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Cell""}, {""token"": ""Rous sarcoma virus"", ""start_span"": 21, ""end_span"": 39, ""type"": ""Organism""}, {""token"": ""transforming growth factors"", ""start_span"": 48, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}]"
This action is not observed with uninfected CEF, and, therefore, appears to require some expression of the viral src gene in the target cells.	"CEF	44	47	Cell"	"src	113	116	Gene_or_gene_product"	"cells	136	141	Cell"	"[{""token"": ""CEF"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Cell""}, {""token"": ""src"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Cell""}]"
The enhancing factors are proteins related to the family of the transforming growth factors ( TGFs) by their molecular weight ( about 20 kd), their heat and acid resistance, and their sensitivity to dithiothreitol.	"transforming growth factors	64	91	Gene_or_gene_product"	"TGFs	94	98	Gene_or_gene_product"	"dithiothreitol	199	213	Chemical"	"[{""token"": ""transforming growth factors"", ""start_span"": 64, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGFs"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""dithiothreitol"", ""start_span"": 199, ""end_span"": 213, ""type"": ""Chemical""}]"
Molecular events leading to enhanced glucose transport in Rous sarcoma virus - transformed cells.	"glucose	37	44	Chemical"	"Rous sarcoma virus	58	76	Organism"	"cells	91	96	Cell"	"[{""token"": ""glucose"", ""start_span"": 37, ""end_span"": 44, ""type"": ""Chemical""}, {""token"": ""Rous sarcoma virus"", ""start_span"": 58, ""end_span"": 76, ""type"": ""Organism""}, {""token"": ""cells"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Cell""}]"
The increased rate of glucose transport is dependent on the activity of pp60src, the transforming protein of Rous sarcoma virus.	"glucose	22	29	Chemical"	"pp60src	72	79	Gene_or_gene_product"	"Rous sarcoma virus	109	127	Organism"	"[{""token"": ""glucose"", ""start_span"": 22, ""end_span"": 29, ""type"": ""Chemical""}, {""token"": ""pp60src"", ""start_span"": 72, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rous sarcoma virus"", ""start_span"": 109, ""end_span"": 127, ""type"": ""Organism""}]"
One of these mutants ( CU2) increases the rate of glucose transport only slightly and does not render the infected cells fully anchorage independent or tumorigenic ( although other transformation parameters are fully induced).	"CU2	23	26	Organism"	"glucose	50	57	Chemical"	"cells	115	120	Cell"	"[{""token"": ""CU2"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Organism""}, {""token"": ""glucose"", ""start_span"": 50, ""end_span"": 57, ""type"": ""Chemical""}, {""token"": ""cells"", ""start_span"": 115, ""end_span"": 120, ""type"": ""Cell""}]"
Cells infected with this mutant display a 36, 000 - dalton protein that is phosphorylated to a considerably lesser extent than cells infected with wild - type virus.	"Cells	0	5	Cell"	"cells	127	132	Cell"	"wild - type virus	147	164	Organism"	"[{""token"": ""Cells"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 127, ""end_span"": 132, ""type"": ""Cell""}, {""token"": ""wild - type virus"", ""start_span"": 147, ""end_span"": 164, ""type"": ""Organism""}]"
Analyses of this sort may help to identify the cellular targets of pp60src whose phosphorylation is necessary for the increased glucose transport rate.	"cellular	47	55	Cell"	"pp60src	67	74	Gene_or_gene_product"	"glucose	128	135	Chemical"	"[{""token"": ""cellular"", ""start_span"": 47, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""pp60src"", ""start_span"": 67, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""glucose"", ""start_span"": 128, ""end_span"": 135, ""type"": ""Chemical""}]"
In contrast, at least some of these sites were not methylated in DNA from the B - cells expressing high levels of DR alpha mRNA.	"DNA	65	68	Cellular_component"	"B - cells	78	87	Cell"	"DR alpha	114	122	Gene_or_gene_product"	"[{""token"": ""DNA"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Cellular_component""}, {""token"": ""B - cells"", ""start_span"": 78, ""end_span"": 87, ""type"": ""Cell""}, {""token"": ""DR alpha"", ""start_span"": 114, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}]"
These results suggest that the tumor - bearing animal, even prior to significant cachexia, has an excess demand for energy, the provision of which may be a significant factor in malignant cachexia.	"tumor	31	36	Cancer"	"cachexia	81	89	Cancer"	"malignant cachexia	178	196	Cancer"	"[{""token"": ""tumor"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Cancer""}, {""token"": ""cachexia"", ""start_span"": 81, ""end_span"": 89, ""type"": ""Cancer""}, {""token"": ""malignant cachexia"", ""start_span"": 178, ""end_span"": 196, ""type"": ""Cancer""}]"
SVLT mutants, defective either in the Rb binding site, near the N - terminal end, in a region that affects binding to p53, or in the nuclear transport signal, were also employed to determine whether the interference was especially dependent on these functional domains.	"SVLT	0	4	Gene_or_gene_product"	"Rb	38	40	Gene_or_gene_product"	"p53	118	121	Gene_or_gene_product"	"[{""token"": ""SVLT"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rb"", ""start_span"": 38, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}]"
The remaining SVLT mutants presented different degrees of ability to inhibit differentiation ( as shown by the expression of tissue - specific markers in transformants).	"SVLT	14	18	Gene_or_gene_product"	"tissue	125	131	Tissue"	"transformants	154	167	Cell"	"[{""token"": ""SVLT"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissue"", ""start_span"": 125, ""end_span"": 131, ""type"": ""Tissue""}, {""token"": ""transformants"", ""start_span"": 154, ""end_span"": 167, ""type"": ""Cell""}]"
A transcript from the long terminal repeats of a murine retrovirus associated with trans activation of cellular genes.	"long terminal repeats	22	43	Cellular_component"	"murine retrovirus	49	66	Organism"	"cellular	103	111	Cell"	"[{""token"": ""long terminal repeats"", ""start_span"": 22, ""end_span"": 43, ""type"": ""Cellular_component""}, {""token"": ""murine retrovirus"", ""start_span"": 49, ""end_span"": 66, ""type"": ""Organism""}, {""token"": ""cellular"", ""start_span"": 103, ""end_span"": 111, ""type"": ""Cell""}]"
Anti - transforming growth factor ( TGF) - beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity.	"breast cancer cell	67	85	Cell"	"mouse	114	119	Organism"	"spleen natural killer cell	120	146	Cell"	"[{""token"": ""breast cancer cell"", ""start_span"": 67, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""mouse"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Organism""}, {""token"": ""spleen natural killer cell"", ""start_span"": 120, ""end_span"": 146, ""type"": ""Cell""}]"
TGF - beta effects on angiogenesis, stroma formation, and immune function suggest its possible involvement in tumor progression.	"TGF - beta	0	10	Gene_or_gene_product"	"stroma	36	42	Tissue"	"tumor	110	115	Cancer"	"[{""token"": ""TGF - beta"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""stroma"", ""start_span"": 36, ""end_span"": 42, ""type"": ""Tissue""}, {""token"": ""tumor"", ""start_span"": 110, ""end_span"": 115, ""type"": ""Cancer""}]"
Inoculation of these cells in athymic mice decreases mouse spleen natural killer ( NK) cell activity.	"cells	21	26	Cell"	"athymic mice	30	42	Organism"	"mouse	53	58	Organism"	"[{""token"": ""cells"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""athymic mice"", ""start_span"": 30, ""end_span"": 42, ""type"": ""Organism""}, {""token"": ""mouse"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Organism""}]"
Intraperitoneal administration of 2G7 resulted in a marked increase in mouse spleen NK cell activity.	"Intraperitoneal	0	15	Immaterial_anatomical_entity"	"mouse	71	76	Organism"	"spleen NK cell	77	91	Cell"	"[{""token"": ""Intraperitoneal"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""mouse"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Organism""}, {""token"": ""spleen NK cell"", ""start_span"": 77, ""end_span"": 91, ""type"": ""Cell""}]"
These data support a possible role for tumor cell TGF - beta in the progression of mammary carcinomas by suppressing host immune surveillance.	"tumor cell	39	49	Cell"	"TGF - beta	50	60	Gene_or_gene_product"	"mammary carcinomas	83	101	Cancer"	"[{""token"": ""tumor cell"", ""start_span"": 39, ""end_span"": 49, ""type"": ""Cell""}, {""token"": ""TGF - beta"", ""start_span"": 50, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""mammary carcinomas"", ""start_span"": 83, ""end_span"": 101, ""type"": ""Cancer""}]"
Bicistronic retroviral vector reveals capacity of v - erbA to induce erythroleukemia and to co - operate with v - myb.	"v - erbA	50	58	Gene_or_gene_product"	"erythroleukemia	69	84	Cancer"	"v - myb	110	117	Gene_or_gene_product"	"[{""token"": ""v - erbA"", ""start_span"": 50, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""erythroleukemia"", ""start_span"": 69, ""end_span"": 84, ""type"": ""Cancer""}, {""token"": ""v - myb"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}]"
Previous studies have shown that v - erbA and v - myb can induce the proliferation of avian erythroid cells in culture.	"v - erbA	33	41	Gene_or_gene_product"	"v - myb	46	53	Gene_or_gene_product"	"erythroid cells	92	107	Cell"	"[{""token"": ""v - erbA"", ""start_span"": 33, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""v - myb"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""erythroid cells"", ""start_span"": 92, ""end_span"": 107, ""type"": ""Cell""}]"
To study the combined effects of v - erbA and v - myb, the two oncogenes were engineered into a retrovirus bicistronic vector with an internal ribosomal entry site ( IRES) or into a vector with a splice acceptor ( SPL).	"v - erbA	33	41	Gene_or_gene_product"	"v - myb	46	53	Gene_or_gene_product"	"ribosomal	143	152	Cellular_component"	"[{""token"": ""v - erbA"", ""start_span"": 33, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""v - myb"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""ribosomal"", ""start_span"": 143, ""end_span"": 152, ""type"": ""Cellular_component""}]"
Surprisingly, when injected into chicken embryos in the presence of helper virus, both viruses induced an erythroleukemia in about half of the animals.	"chicken	33	40	Organism"	"embryos	41	48	Developing_anatomical_structure"	"erythroleukemia	106	121	Cancer"	"[{""token"": ""chicken"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Organism""}, {""token"": ""embryos"", ""start_span"": 41, ""end_span"": 48, ""type"": ""Developing_anatomical_structure""}, {""token"": ""erythroleukemia"", ""start_span"": 106, ""end_span"": 121, ""type"": ""Cancer""}]"
These results show that v - erbA is capable of inducing an erythroleukemia when expressed by a high titer bicistronic retrovirus under conditions of virus spreading and that its in vitro and in vivo transforming potential can be enhanced by v - myb.	"v - erbA	24	32	Gene_or_gene_product"	"erythroleukemia	59	74	Cancer"	"v - myb	241	248	Gene_or_gene_product"	"[{""token"": ""v - erbA"", ""start_span"": 24, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""erythroleukemia"", ""start_span"": 59, ""end_span"": 74, ""type"": ""Cancer""}, {""token"": ""v - myb"", ""start_span"": 241, ""end_span"": 248, ""type"": ""Gene_or_gene_product""}]"
Under similar conditions, both uninfected HUVECs and HUVECs infected with AdCMV. beta gal did not differentiate.	"HUVECs	42	48	Cell"	"HUVECs	53	59	Cell"	"beta gal	81	89	Gene_or_gene_product"	"[{""token"": ""HUVECs"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""HUVECs"", ""start_span"": 53, ""end_span"": 59, ""type"": ""Cell""}, {""token"": ""beta gal"", ""start_span"": 81, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}]"
VEGF165 or AdCMV. beta gal ( 2 x 10 ( 10) pfu) was resuspended in 0. 5 mL Matrigel and injected subcutaneously into mice.	"VEGF165	0	7	Gene_or_gene_product"	"beta gal	18	26	Gene_or_gene_product"	"mice	116	120	Organism"	"[{""token"": ""VEGF165"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta gal"", ""start_span"": 18, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Organism""}]"
Two weeks after injection, there was histological evidence of neovascularization in the tissues surrounding the Matrigel containing AdCMV. VEGF165, whereas no significant angiogenesis was observed in response to AdCMV. beta gal.	"tissues	88	95	Tissue"	"VEGF165	139	146	Gene_or_gene_product"	"beta gal	219	227	Gene_or_gene_product"	"[{""token"": ""tissues"", ""start_span"": 88, ""end_span"": 95, ""type"": ""Tissue""}, {""token"": ""VEGF165"", ""start_span"": 139, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta gal"", ""start_span"": 219, ""end_span"": 227, ""type"": ""Gene_or_gene_product""}]"
Furthermore, the Matrigel plugs with AdCMV. VEGF165 demonstrated hemoglobin content fourfold higher than the plugs with AdCMV. beta gal.	"VEGF165	44	51	Gene_or_gene_product"	"hemoglobin	65	75	Gene_or_gene_product"	"beta gal	127	135	Gene_or_gene_product"	"[{""token"": ""VEGF165"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""hemoglobin"", ""start_span"": 65, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta gal"", ""start_span"": 127, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}]"
Modulation of apoptosis in human myeloid leukemic cells by GM - CSF.	"human	27	32	Organism"	"myeloid leukemic cells	33	55	Cell"	"GM - CSF	59	67	Gene_or_gene_product"	"[{""token"": ""human"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Organism""}, {""token"": ""myeloid leukemic cells"", ""start_span"": 33, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""GM - CSF"", ""start_span"": 59, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}]"
These findings indicate that disparate mechanisms of enhancing or inhibiting apoptosis exist in myeloid leukemic cells related to environmental conditions, including HGF - regulated cellular synthesis of distinct proteins and mRNA.	"myeloid leukemic cells	96	118	Cell"	"HGF	166	169	Gene_or_gene_product"	"cellular	182	190	Cell"	"[{""token"": ""myeloid leukemic cells"", ""start_span"": 96, ""end_span"": 118, ""type"": ""Cell""}, {""token"": ""HGF"", ""start_span"": 166, ""end_span"": 169, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 182, ""end_span"": 190, ""type"": ""Cell""}]"
Increased MP activity has been correlated with the metastatic potential of many cancers, including breast cancer.	"MP	10	12	Gene_or_gene_product"	"cancers	80	87	Cancer"	"breast cancer	99	112	Cancer"	"[{""token"": ""MP"", ""start_span"": 10, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancers"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Cancer""}, {""token"": ""breast cancer"", ""start_span"": 99, ""end_span"": 112, ""type"": ""Cancer""}]"
Several reports have indicated that tetracyclines can suppress tumor MPs as well.	"tetracyclines	36	49	Chemical"	"tumor	63	68	Cancer"	"MPs	69	72	Gene_or_gene_product"	"[{""token"": ""tetracyclines"", ""start_span"": 36, ""end_span"": 49, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 63, ""end_span"": 68, ""type"": ""Cancer""}, {""token"": ""MPs"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}]"
Transforming growth factor beta 1 promotes spontaneous transformation of cultured rat liver epithelial cells.	"Transforming growth factor beta 1	0	33	Gene_or_gene_product"	"rat	82	85	Organism"	"liver epithelial cells	86	108	Cell"	"[{""token"": ""Transforming growth factor beta 1"", ""start_span"": 0, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""rat"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Organism""}, {""token"": ""liver epithelial cells"", ""start_span"": 86, ""end_span"": 108, ""type"": ""Cell""}]"
However, when the same cells were exposed to step - wise increases of TGF - beta concentration in their culture medium, the development of TGF - beta resistance was accelerated.	"cells	23	28	Cell"	"TGF - beta	70	80	Gene_or_gene_product"	"TGF - beta	139	149	Gene_or_gene_product"	"[{""token"": ""cells"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Cell""}, {""token"": ""TGF - beta"", ""start_span"": 70, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF - beta"", ""start_span"": 139, ""end_span"": 149, ""type"": ""Gene_or_gene_product""}]"
Cells which had been grown in medium containing 1 ng / ml TGF - beta developed colony - forming capacity in soft agar containing epidermal growth factor.	"Cells	0	5	Cell"	"TGF - beta	58	68	Gene_or_gene_product"	"epidermal growth factor	129	152	Gene_or_gene_product"	"[{""token"": ""Cells"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Cell""}, {""token"": ""TGF - beta"", ""start_span"": 58, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""epidermal growth factor"", ""start_span"": 129, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}]"
When MDV was reactivated by treatment of lymphoblastoid cells with 25 micrograms of iododeoxyuridine per ml, the relative levels of the transcripts decreased.	"MDV	5	8	Organism"	"lymphoblastoid cells	41	61	Cell"	"iododeoxyuridine	84	100	Chemical"	"[{""token"": ""MDV"", ""start_span"": 5, ""end_span"": 8, ""type"": ""Organism""}, {""token"": ""lymphoblastoid cells"", ""start_span"": 41, ""end_span"": 61, ""type"": ""Cell""}, {""token"": ""iododeoxyuridine"", ""start_span"": 84, ""end_span"": 100, ""type"": ""Chemical""}]"
By using Northern hybridization, RNase protection assays, and primer extension analysis, the MSRs were determined to map antisense to the predicted translational start site of the ICP4 homolog gene.	"RNase	33	38	Gene_or_gene_product"	"MSRs	93	97	Gene_or_gene_product"	"ICP4 homolog	180	192	Gene_or_gene_product"	"[{""token"": ""RNase"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""MSRs"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""ICP4 homolog"", ""start_span"": 180, ""end_span"": 192, ""type"": ""Gene_or_gene_product""}]"
The host and tumor sensitivities to insulin are critical for such treatments, which aim to improve patient nutrition.	"tumor	13	18	Cancer"	"insulin	36	43	Gene_or_gene_product"	"patient	99	106	Organism"	"[{""token"": ""tumor"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Cancer""}, {""token"": ""insulin"", ""start_span"": 36, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""patient"", ""start_span"": 99, ""end_span"": 106, ""type"": ""Organism""}]"
The authors studied insulin effects on tumor and skeletal muscle metabolism with 2 - [ 18F] - fluoro - 2 - deoxy - D - glucose ( [ 18F] FDG) and positron emission tomography ( PET).	"insulin	20	27	Gene_or_gene_product"	"tumor	39	44	Cancer"	"skeletal muscle	49	64	Tissue"	"[{""token"": ""insulin"", ""start_span"": 20, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Cancer""}, {""token"": ""skeletal muscle"", ""start_span"": 49, ""end_span"": 64, ""type"": ""Tissue""}]"
The [ 18F] FDG uptake in muscle and the whole body glucose use during euglycemic hyperinsulinemic clamp were compared with those of weight - matched healthy subjects studied under similar circumstances.	"muscle	25	31	Organ"	"body	46	50	Organism_subdivision"	"glucose	51	58	Chemical"	"[{""token"": ""muscle"", ""start_span"": 25, ""end_span"": 31, ""type"": ""Organ""}, {""token"": ""body"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Organism_subdivision""}, {""token"": ""glucose"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Chemical""}]"
CONCLUSIONS: We found that insulin does not induce major changes in glucose uptake of lymphomatous tissue.	"insulin	27	34	Gene_or_gene_product"	"glucose	68	75	Chemical"	"lymphomatous tissue	86	105	Tissue"	"[{""token"": ""insulin"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""glucose"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Chemical""}, {""token"": ""lymphomatous tissue"", ""start_span"": 86, ""end_span"": 105, ""type"": ""Tissue""}]"
The decrease in ATP level might be explained through the interaction of the amine oxide with the cell membrane integrity.	"ATP	16	19	Chemical"	"amine oxide	76	87	Chemical"	"cell membrane	97	110	Cellular_component"	"[{""token"": ""ATP"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Chemical""}, {""token"": ""amine oxide"", ""start_span"": 76, ""end_span"": 87, ""type"": ""Chemical""}, {""token"": ""cell membrane"", ""start_span"": 97, ""end_span"": 110, ""type"": ""Cellular_component""}]"
Although several hypotheses for human carcinogenesis have been proposed, the specific genetic changes that cause normal cells to become cancer cells have not been identified.	"human	32	37	Organism"	"cells	120	125	Cell"	"cancer cells	136	148	Cell"	"[{""token"": ""human"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Organism""}, {""token"": ""cells"", ""start_span"": 120, ""end_span"": 125, ""type"": ""Cell""}, {""token"": ""cancer cells"", ""start_span"": 136, ""end_span"": 148, ""type"": ""Cell""}]"
Increased nm23 - H1 and nm23 - H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potential.	"nm23 - H1	10	19	Gene_or_gene_product"	"nm23 - H2	24	33	Gene_or_gene_product"	"colon carcinomas	87	103	Cancer"	"[{""token"": ""nm23 - H1"", ""start_span"": 10, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""nm23 - H2"", ""start_span"": 24, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""colon carcinomas"", ""start_span"": 87, ""end_span"": 103, ""type"": ""Cancer""}]"
PURPOSE: This study was designed to reconcile our previous findings with the recent report of nm23 - H1 allelic deletion in human colon cancers associated with poor prognosis.	"nm23 - H1	94	103	Gene_or_gene_product"	"human	124	129	Organism"	"colon cancers	130	143	Cancer"	"[{""token"": ""nm23 - H1"", ""start_span"": 94, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Organism""}, {""token"": ""colon cancers"", ""start_span"": 130, ""end_span"": 143, ""type"": ""Cancer""}]"
Lymphoma prevalence was minimal in the T lineage but significant, although low ( 3 - 15%), in the B lineage.	"Lymphoma	0	8	Cancer"	"T lineage	39	48	Cell"	"B lineage	98	107	Cell"	"[{""token"": ""Lymphoma"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Cancer""}, {""token"": ""T lineage"", ""start_span"": 39, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""B lineage"", ""start_span"": 98, ""end_span"": 107, ""type"": ""Cell""}]"
Among the members of this superfamily there are proteins with a regulatory function, such as ras, and proteins involved in vesicular trafficking, such as the family of rab proteins.	"ras	93	96	Gene_or_gene_product"	"vesicular	123	132	Multi"	"rab	168	171	Gene_or_gene_product"	"[{""token"": ""ras"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}, {""token"": ""vesicular"", ""start_span"": 123, ""end_span"": 132, ""type"": ""Multi""}, {""token"": ""rab"", ""start_span"": 168, ""end_span"": 171, ""type"": ""Gene_or_gene_product""}]"
By contrast, ras - induced tumors were poorly differentiated fibrosarcomas.	"ras	7	10	Gene_or_gene_product"	"tumors	27	33	Cancer"	"fibrosarcomas	61	74	Cancer"	"[{""token"": ""ras"", ""start_span"": 7, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 27, ""end_span"": 33, ""type"": ""Cancer""}, {""token"": ""fibrosarcomas"", ""start_span"": 61, ""end_span"": 74, ""type"": ""Cancer""}]"
The same result was obtained when the model contained ER status and ER - tamoxifen interaction.	"ER	54	56	Gene_or_gene_product"	"ER	68	70	Gene_or_gene_product"	"tamoxifen	73	82	Chemical"	"[{""token"": ""ER"", ""start_span"": 54, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""ER"", ""start_span"": 68, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""tamoxifen"", ""start_span"": 73, ""end_span"": 82, ""type"": ""Chemical""}]"
Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo.	"DNA	23	26	Cellular_component"	"vascular endothelial growth factor	58	92	Gene_or_gene_product"	"collateral	104	114	Multi"	"[{""token"": ""DNA"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Cellular_component""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 58, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""collateral"", ""start_span"": 104, ""end_span"": 114, ""type"": ""Multi""}]"
Vascular endothelial growth factor ( VEGF) is a naturally secreted endothelial cell - specific mitogen.	"Vascular endothelial growth factor	0	34	Gene_or_gene_product"	"VEGF	37	41	Gene_or_gene_product"	"endothelial cell	67	83	Cell"	"[{""token"": ""Vascular endothelial growth factor"", ""start_span"": 0, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 67, ""end_span"": 83, ""type"": ""Cell""}]"
Similar results were obtained with phVEGF121, phVEGF165, and phVEGF189, which suggests that these isoforms are biologically equivalent with respect to in vivo angiogenesis.	"phVEGF121	35	44	Gene_or_gene_product"	"phVEGF165	46	55	Gene_or_gene_product"	"phVEGF189	61	70	Gene_or_gene_product"	"[{""token"": ""phVEGF121"", ""start_span"": 35, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""phVEGF165"", ""start_span"": 46, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""phVEGF189"", ""start_span"": 61, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}]"
Arterial gene transfer of naked DNA encoding for a secreted angiogenic cytokine, thus, represents a potential alternative to recombinant protein administration for stimulating collateral vessel development.	"Arterial	0	8	Multi"	"DNA	32	35	Cellular_component"	"collateral vessel	176	193	Multi"	"[{""token"": ""Arterial"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Multi""}, {""token"": ""DNA"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Cellular_component""}, {""token"": ""collateral vessel"", ""start_span"": 176, ""end_span"": 193, ""type"": ""Multi""}]"
On the other hand, MnSO4 only induced transformation in Rat 6 / c - myc cells, but not the parental Rat 6 cells.	"MnSO4	19	24	Chemical"	"c - myc	64	71	Gene_or_gene_product"	"Rat 6 cells	100	111	Cell"	"[{""token"": ""MnSO4"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Chemical""}, {""token"": ""c - myc"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rat 6 cells"", ""start_span"": 100, ""end_span"": 111, ""type"": ""Cell""}]"
It is believed that the role of the E1B - 55kDa protein in transformation is to protect against p53 - dependent apoptosis by binding to and inactivating p53.	"E1B	36	39	Gene_or_gene_product"	"p53	96	99	Gene_or_gene_product"	"p53	153	156	Gene_or_gene_product"	"[{""token"": ""E1B"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}]"
Non - invasive grading of primary brain tumours: results of a comparative study between SPET with 123I - alpha - methyl tyrosine and PET with 18F - deoxyglucose.	"brain tumours	34	47	Cancer"	"123I - alpha - methyl tyrosine	98	128	Chemical"	"18F - deoxyglucose	142	160	Chemical"	"[{""token"": ""brain tumours"", ""start_span"": 34, ""end_span"": 47, ""type"": ""Cancer""}, {""token"": ""123I - alpha - methyl tyrosine"", ""start_span"": 98, ""end_span"": 128, ""type"": ""Chemical""}, {""token"": ""18F - deoxyglucose"", ""start_span"": 142, ""end_span"": 160, ""type"": ""Chemical""}]"
It was the aim of this study to compare the value of measurement of glucose metabolism with that of measurement of 123I - IMT uptake for the non - invasive grading of brain tumours.	"glucose	68	75	Chemical"	"123I - IMT	115	125	Chemical"	"brain tumours	167	180	Cancer"	"[{""token"": ""glucose"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Chemical""}, {""token"": ""123I - IMT"", ""start_span"": 115, ""end_span"": 125, ""type"": ""Chemical""}, {""token"": ""brain tumours"", ""start_span"": 167, ""end_span"": 180, ""type"": ""Cancer""}]"
18F - FDG and 123I - IMT uptake was quantified as ratios between the uptake by the tumour and contralateral regions of reference.	"18F - FDG	0	9	Chemical"	"123I - IMT	14	24	Chemical"	"tumour	83	89	Cancer"	"[{""token"": ""18F - FDG"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical""}, {""token"": ""123I - IMT"", ""start_span"": 14, ""end_span"": 24, ""type"": ""Chemical""}, {""token"": ""tumour"", ""start_span"": 83, ""end_span"": 89, ""type"": ""Cancer""}]"
Glucose metabolism and amino acid uptake of the brain tumours correlated significantly ( r = 0. 71, P < 0. 001).	"Glucose	0	7	Chemical"	"amino acid	23	33	Amino_acid"	"brain tumours	48	61	Cancer"	"[{""token"": ""Glucose"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""amino acid"", ""start_span"": 23, ""end_span"": 33, ""type"": ""Amino_acid""}, {""token"": ""brain tumours"", ""start_span"": 48, ""end_span"": 61, ""type"": ""Cancer""}]"
It is concluded that there is no major difference between the PET investigation of glucose metabolism and the less expensive SPET measurement of amino acid uptake in terms of their accuracy in evaluating the malignancy grade of primary brain tumours.	"glucose	83	90	Chemical"	"amino acid	145	155	Amino_acid"	"brain tumours	236	249	Cancer"	"[{""token"": ""glucose"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Chemical""}, {""token"": ""amino acid"", ""start_span"": 145, ""end_span"": 155, ""type"": ""Amino_acid""}, {""token"": ""brain tumours"", ""start_span"": 236, ""end_span"": 249, ""type"": ""Cancer""}]"
This encourages the performance of further studies to analyse the potential impact of 123I - IMT SPET on the therapeutic management of patients with brain tumours.	"123I - IMT	86	96	Chemical"	"patients	135	143	Organism"	"brain tumours	149	162	Cancer"	"[{""token"": ""123I - IMT"", ""start_span"": 86, ""end_span"": 96, ""type"": ""Chemical""}, {""token"": ""patients"", ""start_span"": 135, ""end_span"": 143, ""type"": ""Organism""}, {""token"": ""brain tumours"", ""start_span"": 149, ""end_span"": 162, ""type"": ""Cancer""}]"
The Wilms tumor suppressor gene WT1 induces G1 arrest and apoptosis in myeloblastic leukemia M1 cells.	"Wilms tumor	4	15	Cancer"	"WT1	32	35	Gene_or_gene_product"	"myeloblastic leukemia M1 cells	71	101	Cell"	"[{""token"": ""Wilms tumor"", ""start_span"": 4, ""end_span"": 15, ""type"": ""Cancer""}, {""token"": ""WT1"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""myeloblastic leukemia M1 cells"", ""start_span"": 71, ""end_span"": 101, ""type"": ""Cell""}]"
WT1 was isolated as a tumor suppressor gene of Wilms tumor.	"WT1	0	3	Gene_or_gene_product"	"tumor	22	27	Cancer"	"Wilms tumor	47	58	Cancer"	"[{""token"": ""WT1"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Cancer""}, {""token"": ""Wilms tumor"", ""start_span"": 47, ""end_span"": 58, ""type"": ""Cancer""}]"
[ Expression of metastasis suppressor gene nm23 in human hepatocellular carcinoma].	"nm23	43	47	Gene_or_gene_product"	"human	51	56	Organism"	"hepatocellular carcinoma	57	81	Cancer"	"[{""token"": ""nm23"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Organism""}, {""token"": ""hepatocellular carcinoma"", ""start_span"": 57, ""end_span"": 81, ""type"": ""Cancer""}]"
CD56 + putative natural killer cell lymphomas: production of cytolytic effectors and related proteins mediating tumor cell apoptosis?	"CD56	0	4	Gene_or_gene_product"	"natural killer cell lymphomas	16	45	Cancer"	"tumor cell	112	122	Cell"	"[{""token"": ""CD56"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""natural killer cell lymphomas"", ""start_span"": 16, ""end_span"": 45, ""type"": ""Cancer""}, {""token"": ""tumor cell"", ""start_span"": 112, ""end_span"": 122, ""type"": ""Cell""}]"
This study was aimed to investigate whether there is selective expression of these cytolytic markers in the putative NK - cell lymphomas and whether there is correlation with zonal tumor cell death in these tumors.	"NK - cell lymphomas	117	136	Cancer"	"tumor cell	181	191	Cell"	"tumors	207	213	Cancer"	"[{""token"": ""NK - cell lymphomas"", ""start_span"": 117, ""end_span"": 136, ""type"": ""Cancer""}, {""token"": ""tumor cell"", ""start_span"": 181, ""end_span"": 191, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 207, ""end_span"": 213, ""type"": ""Cancer""}]"
There was strong correlation between percentage perforin - positive cells and zonal tumor cell death.	"perforin	48	56	Gene_or_gene_product"	"cells	68	73	Cell"	"zonal tumor cell	78	94	Cell"	"[{""token"": ""perforin"", ""start_span"": 48, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 68, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""zonal tumor cell"", ""start_span"": 78, ""end_span"": 94, ""type"": ""Cell""}]"
Prophylactic thyroidectomy in MEN IIA: does the calcitonin level correlate with tumor spread?	"MEN IIA	30	37	Cancer"	"calcitonin	48	58	Gene_or_gene_product"	"tumor	80	85	Cancer"	"[{""token"": ""MEN IIA"", ""start_span"": 30, ""end_span"": 37, ""type"": ""Cancer""}, {""token"": ""calcitonin"", ""start_span"": 48, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Cancer""}]"
One 9 - year - old boy with bilateral microcarcinoma already had a lymph node metastasis.	"boy	19	22	Organism"	"microcarcinoma	38	52	Cancer"	"lymph node	67	77	Multi"	"[{""token"": ""boy"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Organism""}, {""token"": ""microcarcinoma"", ""start_span"": 38, ""end_span"": 52, ""type"": ""Cancer""}, {""token"": ""lymph node"", ""start_span"": 67, ""end_span"": 77, ""type"": ""Multi""}]"
The mean baseline calcitonin level correlated with the histologic findings ( r = 0. 71, P = 0. 003) but there was no correlation between pentagastrin - stimulated calcitonin levels and histology ( r = 0. 21, P = 0. 47).	"calcitonin	18	28	Gene_or_gene_product"	"pentagastrin	137	149	Chemical"	"calcitonin	163	173	Gene_or_gene_product"	"[{""token"": ""calcitonin"", ""start_span"": 18, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""pentagastrin"", ""start_span"": 137, ""end_span"": 149, ""type"": ""Chemical""}, {""token"": ""calcitonin"", ""start_span"": 163, ""end_span"": 173, ""type"": ""Gene_or_gene_product""}]"
Ets - 1, a transcription factor, is induced in endothelial cells ( ECs) during angiogenesis.	"Ets - 1	0	7	Gene_or_gene_product"	"endothelial cells	47	64	Cell"	"ECs	67	70	Cell"	"[{""token"": ""Ets - 1"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 47, ""end_span"": 64, ""type"": ""Cell""}, {""token"": ""ECs"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Cell""}]"
An immunohistochemical analysis revealed that Ets - 1 accumulated in migrating cells at the wound edge and returned to basal level when reendothelialization was accomplished.	"Ets - 1	46	53	Gene_or_gene_product"	"migrating cells	69	84	Cell"	"wound edge	92	102	Pathological_formation"	"[{""token"": ""Ets - 1"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""migrating cells"", ""start_span"": 69, ""end_span"": 84, ""type"": ""Cell""}, {""token"": ""wound edge"", ""start_span"": 92, ""end_span"": 102, ""type"": ""Pathological_formation""}]"
This induction of Ets - 1 could be reproduced in in vivo denudation of rat aortic endothelium by a balloon catheter.	"Ets - 1	18	25	Gene_or_gene_product"	"rat	71	74	Organism"	"aortic endothelium	75	93	Tissue"	"[{""token"": ""Ets - 1"", ""start_span"": 18, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""rat"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Organism""}, {""token"": ""aortic endothelium"", ""start_span"": 75, ""end_span"": 93, ""type"": ""Tissue""}]"
These results indicate that Ets - 1 is induced in ECs after denudation through activation of p38.	"Ets - 1	28	35	Gene_or_gene_product"	"ECs	50	53	Cell"	"p38	93	96	Gene_or_gene_product"	"[{""token"": ""Ets - 1"", ""start_span"": 28, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""ECs"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Cell""}, {""token"": ""p38"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}]"
SV40 Tag transformation of the normal invasive trophoblast results in a premalignant phenotype.	"SV40	0	4	Organism"	"Tag	5	8	Gene_or_gene_product"	"trophoblast	47	58	Cell"	"[{""token"": ""SV40"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Organism""}, {""token"": ""Tag"", ""start_span"": 5, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""trophoblast"", ""start_span"": 47, ""end_span"": 58, ""type"": ""Cell""}]"
Invasion of the uterus by first trimester human placental extravillous trophoblast ( EVT) cells depends on mechanisms shared by malignant cells.	"uterus	16	22	Organ"	"human	42	47	Organism"	"malignant cells	128	143	Cell"	"[{""token"": ""uterus"", ""start_span"": 16, ""end_span"": 22, ""type"": ""Organ""}, {""token"": ""human"", ""start_span"": 42, ""end_span"": 47, ""type"": ""Organism""}, {""token"": ""malignant cells"", ""start_span"": 128, ""end_span"": 143, ""type"": ""Cell""}]"
However, unlike tumor invasion, trophoblast invasion of the uterus is stringently controlled in situ by local molecules such as transforming growth factor ( TGF) beta.	"tumor	16	21	Cancer"	"trophoblast	32	43	Cell"	"uterus	60	66	Organ"	"[{""token"": ""tumor"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Cancer""}, {""token"": ""trophoblast"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Cell""}, {""token"": ""uterus"", ""start_span"": 60, ""end_span"": 66, ""type"": ""Organ""}]"
Since EVT cells possess active invasion - associated genes but are nontumorigenic, our objective was to induce premalignant and then malignant phenotype into a normal EVT cell line in order to identify the molecular basis of tumor progression.	"EVT cells	6	15	Cell"	"EVT cell line	167	180	Cell"	"tumor	225	230	Cancer"	"[{""token"": ""EVT cells"", ""start_span"": 6, ""end_span"": 15, ""type"": ""Cell""}, {""token"": ""EVT cell line"", ""start_span"": 167, ""end_span"": 180, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 225, ""end_span"": 230, ""type"": ""Cancer""}]"
A long - lived line, RSVT - 2, was produced and an immortalized subclone, RSVT2 / C, was further derived under a forced crisis regimen.	"line	15	19	Cell"	"RSVT - 2	21	29	Cell"	"RSVT2 / C	74	83	Cell"	"[{""token"": ""line"", ""start_span"": 15, ""end_span"": 19, ""type"": ""Cell""}, {""token"": ""RSVT - 2"", ""start_span"": 21, ""end_span"": 29, ""type"": ""Cell""}, {""token"": ""RSVT2 / C"", ""start_span"": 74, ""end_span"": 83, ""type"": ""Cell""}]"
RSVT - 2 and RSVT2 / C cell lines were hyperproliferative and hyperinvasive when compared with the parental HTR8 cell line.	"RSVT - 2	0	8	Cell"	"RSVT2 / C cell lines	13	33	Cell"	"HTR8 cell line	108	122	Cell"	"[{""token"": ""RSVT - 2"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Cell""}, {""token"": ""RSVT2 / C cell lines"", ""start_span"": 13, ""end_span"": 33, ""type"": ""Cell""}, {""token"": ""HTR8 cell line"", ""start_span"": 108, ""end_span"": 122, ""type"": ""Cell""}]"
Both cell lines showed reduced expression of tissue inhibitor of metalloproteases ( TIMP) - 1, while TIMP - 2 and plasminogen activator inhibitor ( PAI) - I expression was was also reduced in RSVT2 / C cells, thus contributing to their hyperinvasiveness.	"cell lines	5	15	Cell"	"TIMP - 2	101	109	Gene_or_gene_product"	"RSVT2 / C cells	192	207	Cell"	"[{""token"": ""cell lines"", ""start_span"": 5, ""end_span"": 15, ""type"": ""Cell""}, {""token"": ""TIMP - 2"", ""start_span"": 101, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""RSVT2 / C cells"", ""start_span"": 192, ""end_span"": 207, ""type"": ""Cell""}]"
A low - Km, mitochondrial type II - like tumor HK is described as the predominant form in hepatomas.	"mitochondrial	12	25	Cellular_component"	"type II - like tumor HK	26	49	Gene_or_gene_product"	"hepatomas	90	99	Cancer"	"[{""token"": ""mitochondrial"", ""start_span"": 12, ""end_span"": 25, ""type"": ""Cellular_component""}, {""token"": ""type II - like tumor HK"", ""start_span"": 26, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""hepatomas"", ""start_span"": 90, ""end_span"": 99, ""type"": ""Cancer""}]"
Highly sensitive reverse - transcription polymerase chain reaction identifies an induction and overexpression of a type II - like tumor HK RNA in a range of cancer cell lines irrespective of tissue origin.	"type II - like tumor HK	115	138	Gene_or_gene_product"	"cancer cell lines	157	174	Cell"	"tissue	191	197	Tissue"	"[{""token"": ""type II - like tumor HK"", ""start_span"": 115, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer cell lines"", ""start_span"": 157, ""end_span"": 174, ""type"": ""Cell""}, {""token"": ""tissue"", ""start_span"": 191, ""end_span"": 197, ""type"": ""Tissue""}]"
Homeobox genes have a strikingly conserved 61 - amino acid sequence, encoding DNA - binding domain.	"Homeobox	0	8	Gene_or_gene_product"	"amino acid	48	58	Amino_acid"	"DNA	78	81	Cellular_component"	"[{""token"": ""Homeobox"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""amino acid"", ""start_span"": 48, ""end_span"": 58, ""type"": ""Amino_acid""}, {""token"": ""DNA"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Cellular_component""}]"
There are examples of the aberrant expression of a homeobox gene causing leukemias in humans.	"homeobox	51	59	Gene_or_gene_product"	"leukemias	73	82	Cancer"	"humans	86	92	Organism"	"[{""token"": ""homeobox"", ""start_span"": 51, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""leukemias"", ""start_span"": 73, ""end_span"": 82, ""type"": ""Cancer""}, {""token"": ""humans"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Organism""}]"
In acute myeloid leukemia ( AML) with t ( 7; 11) translocation, the HOX A9 gene is rearranged.	"acute myeloid leukemia	3	25	Cancer"	"AML	28	31	Cancer"	"HOX A9	68	74	Gene_or_gene_product"	"[{""token"": ""acute myeloid leukemia"", ""start_span"": 3, ""end_span"": 25, ""type"": ""Cancer""}, {""token"": ""AML"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Cancer""}, {""token"": ""HOX A9"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}]"
In this review article, many functions of homeobox genes both at the early stem cell level as well as at the later stages of hematopoietic differentiation, and the leukemogenic effect of altered homeobox genes are discussed.	"homeobox	42	50	Gene_or_gene_product"	"stem cell	75	84	Cell"	"homeobox	195	203	Gene_or_gene_product"	"[{""token"": ""homeobox"", ""start_span"": 42, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""stem cell"", ""start_span"": 75, ""end_span"": 84, ""type"": ""Cell""}, {""token"": ""homeobox"", ""start_span"": 195, ""end_span"": 203, ""type"": ""Gene_or_gene_product""}]"
Store - operated calcium entry promotes shape change in pulmonary endothelial cells expressing Trp1.	"calcium	17	24	Chemical"	"pulmonary endothelial cells	56	83	Cell"	"Trp1	95	99	Gene_or_gene_product"	"[{""token"": ""calcium"", ""start_span"": 17, ""end_span"": 24, ""type"": ""Chemical""}, {""token"": ""pulmonary endothelial cells"", ""start_span"": 56, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""Trp1"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}]"
They were consistent with the concept of the existence of 2 pools of both lactate and pyruvate, of which 1 pool was closely connected with exogenous lactate and oxidative metabolism, and the other pool was closely related to glycolysis and disconnected from oxidative metabolism.	"lactate	74	81	Chemical"	"pyruvate	86	94	Chemical"	"lactate	149	156	Chemical"	"[{""token"": ""lactate"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Chemical""}, {""token"": ""pyruvate"", ""start_span"": 86, ""end_span"": 94, ""type"": ""Chemical""}, {""token"": ""lactate"", ""start_span"": 149, ""end_span"": 156, ""type"": ""Chemical""}]"
This demonstrates that RPE tumor cells metastasize to lymph node and spleen.	"RPE tumor cells	23	38	Cell"	"lymph node	54	64	Multi"	"spleen	69	75	Organ"	"[{""token"": ""RPE tumor cells"", ""start_span"": 23, ""end_span"": 38, ""type"": ""Cell""}, {""token"": ""lymph node"", ""start_span"": 54, ""end_span"": 64, ""type"": ""Multi""}, {""token"": ""spleen"", ""start_span"": 69, ""end_span"": 75, ""type"": ""Organ""}]"
RESULTS: U - 995 ( 15 and 30 micrograms / ml) markedly inhibited HUVEC migration and, at 15 - 50 micrograms / ml produced a dose - dependent decline in [ 3H] - thymidine incorporation.	"U - 995	9	16	Gene_or_gene_product"	"HUVEC	65	70	Cell"	"thymidine	160	169	Chemical"	"[{""token"": ""U - 995"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""HUVEC"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Cell""}, {""token"": ""thymidine"", ""start_span"": 160, ""end_span"": 169, ""type"": ""Chemical""}]"
30 and 50 micrograms / ml of U - 995, when added to TNF alpha - induced angiogenesis caused discontinuous and disrupted blood vessels.	"U - 995	29	36	Gene_or_gene_product"	"TNF alpha	52	61	Gene_or_gene_product"	"blood vessels	120	133	Multi"	"[{""token"": ""U - 995"", ""start_span"": 29, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""TNF alpha"", ""start_span"": 52, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""blood vessels"", ""start_span"": 120, ""end_span"": 133, ""type"": ""Multi""}]"
